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Abstract 
Specification of a germ cell lineage and appropriate maturation are essential for the 
transfer of genetic information from one generation to the next. Germ cells form 
from pluripotent precursor cells that migrate into the gonadal ridge and undergo 
commitment to either the female or male lineage. In the fetal ovary, germ cells enter 
meiotic prophase I, then arrest at the diplotene stage; in the testis germ cells do not 
begin meiosis until puberty. Abnormal differentiation of germ cells can result in 
malignant transformation. Somatic cells play a key role in modulating the 
developmental fate of the germ cells. Research into germ cell development during 
fetal life has almost exclusively focused on studies in rodents, but we, and others, 
have reported several fundamental differences in the expression of germ cell specific 
markers in the human compared with the mouse. The studies described in this thesis 
have investigated germ cell-specific gene expression and the possible impact of the 
somatic cells during development. This was achieved by studying human fetal 
gonads obtained during the 1st and 2nd trimesters of pregnancy and through the use of 
both wild-type and mutant mouse ES cell lines. 
 
Studies on germ cells in the human fetal testis have extended the findings of others, 
and confirmed that germ cell populations at different stages of maturation co-exist in 
the human fetal testis, a situation that is in contrast to that in rodents.  For example 
expression of M2A and AP2γ was restricted to the OCT4-positive gonocyte 
population, while VASA and NANOS1 were localised exclusively to the to the 
OCT4-negative prespermatogonia. DAZL was expressed in both populations. 
Analysis also revealed that both the gonocyte and prespermatogonial populations 
proliferate throughout the 2nd trimester.  Recent studies have implicated retinoic acid 
(RA) in the control of meiotic entry in germ cells of the fetal mouse ovary. In this 
study we demonstrated for the first time that two genes implicated in the action of 
RA in mouse gonad, STRA8 and NANOS2, are also expressed in a similar sex-
specific-manner in the human fetal gonads, and that the RA receptors are present in 
both somatic and germ cells suggesting that RA may regulate germ cell function in 
the human as well as the mouse. However, whilst the mesonephros appears to be the 
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primary site of RA synthesis in the mouse our initial studies indicate that in the 
human the gonad itself may be a more likely site of RA biosynthesis. In the fetal 
mouse testis, RA is degraded by the enzyme Cyp26b1 present in the somatic cells 
and germ cells do not enter meiosis, our novel findings suggest that CYP26B1 is 
more abundant in the human fetal ovary than the testis, suggesting that meiotic entry 
may be controlled by an alternative signalling pathway in the human.    
 
One of the methods that can aid our understanding of somatic cell gene expression in 
the gonad is in vitro culture. To date, there have been no published reports of the 
successful in vitro culture of somatic cells from the human fetal testis. In the current 
study, populations of human somatic cells were dissociated and maintained in vitro 
and characterised. Analysis demonstrated that cells expressing mRNAs characteristic 
of Sertoli cells, Leydig cells and peritubular myoid (PTM) cells were present 
initially, but long-term culture resulted in downregulation in expression of mRNAs 
specific for Sertoli cells and Leydig cells, suggesting that these cells either failed to 
survive or underwent alterations to their phenotype. In contrast PTM/fibroblast cells 
proliferated in vitro and initially maintained androgen receptor expression. These 
cultures therefore hold promise for studies into the signalling or cell-cell interactions 
in testicular somatic cells especially those relevant to the PTM population.   
 
Several studies have claimed differentiation of putative germ cells from ES cells. In 
the current study, analysis of mouse ES cell lines has expanded on results showing 
that ES cells and early germ cells express a number of genes in common. Kit 
signalling was shown to be important for ES cell survival as they differentiate 
although expression of Kit was heterogeneous.  We also demonstrated that ES cells 
that did not express Kit displayed a decreased expression of the early germ cell 
genes Blimp1, Fragilis and Stella, implicating Kit signalling in the control of germ 
cell-associated gene expression in ES cells. This may be important to future studies 
optimising germ cell derivation from ES cells. 
In conclusion, this study has demonstrated important differences in protein 
expression patterns in germ cells of the human fetal testis compared to the mouse, 
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and has raised questions about whether the proposed mechanism controlling meiotic 
entry of germ cells in the mouse can be applied to the human.  The establishment of 
a system for culturing human fetal gonadal somatic cells may lead to further 
understanding of gene expression and development in the human fetal testis, and 
data suggest that the Kit/Kitl signalling system may influence germ cell gene 
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Definition 
3βHSD 3-β-hydroxysteroid dehydrogenase 
ACTR IIB activin receptor IIB 
ACTRIIA activin receptor IIA 
ALDH1A2 aldehyde dehydrogenase 1 family, member A2    
ALDH1A3 aldehyde dehydrogenase 1 family, member A3    
ALK2 cytochrome P450 alkane hydroxylase 2 
ALK4 cytochrome P450 alkane hydroxylase 4 
AMH anti-Mullerian hormone 
Ap2γ activating enhancer binding protein 2 γ   
AR androgen receptor 
Blimp1 B-lymphocyte induced maturation protein 1 
CIS carcinoma in situ 
CYP26A1 cytochrome p45026A1 
CYP26B1 cytochrome p45026B1 
CYP26C1 cytochrome p45026A1 
DAB 3,3'-diaminobenzidine 
DES desmin 
DHH desert hedgehog 
e embryonic day 
ES embryonic stem 
GATA4 GATA-binding factor 4, 
GFP green fluorescent protein 




human fetal testis 
   ix
ICM inner cell mass 
Kit proto-oncogene tyrosine-protein kinase receptor 
Kitl Kit ligand 
LNA locked nucleic acid 
Mvh mouse vasa homologue 
OCT4 octamer-binding transcription factor 4 
p passage 
PGC primordial germ cell 
PTM peritubular myoid cell 
RA retinoic acid 
RAR retinoic acid receptor 
RXR retinoid X receptor 
SCCp450 
sem 
side chain cleavage p450 
standard error of the mean 
SF1 steroidogenic factor 1 
SMAD2 mothers against DPP homolog 2 
SOX2 SRY-box2 
SOX9 SRY-box 9 
SRY sex-determining region of the Y chromosome 
STRA8 stimulated by retinoic acid gene 8 
TBS tris buffered saline solution 
TGCT testicular germ cell tumours 
VIM vimentin 
WT wild-type 
WT1 Wilms tumour 1 
α-SMA α -smooth muscle actin 
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1 Literature Review 
1.1 General Introduction   
During fetal development, the genital ridges appear as a thickening of the 
intermediate mesoderm (Wartenberg, 1981).  Primordial germ cells (PGCs) arise 
from the proximal epiblast as a result of extraembryonic signals (Lawson and Hage, 
1994) and migrate into the gonad by e10.5 in the mouse and five weeks gestation in 
the human, as dated from last menstrual period (Wartenberg, 1981).  In the ovary 
nests of syncytial germ cells form that are linked by cytoplasmic bridges (McNatty et 
al., 2000), these cells enter meiosis and arrest at the diplotene stage of the first 
meiotic division (McLaren and Southee, 1997) at which time primordial follicles are 
formed (Hirshfield, 1992).  In the male gonad, the germ cells become enclosed 
within the testicular cords and proliferate but do not enter meiosis until puberty.  The 
somatic cells are thought to play an important role in germ cell maturation.  Recent 
studies in the mouse suggest that retinoic acid (RA) induces germ cells in the female 
to enter meiosis, while the expression in the testis cords of the RA metabolising 
enzyme Cyp26b1 inhibits this in the male (Bowles and Koopman, 2007).  The 
majority of studies on mammalian germ cell development have focused on the 
mouse.  However, previous work in our laboratory has shown that in the second 
trimester human fetal testis, germ cells are morphologically distinct and can be 
categorised into OCT4-positive gonocytes and OCT4-negative prespermatogonia 
(Gaskell et al., 2004).  This is in contrast to the situation in the rodent testis where 
germ cells are homogenous.  The primary aim of this thesis was to further understand 
germ cell development and the influence of the somatic cells in the human fetal 
gonad.  These studies have used human gonads obtained following elective 
termination of pregnancy during the 1st and 2nd trimester.  This thesis also aimed to 
understand germ cell gene expression in mouse embryonic stem (ES) cells, using 
wild-type and mutant cells. 
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1.2 Development of gonadal somatic cells  
1.2.1 Morphological development  
As the gonad develops, it is initially ‘bipotential’, with the ability to form either 
ovaries or testes.  The mammalian gonad forms within the urogenital ridge, where it 
appears as a thickening of the intermediate mesoderm, situated on the ventromedial 
side of the mesonephros at e10.5 in the mouse (McLaren, 1991a), and 4 weeks 
gestation in the human (Wartenberg, 1981) (Figure 1-1a).  The gonad forms through 
proliferation of the coelomic epithelium within the medio-lateral side of the 
mesonephros (Wartenberg, 1981) (Figure 1-1b). 
 
Sexual differentiation begins at e10.5 in the mouse and 6 weeks gestation in the 
human (McLaren, 1991b) (Wartenberg, 1981; Wartenberg, 1982).  As the testis 
develops, cell proliferation increases within the  coelomic epithelium between e11.3 
and e12.1 in the mouse (Schmahl et al., 2000), and between 6-8 weeks gestation in 
the human (Wartenberg, 1981)(Figure 1-1c).  In males, the somatic Sertoli cells are 
thought to arise from the coelomic epithelium (Karl and Capel, 1998).  As they 
differentiate, they polarize and aggregate around the germ cells, which have migrated 
into the developing gonad by e11.5 in the mouse and week 5 of gestation in the 
human (Wartenberg, 1981) (refer to section 1.3.1).   
 
Development of the testis is driven by the Sertoli cells, once the Sertoli cells have 
differentiated, other bipotential cell types of the gonad are committed to the male 
pathway (McLaren and Southee, 1997).  The Sertoli cells themselves become 
surrounded by the peritubular myoid cells (PTM) cells, which form a single flat cell 
layer around the Sertoli cells allowing the male gonad to subsequently become 
organized into two distinct compartments: the testis cords, containing the germ cells 
and the Sertoli cells, and the interstitium which is located between the cords (Figure 
1-2).  Within the interstitium there are blood vessels, interstitial fibroblasts and 
Leydig cells.  The Leydig cells form clusters of cells, often situated in close 
proximity to blood vessels (O'Shaughnessy et al., 2006) (Figure 1-2).  The Leydig 
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cells are responsible for the production of androgens (Habert and Picon, 1984).  For 
normal testis development to occur, cells must migrate into the male gonad from the 
adjoining mesonephros.  Experimental studies have determined that mesonephric 
cells can develop into vascular endothelial cells, interstitial fibroblast and possibly 
PTM cells and Leydig cells (Buehr et al., 1993; Merchant-Larios and Moreno-
Mendoza, 1998; Merchant-Larios et al., 1993; Nishino et al., 2001). 
 
Migrating endothelial cells associate to establish the male-specific coelomic vessel 
(Figure 1-2) which increases blood flow through the developing testis, and is thought 
to be important for the efficient export of androgens (Brennan et al., 2002). 
 
In the developing female gonad, the surface epithelium continues to proliferate, 
forming the cortical sex cords (Figure 1-1e).  The germ cells are found closer to the 
surface of the gonad than the male and the cortical sex cords break up, and form 
clusters, each surrounding a single germ cell (Figure 1-1f).  The cortical sex cords 
will differentiate into the granulosa cells, while the surrounding mesenchymal cells 
differentiate into the thecal cells (Konishi et al., 1986; Gilbert, 2003; McLaren, 
1991a).  The thecal cells and granulosa cells will together form the follicles. 
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Figure 1-1 Summary of the differentiation of the human gonads shown in transverse 
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Figure 1-2 Structural organisation of the fetal testis at e12.5, from Brennan and Capel, 
2004 (GC=germ cell, S=Sertoli cells, L=Leydig cells, PM=peritubular myoid cells, 
I=interstitial cells, CV=coelomic vessel, TC= testicular cords ) 
 
1.2.2 Molecules controlling Sertoli cell differentiation  
1.2.2.1 SRY 
In chimeric mice formed from XX and XY embryos, Sertoli cells were found to be 
over 90% genetically male, suggesting that Sertoli cell differentiation is dependent 
upon the presence of the Y chromosome (Palmer and Burgoyne, 1991).  The gene 
responsible for sex determination is known as the sex determining region on the Y 
chromosome (Sry).  Sry is the founding member of the Sox (Sry-related high 
mobility group HMG box) family of transcription factors.  The majority of mammals 
determine their sex through Sry (Wallis et al., 2008).  Mice which are genetically 
male but do not express Sry develop an ovary and appear phenotypically female 
(Gubbay et al., 1992; Lovell-Badge and Robertson, 1990), while XX mice with a 
transgenic autosomal copy of Sry develop a testis containing Sertoli cells and Leydig 
cells, and display male secondary sex characteristics (Koopman et al., 1990).  In 
humans, SRY mutations have been shown to be responsible for 10% of sex reversal 
cases and often result in gonadal dysgenesis (Berta et al., 1990).  Almost all 
mutations in SRY resulting in sex reversal are located within the highly conserved 
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HMG box, suggesting only minor functionality for other regions of the protein 
(Wilhelm et al., 2007).  It is speculated that Sry acts through binding and bending of 
target DNA, allowing upstream and downstream factors to interact and thus enabling 
transcription (Harley et al., 1992; Giese et al., 1992; Jager et al., 1992; Harley et al., 
2003).  
 
In the mouse, Sry mRNA and protein are first detectable in the male gonad at e10.5, 
in a small number of somatic cells thought to be the pre-Sertoli cells (Albrecht and 
Eicher, 2001; Hacker et al., 1995).  Sry is expressed in a transient manner, where it is 
initially restricted to the centre of the gonads, but then expands to the poles, before 
being quickly downregulated, first at the anterior pole and finally at the posterior 
pole, with protein expression completely lost by e12.5 (Hacker et al., 1995; Swain 
and Lovell-Badge, 1999).  The timings of Sry are crucial for its functions, if 
expression begins too late, ovotestes are formed (Bullejos and Koopman, 2005), 
while a threshold level of Sry must be achieved for it to function efficiently (Harley 
et al., 2003).  In the human SRY expression begins in the gonadal ridge at 44 days 
post-ovulation, once the cords form.  Curiously, human SRY does not display the 
transient expression which occurs in the mouse, instead, expression is maintained 
throughout development (Hanley et al., 2000), and can even be detected in the adult 
testis (Salas-Cortes et al., 1999).   
 
1.2.2.2 SOX9  
Although the transcriptional targets of Sry have not been fully identified, one 
probable action of Sry is the upregulation of one of its family members, the Sry-like 
HMG-box protein 9 (Sox9) (Bowles et al., 2000) (Figure 1-3).  The promoter of Sox9 
contains potential Sry-binding sites, although no direct molecular interaction 
between the two has yet been demonstrated (Bishop et al., 2000; Vidal et al., 2001).  
Sox9 is initially expressed throughout the genital ridge of both the male and female, 
however after the onset of expression of Sry in the male genital ridge, Sox9 is 
dramatically upregulated by e11.5 (Kanai et al., 2005).  Experiments with mice 
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expressing a Myc-epitope tagged Sry protein have shown that Sox9 upregulation is 
exclusive to those cells expressing Sry (Sekido et al., 2004).  It is still to be 
established whether the only action of Sry is to regulate expression of Sox9 or if it 
has other downstream targets.  However, ectopic activation of Sox9 in XX embryos 
resulted in female-to-male sex reversal, suggesting that Sox9 may be the only 
important gene under Sry regulation (Bishop et al., 2000; Vidal et al., 2001).  In the 
mouse, once Sox9 has reached a threshold level, Sry expression becomes repressed, 
possibly due to a Sox9-dependent negative feedback loop (Chaboissier et al., 2004; 
Sekido et al., 2004) and expression of Sox9 is maintained in the testis thereafter 
(Morais da Silva et al., 1996).  In humans, mutations in SOX9 result in campomelic 
dysplasia, where patients have abnormalities consistent with a role for SOX9 in 
chondrogenesis (Wright et al., 1995), and the majority of male patients also display 
sex reversal (Foster et al., 1994; Wagner et al., 1994).  In the human male gonad, 
SOX9 expression follows a similar pattern to that of SRY (Hanley et al., 2000).  
Interestingly, SOX9 transcripts have also been detected in the human fetal ovary after 
sex determination has occurred, despite being absent in the mouse ovary (Hanley et 
al., 2000). 
 
Although the evidence suggests that Sox9 is under the control of Sry, experiments 
have also shown that expression of Sox9 can become activated in the gonad by 
factors other than Sry.  In female mouse gonads lacking both oestrogen receptors, 
ERα and ERβ, sex reversal occurs postnatally, with granulosa cells upregulating 
Sox9 and apparently undergoing transdifferentiation into Sertoli cells (Couse and 
Korach, 1999; Dupont et al., 2003).   
 
In addition to Sry, a number of other molecules have also been implicated in Sox9 
transcriptional control.  For example, Steroidogenic factor 1 (Sf1) is an orphan 
nuclear receptor which is involved in the transcriptional regulation of genes encoding 
a number of steroidogenic enzymes in both the gonad and adrenal gland (Lala et al., 
1992; Luo et al., 1994; Parker and Schimmer, 1997).  Recent evidence suggests that 
both Sf1 and Sry bind to multiple elements within a gonad-specific enhancer on the 
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Sox9 gene.  It appears that Sry and Sf1 can act together to upregulate Sox9, and in the 
mouse after Sry expression is lost, Sf1 and Sox9 cooperatively bind to the Sox9 
enhancer, allowing Sox9 expression to be maintained after Sry expression is lost, 
implicating Sox9 in the autoregulation of its own expression (Sekido and Lovell-
Badge, 2008).   
 
In the absence of Sry, Wilms Tumour 1 (WT1) may also act to control Sox9 
transcription.  Wt1 is a zinc finger containing DNA binding protein which exists in 
multiple splice isoforms and can enhance or repress transcription (Hohenstein and 
Hastie, 2006; Yang et al., 2007).  When Wt1 is knocked-out specifically in Sertoli 
cells, although Sox9 is initially expressed, it becomes downregulated after Sry 
switches off, suggesting that in the absence of Wt1, Sox9 cannot be maintained, after 
Sry is downregulated (Gao et al., 2006).    
 
Also implicated in the control of Sox9 transcription is Gata4, a member of the Gata 
family of zinc finger proteins (Arceci et al., 1993; Tevosian et al., 2002; Viger et al., 
2008).  Gata4 is expressed in all somatic cells of the mouse testis, and is reported to 
be expressed at high levels in Sertoli cells by e11.5 (Viger et al., 1998).  In mice, a 
mutation in the co-factor for Gata4,  the so called Friend of Gata 2 (Fog2) (Tevosian 
et al., 2002)  or a Gata4 knock-in mutation (Crispino et al., 2001), which inhibits the 
interaction of Gata4 and Fog2,  both result in identical phenotypes, with impaired 
cell proliferation, and defective Sertoli cell and Leydig cell development.  In these 
two mutants, Sox9 levels are undetectable.  Recently a Gata4/Fog2 transcriptional 
complex has been shown to be required for the transcription of Sox9 (Manuylov et 
al., 2007).   
 
In the mouse, twelve hours after the upregulation of Sox9, another of the Sox gene 
family members, Sox8 is also expressed specifically in the Sertoli cells.  Sox8 has 
been shown to perform a number of similar molecular roles to Sox9 (Schepers et al., 
2003) but studies now suggest that it is functionally redundant (Chaboissier et al., 
2004). 
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The cellular localisation of Sox9 appears to have important implications for its 
function.  Initially Sox9 is detected in the cytoplasm of the undifferentiated gonad, 
but upon expression of Sry, the protein is phosphorylated and translocates to the 
nuclear compartment.  The active transport of Sox9 across the nuclear membrane 
appears to be mediated by nuclear localisation signals contained within Sox9, for 
example, the C-terminal of Sox9 has been shown to bind importin β (Sudbeck and 
Scherer, 1997).  When bound with importin β, Sox9 can interact with Ran-binding 
protein 2 (RanBP2), which mediates the nuclear translocation of importin β bound 
proteins (Stewart, 2007).  Additionally, in vitro studies have shown that the N-
terminal nuclear localisation signal of Sox9 is capable of binding calmodulin (Harley 
et al., 1996; Argentaro et al., 2003), which acts to facilitate the transportation of 
target proteins through the nuclear pore complex (Sweitzer and Hanover, 1996).  
Some Sox9 XY sex reversal mutations display reduced binding to calmodulin, 
suggesting that this function may be necessary for sex determination (Sim et al., 
2005).  
 
In the female, Sox9 remains cytoplasmic, and expression is rapidly downregulated 
(Morais da Silva et al., 1996).  Studies in the mouse suggest that in the female, the 
intracellular location of Sox9 is also important.  For example, the Sox9 HMG box 
contains a nuclear export signal, which allows it to exit the nucleus, and inhibition of 
this in cultured XX mouse gonads results in female-to-male sex reversal (Gasca et 
al., 2002).   
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Figure 1-3 Summary of the molecular control of gonadal development. From Sim et al., 
2008 
 
1.2.2.3 Paracrine signalling mechanisms controlling Sertoli cell      
development 
Studies have shown that in an XX/XY chimeric mouse, 90% of the cells which form 
Sertoli cells are XY, consistent with evidence that commitment to the Sertoli cell 
lineage is critically dependent on expression of Sry (Palmer and Burgoyne, 1991; 
Wilhelm et al., 2005).  However, as approximately 10% of the Sertoli cells in the 
chimeric mouse are XX, this suggests that a possible paracrine signalling system may 
be actively recruiting XX cells or cells that have not upregulated Sry into the Sertoli 
cell lineage.  Candidate molecules involved in paracrine signalling at the time of sex 
determination are discussed below. 
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1.2.2.3.1 Prostaglandin D2 
Prostaglandin D2 (PGD2) is a paracrine signalling molecule that is produced by the 
enzyme prostaglandin D synthase (Urade and Hayaishi, 2000).  Studies suggest that 
PGD2 may act by inducing Sox9 nuclear translocation and subsequent Sertoli cell 
differentiation (Figure 1-4).  Expression of prostaglandin D synthase was found to be 
highly upregulated in the male gonad at the time when sex determination is 
occurring, from e11.5 in both the Sertoli cells and the germ cells (Adams and 
McLaren, 2002; Malki et al., 2005).  When XX gonads in vitro were treated with 
PGD2, they underwent masculinisation, with increased expression of Sox9 and Amh, 
and evidence of PTM-like and Sertoli-like cells present within disorganised cord-like 
structures (Adams and McLaren, 2002; Wilhelm et al., 2005).  Specificity was 
demonstrated by using an antagonist to the PGD2 receptor, prostaglandin DP 
receptor (Wilhelm et al., 2005) and in vitro PGD2 treatment induced Sox9 nuclear 
translocation (Malki et al., 2005).  PGD2 may therefore have a role in vivo during 
testis development to recruit supporting cells into the male lineage (Malki et al., 
2005).  A paired Sox9/Sry binding site has been identified on the prostaglandin D 
synthase  promoter, and there is functional evidence that Sox9, transactivates this 
promoter (Wilhelm et al., 2007).  Mice lacking prostaglandin D synthase or the 
prostaglandin DP receptor display a normal gonadal phenotype, however this could 
reflect a degree of redundancy, as other prostaglandin synthases and receptors are 







Chapter 1 Literature Review 12 
 
 
Figure 1-4. Summary diagram showing the role that PGD2 could have in the control of 
Sox9 in the mouse testis, from Wilhelm et al., 2007. 1) SRY induces the expression of 
Sox9. 2) Sox9 maintains its own expression in an auto regulatory loop 3) Sox9 
upregulates prostaglandin D2 synthase  (PGDS) 4) This leads to the expression of 
prostaglandin D2 and its secretion 5) Prostaglandin D2 binds to the DP receptor 6) 
This acts to upregulate Sox9 in either a paracrine or autocrine manner.  
1.2.2.3.2 Fibroblast growth factor 9 (FGF9) 
Fibroblast growth factor 9 (FGF9), is a member of a large family of growth factors, 
important for a number of developmental processes (Ornitz and Itoh, 2001).  A role 
for Fgf9  in sex determination was highlighted after Fgf9 homozygous null mice 
were found to display a range of sex reversal phenotypes, ranging from abnormal 
testis development to complete sex reversal (Colvin et al., 2001).  Fgf9 can be 
detected at e11.5 in gonads of both sexes, but later becomes restricted to the testis 
cords of the XY gonad (Schmahl et al., 2004).  Fgf9 may therefore play a role in 
Sertoli cell induction, proliferation and differentiation and may stimulate the 
expression of Sox9.  In Fgf9 mutant mice, Sry and Sox9 are initially expressed as 
normal, but expression of Sox9 is not maintained, and there is increased expression 
of female specific genes.  Further evidence comes from in vitro studies where Fgf9 
Chapter 1 Literature Review 13 
induces Sox9 expression in XX somatic cells (DiNapoli et al., 2006; Kim et al., 
2006), and similar results have been found in cell lines (Schaefer et al., 2003).   
 
The actions of Fgf9 may be mediated by binding to the Fgf receptor 2 (Fgfr2), which 
is highly expressed in a male-specific manner, on the membrane of actively 
proliferating coelomic epithelial cells and the nucleus of pre-Sertoli cells (Schmahl et 
al., 2004).  Mouse conditional knock-outs of Fgf2r phenocopy the Fgf9 mutants 
(Kim et al., 2007; Bagheri-Fam et al., 2008).   
 
1.2.2.3.3 FGF9 and WNT4 functional antagonism  
In female mice with disrupted Wnt4 signalling, expression of ‘testis-specific’ genes 
such as Fgf9, Sox9 and Dhh is upregulated compared with controls, implicating 
Wnt4 in the repression of the male pathway (Jeays-Ward et al., 2004).  Wnt4 is 
expressed at e11 in the indifferent gonad, but by e11.5 it becomes downregulated in 
the male genital ridge, although expression is maintained in the mesonephroi of both 
sexes (Vainio et al., 1999).  Both Wnt4 and the glycoprotein follistatin appear to be 
required for early ovarian development.  Wnt4 appears to be an upstream regulator of 
follistatin (Yao et al., 2004) and both appear to inhibit endothelial cell migration and 
coelomic vessel formation, essential processes for successful testis development 
(Jordan et al., 2003).  Wnt4 may act in conjunction with R-spondin1 to antagonize 
the male pathway (Figure 1-3).  R-Spondin1 is a secreted protein implicated in the 
Wnt pathway (Blaydon et al., 2006) and mutations in the R-Spondin1 gene have been 
identified in XX patients who develop testes (Parma et al., 2006).  Both Wnt4 and R-
Spondin1 have been shown to activate the canonical Wnt pathway (Kim et al., 2006) 
resulting in stabilization of β -catenin, that acts as a cofactor for transcriptional 
activation.  A recent study has shown that ectopic expression of β -catenin in somatic 
cells of the XY gonad can block the male pathway and result in XY sex reversal 
(Maatouk et al., 2008).   
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The addition of Fgf9 to XX gonads results in a downregulation of Wnt4, implicating 
Fgf9 in the inhibition of Wnt4 signalling, while in Wnt4 mutants Fgf9 levels are 
elevated (Kim et al., 2006).  So Wnt4 and Fgf9 may antagonistically control the fate 
of the bipotential gonad.  It is hypothesised that Sry may influence the Wnt4/Fgf9 
balance, by upregulating the expression of Sox9.  Sox9 may then act to upregulate 
Fgf9, and Fgf9 then in turn maintains the expression of Sox9, and downregulates 
Wnt4 (Kim and Capel, 2006) (Figure 1-5). 
 
 
Figure 1-5 Molecular antagonism possibly controlling the fate of the developing testis, 
from Kim and Capel, 2006 
1.2.2.4 Anti-müllerian Hormone (AMH)  
Anti-müllerian hormone (AMH), also known as Müllerian inhibiting substance 
(MIS), is a glycoprotein that shares homology with the transforming growth factor β 
(TGFβ) superfamily.  AMH has been localised to the endoplasmic reticulum and 
Golgi apparatus of fetal and neonatal Sertoli cells (Tran and Josso, 1982; Hayashi et 
al., 1984).  This protein was first identified because of the critical role it plays in the 
regression of the Müllerian duct (Jost et al., 1953; Josso et al, 2002; Josso et al., 
2001;   Josso, 2008).  The protein is also expressed in the granulosa cells of the 
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mature follicle (Rajpert-De Meyts et al., 1999), where it is a useful marker in the 
follicular fluid for polycystic ovary syndrome (Cook et al., 2002). 
 
In the mouse testis, Amh expression begins around 20 hours after the onset of Sry 
expression (Hacker et al., 1995).  In mouse Sertoli cells Amh expression increases 
until e19.5, and then decreases significantly post-partum (Rey et al., 1993; Schwindt 
et al., 1997).  In the human, AMH is expressed by 8 weeks gestation (de Santa 
Barbara et al., 2000; Rajpert-De Meyts et al., 1999) and its expression declines 
during puberty, at the onset of meiosis, coincident with the time when there is a surge 
in androgens (Gaskell et al., 2004; Hirobe et al., 1992).  The mechanisms for this 
decline are still not understood as expression of AMH still decreases in the absence 
of meiotic germ cells and no direct role for androgens has been demonstrated 
(Rajpert-De Meyts et al., 1999).   
 
AMH acts upon its target cells by binding to its type II receptor present on the cell 
membrane, and then recruiting the type I receptor and activating downstream Smads  
(Rajpert-De Meyts et al., 1999; Rey et al., 2003)(refer to Figure 1-17 for a summary 
of TGFβ signalling).  The type II receptor has been localised to the mesenchymal 
cells situated adjacent to the Müllerian duct epithelium.  It has also been found to be 
expressed in the fetal testis, and postnatal Sertoli cells (di Clemente et al., 2003; 
Josso et al., 2001; Baarends et al., 1995). 
 
A number of genes controlling the transcription of AMH have now been identified 
(Figure 1-6), and these appear to be conserved  (Baarends et al., 1994; Lasala et al., 
2004; Tremblay and Viger, 1999).  For example, SOX9 has been shown to be 
required to bind to its specific response element within the AMH promoter, prior to 
AMH transcription (Arango et al., 1999), while AMH is switched on shortly after 
SOX9 translocates into the nucleus in both the mouse (Morais da Silva et al., 1996) 
and human (de Santa Barbara et al., 2000). 
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SF1 may also have an important role in controlling the expression of AMH.  Within 
the AMH promoter, two SF1 binding sites have been identified (Shen et al., 1994) 
(Arango et al., 1999), and SF1 has been shown to directly regulate AMH expression 
in vitro and in vivo (Giuili et al., 1997).  A potential role for GATA4/FOG2 binding 
within the AMH promoter has also been found.  The AMH promoter contains 2 
GATA4 binding sites and GATA4 has been shown to enhance AMH promoter 
activity by directly binding with the DNA (Viger et al., 1998).  Furthermore, one of 
the GATA4 binding sites on the AMH promoter lies adjacent to an SF1 binding site 
(Tremblay and Viger, 1999).  Through the use of reporter assays, GATA4 and SF1 
were found to be capable of direct protein-protein interaction, mediated by the zinc 
finger region of GATA4, and when co-expressed, both GATA4 and SF1 can activate 
the AMH promoter (Tremblay and Viger, 1999)  (Figure 1-6). 
 
Within the AMH promoter, WT1 has been shown to bind to a GC-rich sequence, 
possibly initiating transcription (Hossain and Saunders, 2003) (Figure 1-6 a).  WT1 
may in fact act by synergizing with SF1 and SOX9 to enhance AMH transcription 
(Hossain and Saunders, 2003).  A recent study has also shown that the regulation of 
the AMH promoter by WT1 is also enhanced by WT1/GATA4 synergism (Miyamoto 
et al., 2008).   
 
In contrast, the DAX1 protein may act to repress AMH transcription. DAX1 encodes 
a member of the nuclear hormone receptor family and is thought to act as a 
transcriptional silencer (Muscatelli et al., 1994; Zanaria et al., 1994).  DAX1 may 
repress AMH expression by disrupting GATA4/SF1 and WT1/SF1 synergisms by 
competing for direct interaction with SF1 (Nachtigal et al., 1998; Tremblay et al., 
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Figure 1-6. Molecular control of AMH expression in the human.  SOX9 binds to a 
specific response element within the AMH promoter, SF1, GATA4 and WT1 also bind 
to the AMH promoter.  GATA4/WT1 may also interact with WT1. b) DAX1 may also 
interact with SF1 and disrupt GATA4/SF1 and WT1/SF1 synergism, from Lasala et al., 
2004. 
 
1.2.3 Mesonephric cell migration 
A key process specific to the developing testis is the migration of cells from the 
mesonephros (Buehr et al., 1993;Merchant-Larios et al., 1993).  Migration occurs 
between e11.5-e16.5 in the male mouse (Martineau et al., 1997) and although, due to 
the lack of specific markers for certain cell types, it is difficult to ascertain the exact 
identity of cells that do migrate, it is speculated that endothelial, PTM and 
perivascular cells all migrate to the developing gonad (Merchant-Larios et al., 1993 
Martineau et al., 1997; Nishino et al., 2001).  Additionally, some cells that have 
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migrated into the gonad have been shown to give rise to Leydig cells (Merchant-
Larios and Moreno-Mendoza, 1998;Nishino et al., 2001).  Migration of mesonephric 
cells appears to be essential for development of the testis cords (Tilmann and Capel, 
1999) as studies have shown that if the mesonephros is cultured separately from the 
gonad or if a physical barrier is placed between the two, migration does not occur 
and the cords do not form (Buehr et al., 1993; Tilmann and Capel, 1999). 
 
What controls the migration of these cells, and the factors which make it specific to 
the male are not fully understood.  Sry has been shown to be required for the 
migration of cells from the mesonephros (Capel et al., 1999).  Furthermore, the 
culture of an XY gonad on the surface of an XX gonad resulted in the migration of 
cells from the mesonephros into the XX gonad (Tilmann and Capel, 1999), 
suggesting that a secreted molecule from the male gonad attracts these cells.  Studies 
using organ culture have shown that a number of growth factors can induce 
mesonephric migration.  For example, the addition of recombinant Amh to cultures 
containing XX gonads, induced mesonephric cell migration and the formation of the 
testis cords (Behringer et al., 1990; Bezard et al., 1987).  But since Amh deficient XY 
mice, display no abnormalities in testis cord formation, it appears that there is a 
degree of redundancy in the actions of Amh in the developing testis (Ross et al., 
2003).   Mesonephric cell migration can also be stimulated when gonadal explants 
are cultured in the presence of Fgf9 , and Fgf9 -/- mice display defective 
mesonephric cell migration into the XY gonad, although this mutant phenotype can 
at least partly be attributed to the other testis defects resulting from a lack of Fgf9 
(Colvin et al., 2001).   
 
The addition of nerve growth factor (NGF) has also been claimed to stimulate 
mesonephric migration in vitro (Cupp et al., 2000; Cupp et al., 2003).  Although 
when two of the NGF receptors TrkA and TrkC, are knocked-out, there is only minor 
disruption to the cords and slightly defective interstitial development (Cupp et al., 
2002).  Pdgfrα knock-out mice also display defects in mesonephric cell migration 
(Brennan et al., 2003), although this receptor is required in cells of the gonad, not the 
Chapter 1 Literature Review 19 
mesonephros, suggesting that the cells of the gonad may be stimulated by Pdgf to 
produce an unknown factor which then acts to stimulate migration. 
 
1.2.4 Leydig cell development 
The Leydig cells develop as distinct fetal and adult lineages.  The fetal Leydig cells 
are present from e12.5 in the mouse and numbers quickly decline after birth (Byskov, 
1986; Habert et al., 2001), while in the human they are evident from 9 weeks 
gestation (Codesal et al., 1990; Ostrer et al., 2007).  The origin of Leydig cells has 
not been fully established but they are believed to form from the differentiation of 
mesenchymal-like stem cells (Byskov, 1986; Ge et al., 2006).  These stem cells may 
be derived from the coelomic epithelium (Karl and Capel, 1998) although a more 
recent study suggests that only a small number may arise from here (Brennan et al., 
2003).  They also may arise from migrating mesonephric cells, but following 
removal of the mesonephros at e11.5, a normal Leydig cell population is still formed, 
suggesting that these cells do not migrate or in the absence of migration, redundant 
cells can compensate (Buehr et al., 1993; Merchant-Larios and Moreno-Mendoza, 
1998; Merchant-Larios et al., 1993).   
 
Notably, the Sertoli cells appear to influence the development of Leydig cells, 
through paracrine signalling mechanisms.  One factor thought to be involved is the 
oncogene, Pdgfα, which is secreted by the Sertoli cells, while the Pdgfα receptor, 
Pdgfrα is expressed within the interstitium.  Mouse mutants for Pdgfrα display 
severe defects in Leydig cell development (Brennan et al., 2003), suggesting Pdgfα 
may play an important role in promoting the proliferation and/or differentiation of 
Leydig cells.  Desert hedgehog (Dhh) is another secreted molecule, expressed by the 
Sertoli cells and the Dhh receptor Patched (Ptch1), is expressed by cells within the 
interstitium (Bitgood et al., 1996).  Dhh is expressed at e11.5 in the Sertoli cells, 
while it is absent from the ovary (Clark et al., 2000).  Dhh knock-out mice display 
poor partitioning of the interstitium and the cord regions, and impaired Leydig cell 
development (Yao et al., 2002) and Dhh is also claimed to play a role in upregulating 
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steroidogenic genes within the developing Leydig cells (Yao et al., 2002).  Human 
males with mutations in DHH display fertility problems (Canto et al., 2005; Bitgood 
et al., 1996) and interestingly the levels of expression of DHH was found to be 
reduced in the testes of fetuses from smoking mothers (Fowler et al., 2008). 
 
The primary function of the Leydig cells is the secretion of androgens that are 
essential for masculinisation of the external and internal genitalia (Clark et al., 2000; 
Hu et al., 2002; Welsh et al., 2008).  In the Leydig cells steroid biosynthesis begins 
with the conversion of cholesterol to pregnenolone by the enzyme side-chain 
cleavage p450 (SCCp450) (or Cyp11a1).  The enzyme 3β-dehydrogenase (3βHSD) 
then converts pregnenolone to progesterone. Progesterone is converted to 
androstenedione by cytochrome P450 17α-hydroxylase, and androstenedione is 
converted to testosterone by 17β-hydroxysteroid dehydrogenase (O'Shaughnessy et 
al., 2006) (Figure 1-7). Both Side Chain Cleavage p450 (SCCP450) and 3-β-
hydroxysteroid dehydrogenase (3βHSD) are present throughout the 2nd trimester in 
the human (Murray et al., 2000; Gaskell et al., 2004).  In the mouse, fetal androgen 
production begins at e13, while in the human it peaks between 13-14 weeks gestation 
(Tapanainen et al., 1981).  There are substantial differences in the steroidogenic 
enzymes between the rodent and the human.  For example, there are multiple, 
different human and rodent isoforms of 17β-hydroxysteroid dehydrogenase (Labrie 
et al., 1997), and these display differences in both function and substrate specificity.  
In the rodent, 4-6 functional 3βHSD genes and isoenzymes have been identified 
(Payne et al., 1997), while in the human there are only two (Rheaume et al., 1992). 
 
The Leydig cells are also responsible for the production of insulin-like3 (Insl3), 
which is required for the first phase of testicular descent (transabdominal) (Ivell and 
Hartung, 2003; Klonisch et al., 2004). 
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Figure 1-7 Summary of steroid biosynthesis in Leydig cell. Modified from Ogle, 1996 
 
1.3 Germ cells 
Germ cells have the important role of carrying the genome from one generation to 
the next, and enhancing the genetic diversity of the species.  In order to do this, 
mammalian germ cells have to be specified within the gastrulating embryo and 
migrate into the gonad, while undergoing several rounds of cell division.  
Commitment to either the female or male lineage then occurs depending on their 
somatic cell environment.  The germ cells must not only undergo development and 
maturation, but also successfully enter and complete meiosis at the appropriate time 
in males and females.   
 
1.3.1  Primordial germ cells (PGCs)  
1.3.1.1 PGC specification 
In certain species such as Caenorhabditis elegans and Drosophila melanogaster, 
maternal factors from the germ plasm, deposited in the fertilised egg, are essential for 
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germ cell specification (Eddy, 1975).  In mammals, there is no evidence of a 
germplasm, and the germ line is induced to form independently of maternal factors 
(McLaren and Lawson, 2005).  Due to the difficulties in obtaining early human 
embryos, the early stages of germ cell specification have never been studied in the 
human.  However germ cells at this stage of development has been comprehensively 
studied in the mouse.  Although a number of molecular pathways are likely to be 
conserved and can be extrapolated to the human, it must be born in mind that the 
human embryo is morphologically and structurally distinct from the mouse at the 
time when germ cells are established and therefore humans may have evolved 
additional mechanisms to ensure specification of the germ cell lineage, which have 
yet to be elucidated (Clark and Reijo Pera, 2006). 
 
As gastrulation occurs, mouse embryos consist of three tissue types: the epiblast, the 
extraembryonic ectoderm and the visceral endoderm.  The extraembryonic ectoderm 
and the visceral endoderm give rise to the placenta and other extraembryonic tissues.  
The epiblast cells originate from the inner cell mass, and differentiate into all cell 
types of the embryo, including germ cells (Gilbert, 2003).  The PGC population 
arises from the proximal epiblast, which lies adjacent to the extraembryonic 
ectoderm at the base of the allantois (Ginsburg et al., 1990; Lawson and Hage, 1994).  
Before gastrulation has occurred, PGCs have been shown not to be lineage restricted, 
as cells of the proximal epiblast will not form PGCs when transplanted to distal 
regions, while cells originating from the distal part of the epiblast transplanted 
proximally, are capable of forming PGCs (Tam and Zhou, 1996). 
1.3.1.2 Signals controlling the induction of PGCs  
The induction of cells into the germ cell lineage is at least partly controlled by 
signals from the extraembryonic ectoderm and visceral endoderm.  Lineage studies 
by Lawson et al (1994) demonstrated that it is the regions of the proximal epiblast 
which sit within 1-2 cell diameters of the extraembryonic ectoderm, which gives rise 
to PGCs.  Furthermore, epiblast cells isolated from e5.5 mouse embryos fail to form 
PGCs, unless co-cultured with either feeder cells or in the presence of the visceral 
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endoderm and extraembryonic ectoderm (de Sousa Lopes et al., 2004; Pesce et al., 
2002; Yoshimizu et al., 2001).     
1.3.1.3 Bone morphogenic proteins (BMPs) 
The family of bone morphogenic proteins (BMPs) are members of the TGFβ 
superfamily.  They function as dimers that bind and act through heterodimeric 
receptor complexes, and activate downstream Smads to illicit their signalling 
response, resulting in alterations to gene expression (Shi and Massague, 2003).  The 
BMPs were first implicated in germ cell commitment when it was found that germ 
cells failed to form in Bmp4-/- embryos (Lawson et al., 1999), while embryos 
heterozygous for a mutation in Bmp4, display a 50% reduction in PGC number 
(Lawson et al., 1999).  Bmp4 may act together with other family members such as 
Bmp8b (Ying et al., 2001), as both Bmp4 and Bmp8b have a similar expression 
pattern in the extraembryonic ectoderm and both Bmp8b and Bmp4 mutant mice 
exhibit a similar PGC phenotype.  In experiments where epiblast cells from e6.0 
were cultured in the presence of feeder cells which expressed Bmp4, Bmp8b or a 
combination of both, Bmp8b rescued the Bmp8b deficient epiblast phenotype, while 
culture of Bmp4-/- epiblasts with Bmp4 did not rescue the phenotype, suggesting that 
either Bmp4 induces PGC competence within an earlier time window or that an 
interaction with other molecules is required (Ying et al., 2001).  Bmp4 has since been 
shown to induce a PGC phenotype in a subset of epiblast cells when cultured at e5.5-
6.0, and may induce early PGC proliferation (Pesce et al., 2002).  Bmp2, derived 
from the visceral endoderm has also been shown to influence specification of germ 
cells and is additive to Bmp4 (Ying and Zhao, 2001).  Bmp downstream signalling 
molecules, Smad1 (Tremblay et al., 2001b) and Smad 5 (Chang and Matzuk, 2001) 
are also important for development of PGCs.  It appears that the actions of the Bmps 
may be mediated within the visceral endoderm.  If the Bmp receptor, Alk2 is absent 
in the visceral endoderm at e5.5-e6.0, PGCs do not form, while the expression of a 
constitutively active Alk2 in the visceral endoderm, but not the epiblast, results in 
formation of PGCs in mice deficient in Bmp4 (de Sousa Lopes et al., 2004).  This 
suggests that Bmp4 signalling within the visceral endoderm is important for the 
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Figure 1-8. Schematic diagram showing the possible BMP4 signalling system that 
operates to induce PGCs in the mouse.  BMP4 is produced from the extraembryonic 
ectoderm (ExE), and signals through the Alk2 receptor expressed on the visceral 
endoderm (VE).  This results in phosphorylation of Smad1, which translocates to the 
nucleus to bring about transcriptional changes resulting in the production of an 
unknown paracrine molecule which acts on the epiblast (EE) to induce PGCs, 
possibly via Smad 1/5 signalling.  From de Sousa Lopes et al., 2004 
 
A recent study suggests that the visceral endoderm acts between e6.25-e7.25 to 
regulate the number of germ cells specified, either through promotion of proliferation 
or prevention of cell death, and thereafter is not required. The extraembryonic 
ectoderm appears to have an independent role in restricting the localization of PGC 
precursors to the posterior part of the embryo (Chuva de Sousa Lopes et al., 2007). 
1.3.1.4 The PGC precursor population 
In response to signals derived from the extraembryonic ectoderm, a PGC precursor 
population is induced to form between e6.25-e7.25.  Initially within the embryonic 
ectoderm, there is an upregulation of Fragilis (Saitou et al., 2002; Tanaka and 
Matsui, 2002), a putative interferon-inducible gene encoding a transmembrane 
protein (Lange et al., 2003).  Fragilis expression is absent from the epiblast in Bmp4-
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/- embryos (Saitou et al., 2002).  In a subset of these Fragilis positive cells, 
approximately an initial six cells gain expression of the transcriptional repressor 
Blimp1 (Ohinata et al., 2005).  Cells which express both Blimp1 and Fragilis 
subsequently express Stella (Figure 1-9) (Hayashi et al., 2007).  Despite Stella being 
one of the first genes to be expressed in PGCs, Stella knock-out mice display no 
defects in PGC induction and have normal fertility (Bortvin et al., 2004).  
 
One gene that is essential for germ cell development is the RNA binding protein 
Nanos3.  In Drosophila expression of nanos is essential for successful germ cell 
development (Wang and Lehmann, 1991; Forbes and Lehmann, 1998; Kobayashi et 
al., 1996).  In the mouse there are three Nanos genes.  Nanos3 is only expressed in 
the germ cells after e7.25 (Yabuta et al., 2006) and Nanos3-/- mice display a 
complete loss of germ cells in both males and female (Tsuda et al., 2003); the protein 
appears to maintain the germ cell lineage through the suppression of apoptosis 
(Suzuki et al., 2008). 
 
Once the PGCs form, they migrate out of the primitive streak and are found within 
the extraembryonic mesoderm at the base of the allantois, where they exist as a tight 
cluster of cells (Ginsburg et al., 1990).  In addition, cell-cell contact appears to be 
important for specification, as inhibiting the functions of the cell-adhesion molecule 
E-Cadherin, prevents PGC specification from occurring (Okamura et al., 2003).  By 
e7.25 the cluster of around 40 PGCs found within the base of the allantois can be 
identified by alkaline phosphatase staining (Ginsburg et al., 1990).  One intriguing 
question is how the six cell present at e6.25, can increase to around forty cells in just 
one day.  The large increase in PGC number in such a short period has been 
attributed to either the PGC precursors altering their cell cycle, or more feasibly, 
through the recruitment of local cells into the germ cell lineage (McLaren and 
Lawson, 2005).  
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1.3.1.5 Expression of pluripotent genes in PGCs 
At the early stages of germ cell development, a number of pluripotency-associated 
genes are expressed within the germ cells in mice.  These include the Pou domain 
transcription factor, Oct4 (Pou5f1) (Nichols et al., 1998), Nanog (Chambers et al., 
2003) and high mobility group (HMG) domain containing family member, Sox2 
(Avilion et al., 2003). 
 
In the mouse blastocyst, Oct4 is initially expressed throughout the epiblast but 
gradually becomes restricted to the PGCs by e7.5 (Scholer et al., 1990; Yeom et al., 
1996).  The functional role of Oct4 in developing germ cells is unknown, but without 
it, germ cells fail to survive (Kehler et al., 2004).  Nanog is also expressed in mouse 
PGCs, where it is upregulated at e7.75 (Yamaguchi et al., 2005).  Nanog is essential 
for germ cell development and in chimeric mice created from Nanog null and wild-
type ES cells, although Nanog null cells were initially recruited to the germline, they 
were lost by e11.5 (Chambers et al., 2007).   
 
In the mouse Sox2 expression has also been shown to be restricted to the germ cell 
lineage where it is expressed at e6.75 (Yabuta et al., 2006; Western et al., 2005; 
Perrett et al., 2008).  In ES cells, Sox2 and Oct4 act synergistically to drive the 
expression of a number of pluripotency genes (Okumura-Nakanishi et al., 2005), and 
Oct4/Sox2 heterodomers have been shown to bind to the Nanog promoter (Rodda et 
al., 2005).  Sox2 null epiblasts do not survive, and ES cells from Sox2 null 
blastocysts cannot be obtained (Avilion et al., 2003). 
 
In contrast to mice, SOX2 is not expressed in germ cells of the human fetal gonad 
(de Jong et al., 2008; Perrett et al., 2008), although it can be detected within the inner 
cell mass, embryonic stem cells and embryonal carcinoma cells of the human.  It has 
been suggested that expression of SOX2 ceases either soon after or before PGC 
specification (Perrett et al., 2008).  Another member of the SOX family, SOX17 has 
been shown to be present and highly expressed in germ cells within the human fetal 
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gonad and also germ cell tumours (de Jong et al., 2008) and this protein may 
therefore fulfil the role ascribed to Sox2 in mice. 
 
 
Figure 1-9 Development of germ cells in early postimplantation mouse embryos from 
e5.0 to e7.5.  Proximal epiblast cells respond to signals from the extraembryonic 
tissues, by inducing the expression of Fragilis within the epiblast.  A subset of these 
cells then expresses Blimp1.  After gastrulation PGC precursors locate to the 
posterior proximal regions and form the founder Stella positive population. From 
Hayashi et al., 2007. 
1.3.1.6 Blimp1 suppresses the somatic cell fate 
Blimp1 is a Kruppel-like zinc-finger containing a DNA binding transcriptional 
repressor (Mock et al., 1996).  This gene predominantly plays important roles in 
somatic cell specification, including the terminal differentiation of B cells into 
plasma cells (Shaffer et al., 2004a; Shapiro-Shelef et al., 2003; Turner et al., 1994), 
and the differentiation of macrophages (Chang et al., 2000).  It appears to act by 
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repressing the transcription of genes such as Myc which are important for 
proliferation (Lin et al., 1997).  Blimp1 is highly expressed in several embryonic cell 
types (Chang et al., 2002).  Mouse embryos deficient in Blimp1 die at e10.5, with 
severe placental defects, and notably these mutants lack PGCs, which appear to be 
lost by e7.25 (Skaznik-Wikiel et al., 2007).  In the region of the proximal epiblast, 
cells which express Blimp1 do not express Hox genes, but maintain expression of 
Oct4, Nanog and Sox2 (Yabuta et al., 2006).  It is thought that suppression of the 
somatic cell program is key to the induction of the germ cell lineage (Saitou et al., 
2002), and it appears that Blimp1 is important for this suppression.  For example, at 
early stages of germ cell development, the Blimp1 positive cells express Hox genes 
and mesodermal genes (Ancelin et al., 2006), the expression of these genes continues 
to be upregulated in the neighbouring cells, but they quickly become repressed in the 
Blimp1 positive cells (Yabuta et al., 2006) (Figure 1-9). At this point there is then an 
upregulation of pluripotency genes such as Sox2 (Yabuta et al., 2006) and Nanog 
(Yamaguchi et al., 2005).  In Blimp1 mutant cells, PGCs form a tight cluster and stop 
proliferating, they also fail to downregulate expression of Hoxb1, and do not show 
consistent upregulation of Stella and Sox2 (Hayashi et al., 2007).  A recent gene 
expression analysis of Blimp1 deficient PGCs and their somatic cell neighbours 
points to Blimp1 as a critical regulator in repressing nearly all somatic genes 
(Kurimoto et al., 2008).  The full molecular functions of Blimp1 are far from 
understood, but Blimp1 has been shown to interact with the protein arginine 
methyltransferase 5, Prmt5 (Ancelin et al., 2006) and the Prmt5 homologue, 
capsuleen has been shown to be required for germ cell specification in Drosophila 
(Anne et al., 2007), lending support to the idea that Blimp1 is a key regulatory gene. 
 
Interestingly, a recent report implicates another PR-domain containing transcriptional 
regulator, known as Prdm14, in the induction of germ cells (Yamaji et al., 2008).  
Prdm14 is expressed specifically in Blimp1 positive germ cells from e6.75.  
Expression of this gene is maintained in these cells until e13.5-e14.5.  Prdm14 
mutants display complete germ cell loss by e12.5 and fail to show the characteristic 
upregulation of Sox2 observed in normal PGCs.  Mutant cells also show reduced 
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levels of Stella, although levels of Nanog and Oct4 are normal.  The initial activation 
of Prdm14 appears to be independent of Blimp1, but its subsequent maintenance is 
Blimp1-dependent (Yamaji et al., 2008). 
1.3.1.7 Migration of PGCs  
Analysis of the migratory path taken by PGCs in the mouse embryo has been aided 
by the  fluorescent labelling of PGCs, through the use of reporter constructs such 
Oct4-GFP (Anderson et al., 2000; Molyneaux et al., 2001).  PGCs first migrate into 
the endoderm from the posterior region of the primitive streak.  From between e7.5 
and 8.5, PGCs move from the endoderm and become incorporated into the wall of 
the developing hindgut (Figure 1-10 a and b) (Anderson et al., 2000; Molyneaux et 
al., 2001).  It is not known if colonisation of the hindgut is an active process or if it is 
passive, brought about by the morphogenic movements of the embryo, although at 
e8.5, PGCs have a non-motile morphology, a possible indication that the process is 
passive (Molyneaux et al., 2001).  Once the PGCs enter the hindgut, it extends and 
closes, trapping the PGCs until e9 (Figure 1-10c).  Between e9 and e9.5, PGCs begin 
to migrate laterally through the hindgut and dorsal mesentery (Figure 1-10d), and 
arrive in the gonadal ridge by e10.5 (Clark and Eddy, 1975) (Figure 1-10e).  As they 
are migrating, they are thought to undergo 5-6 rounds of cell division, and there is an 
increase in the numbers of PGCs from less than 100 to approximately 4000 (Tam and 
Snow, 1981).  
 
 
Chapter 1 Literature Review 30 
 
Figure 1-10 Overview of the migratory route taken by PGCs.  a) PGC induction occurs 
within the proximal epiblast.  As gastrulation occurs, PGCs move through the 
primitive streak and invade the definitive endoderm, parietal endoderm and the 
allantois b) PGCs in the definitive endoderm become incorporated into the hindgut.  
Some PGCs can be found remaining within the allantois c) By e9.0 the hindgut is 
extended and closed, PGCs are restrained within the hindgut d) Between e9.0-e9.5, 
PGCs emerge from the hindgut at the dorsal side and migrate to the genital ridge e) 
By e10.5 PGCs form a cluster of cells migrating towards the genital ridge, most of 
which colonize by e11.5 (Molyneaux et al., 2004) 
 
In the human PGCs have been identified in the endoderm of the yolk sac at day 30 
post-ovulation (Witschi, 1948; Freeman, 2003; Motta et al., 1997; Mc et al., 1953).  
During the 4th week of gestation PGCs migrate from the yolk sac along the dorsal 
mesentery of the hindgut (Motta et al., 1997) and enter the genital ridges by week 6 
(Wartenberg, 1981). 
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The mechanism of PGC migration is still not fully understood and what determines 
the direction of travel remains unclear.  Amoeboid movements are thought to be 
important for the active migration of PGCs, and PGCs can be identified by their 
possession of pseudopodia (Chiquoine, 1954).  The contact which PGCs have with 
the surface of the cells over which they are migrating also appears to be important.  It 
has been shown that mouse PGCs adhere to various extracellular matrix 
glycoproteins such as fibronectin, laminin and collagen IV and that they alter their 
adhesiveness to fibronectin and laminin prior to and after completion of migration 
(Garcia-Castro et al., 1997).  Fibronectin has been shown to stimulate the migration 
of PGCs in explant cultures (Ffrench-Constant et al., 1991).  Integrins may also be 
important for PGC migration, as PGCs lacking β1 integrin display poor colonization 
of the gonad (Anderson et al., 1999).  
 
Studies in rodents have also shown the importance for the tyrosine kinase receptor, 
C-kit (Kit), in early germ cell development.  The Kit gene has been localised to the 
W locus, and mice homozygous for mutations in the W locus are deficient in germ 
cells (Chabot et al., 1988; Nocka et al., 1989).  A similar phenotype results when the 
steel locus is mutated (Sl) (Mintz and Russell, 1957).  Steel encodes the ligand for 
Kit, Stem cell factor (Scf) (or Kit Ligand (Kitl)).  PGCs express Kit from e7.5, while 
Kitl is expressed by the somatic cells along their migratory route (Matsui et al., 
1990).  Kitl is required for successful culture of PGCs (De Felici and Dolci, 1991; 
Dolci et al., 1993; Matsui et al., 1991).  Studies suggest that Kitl acts by preventing 
PGC apoptosis (Pesce et al., 1993).   
 
The behaviour of early migratory PGCs can also be influenced by diffusible factors 
released from cultured genital ridges.  Media conditioned by e10.5 genital ridges 
stimulates PGC migration in culture (Godin et al., 1990), as does TGFβ (Godin and 
Wylie, 1991).  The G-protein coupled receptor Cxcr4 and its ligand Sdf1 have also 
been shown to play an important role in PGC migration, and are essential for 
colonisation of the mouse gonad (Molyneaux et al., 2003).  Migratory PGCs express 
Cxcr4, while Sdf1 is found along the dorsal body wall.  The addition of Sdf1 to 
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embryo cultures has detrimental effects on PGC migration, while mutations in the 
Cxcr4 gene results in a reduction in the number of germ cells that colonise the genital 
ridge, even though normal numbers initially reach the hindgut (Molyneaux et al., 
2003).  BMPs may also play a role in the migration of germ cells.  For example, in an 
in vitro culture system, the BMP antagonist Noggin was found to cause migratory 
defects, possibly through interfering with gene expression along the migratory route 
(Dudley et al., 2007). 
 
1.3.2 Germ cells within the developing gonads 
As germ cells enter the gonad they are initially ‘bipotential’ and capable of 
developing down the male or female lineage, however contact with the somatic cells 
causes their fates to diverge. 
1.3.2.1  Epigenetic alterations  
Between e10.5 and e12.5, once murine germ cells have entered the genital ridge, they 
undergo epigenetic reprogramming, with genome-wide demethylation occurring 
(Hajkova et al., 2002; Maatouk et al., 2006).  In females, X chromosome reactivation 
is completed at around the same time (Sugimoto and Abe, 2007).  Reestablishment of 
the sex-specific methylation patterns occurs several days later in the male, but not 
until postnatal life in the female (Hajkova et al., 2002; Maatouk et al., 2006). 
1.3.2.2 Germ cells in the developing testis 
In the male, germ cells enter the gonad and become enclosed within the 
differentiating Sertoli cells forming the testicular cords, thereby separating the germ 
cells from the interstitial compartment.  Germ cells at this stage of development have 
been extensively studied in the mouse and work performed in our lab (Gaskell et al., 
2004) and by others (Honecker et al., 2004) has already demonstrated there are 
several key differences between the subsequent pattern of germ cell development in 
the mouse and human. 
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1.3.2.2.1 Mouse  
In fetal life, gonocytes within the mouse testis, are morphologically similar with a 
large nucleus and small cytoplasm.  The initial populations that colonise the genital 
ridge express both Oct4 and Nanog (Rosner et al., 1990; Yamaguchi et al., 2005).  
Upon entry into the genital ridge, all germ cells also activate expression of the RNA 
helicase, Mouse vasa homologue (Mvh) (Toyooka et al., 2000) and the RNA-binding 
protein Dazl (Seligman and Page, 1998).  All gonocytes within the mouse testis are 
therefore Oct4+/Nanog+/Mvh+/Dazl+, they enter mitotic arrest at e13.5 (Monk and 
McLaren, 1981) and just prior to birth there is a rapid downregulation in expression 
of Oct4 (Ferrara et al., 2006; Zayed et al., 2007).  At the end of pregnancy, the 
gonocytes migrate from the centre of the cords to the basement membrane forming 
prespermatogonia.  A few days after birth the prespermatogonia resume proliferation 
and differentiate into spermatogonial stem cells which are responsible for the 
production of mature spermatozoa throughout the life of the animal (de Rooij, 2001). 
1.3.2.2.2 Human 
Unlike the mouse, germ cells of the human fetal testis appear as a heterogenous 
population of cells within one single testis cord (Fukuda et al., 1975; Gaskell et al., 
2004; Wartenberg, 1976) (Figure 1-11).  Fukuda et al (1975) used histological 
analysis to identify three different subpopulations of human fetal germ cells, which 
they named gonocytes, intermediate cells and prespermatogonia.  The gonocytes 
were described as cells with a high nuclear to cytoplasmic ratio and a prominent 
nucleolus; intermediate cells were often found to be connected to one another though 
intracellular bridges; while the cells with the lowest nucleo-cytoplasmic ratio were 
categorized as the prespermatogonia (Figure 1-11).  
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Figure 1-11 Morphological identification of germ cells in the 2nd trimester human fetal 
testis.  Population 1: Small round cells with a high nuclear to cytoplasmic ratio.  
These are normally single cells in the centre of the cords.  Population 2: Cells with 
round nuclei, often in pairs, with a large cytoplasm.  Population 3: Largest of the cells, 
usually in groups at the periphery of the cords. From Gaskell et al., 2004   
The co-existence of different subpopulations within a single testis cord has been 
conformed by recent studies that have found that, along with the morphological 
differences, human fetal germ cells also vary in their protein expression pattern.  The 
gonocytes are immunopositive for OCT4 and KIT, and have low levels of the 
melanoma associated antigen, MAGE-A4.  The prespermatogonia display little to no 
expression of OCT4 and KIT, but express high levels of MAGE-A4 protein.  An 
intermediate population of cells with low to negative levels of OCT4 and no KIT or 
MAGE-A4 has also been identified (Gaskell et al., 2004).  The gonocytes are the 
predominant cell type in the 1st trimester testis and by the 2nd trimester, gonocytes, 
intermediate cells and prespermatogonia are all present, with the number of 
prespermatogonia increasing towards the end of the 2nd trimester (Gaskell et al., 
2004; Honecker et al., 2003). 
1.3.2.3 Testicular germ cell tumours   
Germ cells tumours are the most common solid tumour in young men between the 
ages of 20-40 (McKiernan et al., 1999).  Testicular germ cell tumours (TGCT) can be 
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divided into two main histological types: the uniform seminomas and the more 
aggressive, nonseminomas. The vast majority of TGCTs arise from a common 
precursor lesion called carcinoma in situ (CIS) (Skakkebaek, 1972).  CIS cells are 
usually located in a single row at the basement membrane of a seminiferous tubule, 
where they are morphologically larger and have more prominent nuclei than 
prespermatogonia (Holstein et al., 1987).  CIS cells resemble that of human fetal 
germ cells (Nielsen et al., 1974) and it is widely speculated that CIS cells arise from 
a failure of fetal germ cells to undergo the normal maturation process, perhaps as a 
consequence of endocrine imbalances (Skakkebaek, 1972).  Although the 
mechanisms are not fully understood, it has been suggested that CIS cells are fetal 
germ cells that have failed to differentiate normally and which therefore persist in the 
testis and undergo malignant transformation post-pubertally (Skakkebaek, 1972).  
After puberty, possibly due to hormonal changes, CIS cells begin to replicate, and as 
a result tubules containing only CIS cells and Sertoli cells are found in the testis 
(Dieckmann and Skakkebaek, 1999).  The CIS cell as the origin of TGCT is strongly 
supported by the fact that CIS cells can be more often detected in ‘at risk’ 
populations (Giwercman et al., 1987), and that these cells are found within tissue 
surrounding a tumour (Jacobsen et al., 1981).  Furthermore, studies have shown that 
over half of patients found to have CIS cells in their testes developed TGCT within 5 
years (Skakkebaek, 1978).   
 
The fetal origin of CIS is also supported by that fact that these cells express a large 
number of proteins in common with fetal germ cells.  Proteins detectable in both fetal 
germ cells and CIS include: placental alkaline phosphatase (PLAP) (Giwercman et 
al., 1991), the most common diagnostic marker for CIS; the pluripotency markers 
OCT4 (Looijenga et al., 2003) and NANOG (Hart et al., 2005); and the transcription 
factor AP2γ (Hoei-Hansen et al., 2004; Pauls et al., 2005) all of which are found in 
fetal gonocytes.  In addition, expression of M2A, a glycosylated monomeric 
sialoglycoprotein, which has an unknown function (Giwercman et al., 1988), DAZL 
(LitSchitz-Mercer, 2002), VASA (Honecker et al., 2004; Zeeman et al., 2002), and 
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the tyrosine kinase receptor KIT (Jorgensen et al., 1995) have all been reported. 
Table 1-1 summarizes the genes reported to be expressed in CIS.  
Table 1-1 Summary of proteins expressed in embryonic stem cells (ESC), primordial 
germ cell (PGC), gonocytes, spermatogonial, spermatids, CIS, seminoma (SEM) and 




An understanding of the mechanisms responsible for the malignant transformation of 
fetal germ cells has been difficult, and has been substantially hindered by the lack of 
an animal model.  The protracted time period over which human fetal gonocytes 
differentiate into prespermatogonia, with the existence of mixed populations of cells, 
some of which express ‘pluripotency’ genes is thought to perhaps be partly 
responsible (Almstrup et al., 2006; Gaskell et al., 2004).  Furthermore, although it is 
apparent that Sertoli cells and Leydig cells are important mediators of this maturation 
process, through the provision of paracrine and hormonal support, the full range of 
factors in the somatic- germ cell dialogue is not fully understood.  Any disturbances 
to this support, due to genetic or environmental factors, could contribute to delayed 
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or arrested germ cell development and persistence of immature proliferating germ 
cells (Almstrup et al., 2006). 
1.3.2.4 Germ cells within the developing ovary  
In the female, pre-meiotic germ cells within the ovary are referred to as oogonia and 
nests of syncytial germ cells form surrounded by a network of stromal cells 
(McNatty et al., 2000).  In mice, the oogonia continue to proliferate until e13.5, in a 
similar manner to the gonocytes (Monk and McLaren, 1981).  However, oogonia 
enter meiosis from e13.5, and thereafter are termed oocytes (Figure 1-12) (McLaren 
and Southee, 1997); most oogonia have entered meiosis by e15.5, although there is 
evidence that a small population of germ cells may not enter meiosis until after birth 
(Hirshfield, 1992).  Oocytes progress through leptotene, pachytene and zygotene 
stages of meiotic prophase and begin to enter meiotic arrest at the diplotene stage by 
e17.5, with the majority reaching diplotene by 5 days post-partum (Borum, 1961).  
As the germ cells enter meiotic arrest, they become surrounded by somatic cells and 
form primary follicles (Hirshfield, 1992).  After puberty, meiosis is not resumed until 
just before ovulation.  In the human, meiotic entry in the fetal ovary begins at 11 
weeks gestation (9 weeks post-conception) (Bendsen et al., 2006).  In the human this 
occurs over a longer period of time, with many oogonia continuing to proliferate, 
while others enter meiosis. 
 
Figure 1-12  Timeline illustrating meiotic progression of female germ cells and mitotic 
arrest of male germ cells in the mouse. From Monk and McLaren, 1981 
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As germ cells enter meiosis Oct4 expression is downregulated (Pesce et al., 1998).  
Sycp3 is a meiosis specific gene, which is essential for the synapses of homologous 
chromosomes (Dobson et al., 1994).  As Oct4 expression is downregulated, Sycp3 is 
upregulated.  This occurs in a rostrocaudal manner between e13.5-e15.5 (Bullejos 
and Koopman, 2004).  Also, the premeiotic marker stimulated by retinoic acid 
(Stra8) and the meiotic recombinase gene Dmc1 have been shown to be upregulated 
along the axis of the gonad as meiosis is occurring, in a similar manner to Sycp3 
(Menke et al., 2003).   
1.3.2.5 Control of meiotic entry 
The decision as to whether the germ cell enters meiosis or undergoes mitotic arrest, 
is not an intrinsic property of the germ cells dependent upon their genetic sex, instead 
the process of meiotic entry is tightly regulated by the somatic cells.  Experiments 
using XX-XY chimeric mice have shown that XX germ cells can develop as 
prespermatogonia and conversely, XY germ cells can enter meiosis and develop 
down the oocyte lineage (Palmer and Burgoyne, 1991).  Similar results have been 
shown in experiments using XX sex-reversed male mice, in these animals Sertoli 
cells form in the gonad and the germ cells develop down the male lineage (McLaren, 
1981).  As it is the somatic cells that control the fate of the male and female germ 
cells, then the obvious question is whether meiotic entry in the female is initiated by 
the ovarian somatic cells, or whether meiotic entry is an intrinsic property of all germ 
cells, and that the somatic cells of the testis play an active role in the prevention of 
meiotic entry. The latter is favoured and the ‘cell-autonomous hypothesis’ suggests 
that germ cells have an intrinsic clock, possibly using a cell cycle counting 
mechanism, to prime entry into meiosis at e13.5 by default (McLaren, 1995). 
 
The examination of germ cells that have failed to migrate to the genital ridges has 
also revealed that germ cells in the male embryo are capable of meiotic entry prior to 
birth (McLaren, 1983).  Growing oocytes have also been found in the developing 
adrenal gland of both male and female mice after birth (Zamboni and Upadhyay, 
1983).  Thus if a substance is stimulating germ cells to enter meiosis then it would 
Chapter 1 Literature Review 39 
have to be present in the female genital ridge, within the mesonephric region as well 
as in the developing adrenal gland.  Furthermore, when both female and male germ 
cells are removed from an e11.5 gonad and grown in lung aggregates, they enter 
meiosis (McLaren and Southee, 1997), suggesting that if a meiosis inducing 
substance exists, it must also be expressed in the lung. 
 
Experiments have also shown that there appears to be a critical window during 
development when germ cells are committed to the male lineage and are no longer 
capable of meiotic entry.  For example, male germ cells enter meiosis when removed 
at e11.5 from the gonad and grown in reconstituted ovaries (Adams and McLaren, 
2002) or in vitro (Nakatsuji and Chuma, 2001), but if they are recovered at e12.5 
they do not enter meiosis (Adams and McLaren, 2002). This implies that at 
approximately e12, the male genital ridge produces a factor which programmes male 
germ cells, committing then to the male lineage, and inhibiting them from entering 
meiosis (Adams and McLaren, 2002).  The commitment of female germ cells to 
oogenesis appears to occur later.  Female germ cells at e12.5 aggregated with a male 
somatic environment, will develop down the male lineage, however by e13.5 they are 
committed to the female lineage (Adams and McLaren, 2002).  This suggests that 
any short-range meiosis inhibiting factor must be produced by the somatic cells in 
the male genital ridge between e11.5-e12.5.  The activity of such a meiosis initiating 
substance appears to be prevented if the somatic cell contacts are disrupted between 
e11.5-e12.5 (McLaren, 1995; McLaren and Southee, 1997). 
 
Alternatively, support for the existence of a meiosis initiating substance is provided 
by the fact in co-culture experiments, ovaries containing germ cells progressing 
through meiosis, can induce meiosis in fetal testis (Byskov and Saxen, 1976), while 
conditioned media from adult ovaries or testis has been shown to induce meiosis in 
mouse fetal testis (Byskov et al., 1993; Byskov et al., 1998).  There is therefore a 
need for further work to resolve apparent inconsistencies in findings.  
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Recently it has been reported that a conserved transmembrane protein, may also play 
have a role in committing germ cells to the male lineage.  Sdmg1 is specifically 
upregulated in the Sertoli cells of embryonic testes at e12.5, where it is localised to 
the endosomes.  Also upregulated in the developing testis are the secretary SNARES, 
vesicle associated membrane protein 8 (Vamp8) and syntaxin 2 (Stx2) (Best et al., 
2008).  In vitro data shows that knock-down of Sdmg1 results in mislocalisation of 
Stx2 from the plasma membrane. This has led the authors to speculate that an 
unknown substance committing the germ cells to the spermatogenic lineage may be 
being secreted by the Sertoli cells at this time, aided by Sdmg1.  If secretion from the 
Sertoli cells is inhibited at e12.5, it results in germ cells undergoing male-to-female 
sex reversal adding further insight into this argument (Best et al., 2008).  
 
1.3.2.5.1 Retinoic acid (RA) signalling 
Retinoic acid (RA) is the biologically active derivative of retinol (Vitamin A) 
(Blomhoff and Blomhoff, 2006).  RA has various effects on cells and tissues during 
development and differentiation (Mendelsohn et al., 1992; Niederreither et al., 2002; 
Wendling et al., 1999).   Retinol is obtained from the diet and stored mainly in the 
liver (Jacobsen et al., 1994), it circulates in the blood bound to retinol-binding 
protein 4 (RBP4).  Target cells take up retinol through the RBP4 receptor, Stra6 
(Kawaguchi et al., 2007) and within the cytoplasm of target cells, retinol binds to 
retinol binding protein 1 (RBP1).  Subsequently, retinol dehydrogenase 10 (RDH10) 
metabolises RA into retinaldehyde (Ral) (Cammas et al., 2007).  A further oxidative 
reaction by the retinaldehyde dehydrogenase  enzymes (Aldh1a 1,2 and 3) converts 
Ral to RA (Maden, 2007; Reijntjes et al., 2005). The pathway leading to the 
production of production of RA and its subsequent receptor interaction is illustrated 
in Figure 1-13.   
 
RA enters the nucleus by binding to CRABP2 (Budhu and Noy, 2002) and then is 
capable of binding to two families of steroid/thyroid hormone nuclear receptors, the 
RA receptors (RAR), of which there are 3 isoforms RARα, RARβ and RARγ.  These 
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receptors act as heterodimers with the retinoid X receptors (RXRs), which also have 
3 isoforms RXRα, RXRβ and RXRγ.  Ligand-bound receptors bind as RAR/RXR 
heterodimers to the polymorphic cis-acting response elements of target genes or RA 
response elements (RARE) (Chambon, 1995; Lohnes et al., 1992) (Figure 1-13). 
 
RA signalling can also be modulated by three RA metabolising enzymes known as 
Cyp26A1, Cyp26B1 and Cyp26C1 (Reijntjes et al., 2005). These enzymes 
metabolize RA into hydroxylated polar derivatives that do not bind the receptors 
(Fujii et al., 1997) (Figure 1-13). 
  
Figure 1-13 Summary of RA production, signalling and metabolism (from Maden et al, 
2007) 
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All of the RARs and RXRs have been localised to cells within the postnatal and adult 
testis of the rodent (Dufour and Kim, 1999; Vernet et al., 2006).  The only study 
documenting the cellular location of the RA receptors on the fetal testis has been 
performed in the rat. Rarα and Rarβ have been immunolocalised to the interstitial 
tissue from e14.5 and the gonocytes from e20.5.  Rarγ protein was not expressed 
until postnatal stages.  Rxrα was immunolocalised to the gonocytes from e13.5 and 
in the Leydig cells at e16.5.  Rxrβ protein was detected in the Leydig cells 
throughout development and Rxrγ was expressed in a variety of cells from e20.5 
(Boulogne et al., 1999). 
1.3.2.5.2 The potential role of RA as a factor responsible for the 
initiation of germ cell meiosis  
In the female mouse gonad, expression of Stra8 is upregulated one day before 
meiotic entry (Menke et al., 2003).  In the male, Stra8 is absent from the embryonic 
testis, and is expressed in postnatal premeiotic germ cells (Menke et al., 2003).  In 
Stra8-deficient ovaries, germ cells develop normally until e13.5, but they fail to 
initiate meiotic prophase, and deteriorate (Koubova et al., 2006).  These germ cells 
appear to arrest before the onset of DNA replication in premeiotic S phase (Koubova 
et al., 2006; Baltus et al., 2006), although recent reports suggest that in the testis, 
Stra8 is not required for preleptotene cells to undergo DNA replication and progress 
into meiotic prophase (Anderson et al, 2008.  Mark et al, 2008).  Stra8 is a member 
of a gene family which has been shown to respond to RA. The observation that Stra8 
is required for meiotic initiation has led researchers to look at any possible effects of 
RA on fetal germ cell fate. 
 
Studies by Koubova et al in 2006 found that when e11.5 ovaries were cultured in the 
presence of an antagonist (BMS-204493) that targets all forms of the RA receptors, 
for 2 days, Stra8 expression was not upregulated, while Stra8 expression in controls 
was, and conversely when cultured in the presence of RA, Stra8 was upregulated, 
specifically in the germ cells.  In 2006, Bowles et al. reported that that the enzyme 
Cyp26b1 was initially expressed in the gonads of both sexes, but became male-
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specific by e12.5.  In males, this enzyme expressed in the testis cords, most probably 
in the Sertoli cells, and was most abundant at e13.5.  Using both a mouse strain 
where LacZ expression was under the control of a RA-response element, and a RA 
reporter cell line, they showed significant amounts of RA were produced by the 
mesonephros.  In addition, they found high levels of expression of the RA producing 
enzyme Aldh1a2 expressed within the mesonephroi, but not the gonads, from e10.5-
e13.5.  In ovarian cultures, treatment with RA resulted in a decrease in Oct4 
expression but an increase in Stra-8, and in contrast female gonads cultured in the 
presence of the RA receptor antagonist AGN193109 displayed a downregulation of 
meiotic genes, and a prolonged Oct4 expression.  While treatment with the 
cytochrome p450 inhibitor ketoconazole, increased expression of meiotic genes in 
the testis, and decreased expression of Oct4.  Based on these results, Bowles et al 
(2006) proposed a model whereby RA, released locally from the mesonephros, 
diffuses into the ovary and induces germ cell meiosis through the upregulation of 
Stra8.  In the male, RA cannot reach the testis because of the expression of the RA 
metabolising enzyme Cyp26b1 within the testis cords and therefore meiotic entry 
does not occur (Figure 1-14).  
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Figure 1-14 Diagram illustrating the bipotential effect of RA in the mouse testis and 
ovary.  RA from the mesonephros enters the anterior gonad via the mesonephric 
tubule.  In the female gonad high concentrations of RA leads to the upregulation of 
meiotic genes such as Stra8 and Dmc1 and downregulation of Oct4 (Pou5f1), initially 
at the anterior end and then throughout the whole gonad.  In the male the RA 
metabolising enzyme, Cyp26b1 present in the male gonad prevents RA from reaching 
the germ cells, and Stra8 is not upregulated.  From Bowles and Koopman, 2007 
This model has been supported by phenotypic analysis of Cyp26b1-/- mice 
(MacLean et al., 2007).  In the testes of these mice, the amount of RA was 3-fold 
higher in wild-type littermates.  At e12.5 the testis appeared normal, but by e13.5 
there were a large number of apoptotic germ cells, with some germ cells at e14.5 
morphologically resembling meiotic cells.  Any cells which remained at e16.5 were 
either apoptotic or displayed signs of meiosis.   
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Additional complexity in the regulation of meiotic entry is provided by a recent study 
that highlights the role for a member of the Nanos family of genes in the inhibition of 
meiotic entry in male embryos.  Nanos2 is expressed specifically in germ cells of the 
testis (Tsuda et al., 2003; Suzuki and Saga, 2008).  It appears to have an indirect role 
in the suppression of Stra8 and therefore prevents male germ cells from entering 
meiosis after Cyp26b1 has been downregulated (Suzuki and Saga, 2008). Ectopic 
expression of Nanos2 in female germ cells also induced their differentiation down 
the male lineage (Suzuki and Saga, 2008) (Figure 1-15). 
 
Figure 1-15 Diagram showing the potential role which Nanos2 might have in inhibiting 
meiosis in this male mouse embryo.  At e13.5 the expression of Cyp26b1 declines in 
the male, but Nanos2 is upregulated and acts to inhibit Stra8, and promotes 
spermatogonial differentiation. From Suzuki et al., 2007    
However there are some questions that remain about the role of RA in initiating 
meiotic entry in female.  For example, experiments in the nineties studying the 
effects of RA on germ cells in vitro, never reported seeing germ cells that displayed 
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signs of meiotic entry.  For example, Koshimizu et al in 1995 cultured both male and 
female mouse germ cells at e8.5, e11.5 and e13.5 in the presence of RA, and reported 
that RA stimulated germ cell proliferation. While in mouse fetal ovarian germ cell 
culture, RA was found to both stimulate germ cell division and survival, but not 
initiate meiosis (Morita and Tilly, 1999).  The fact that RA appears to stimulate 
mitotic division, seems surprising when its role as a meiotic initiator would suggest 
that it should direct germ cells away from mitosis. Furthermore in the culture system 
reported by Bowles et al., 2006; Koubova et al., 2006, RA was able to initiate the 
expression of  meiotic genes in male germ cells at e12.5, but this contradicts work by 
Adams and McLaren, 2002 that germ cells removed from an e12.5 gonad are already 
committed to spermatogenesis and are unable to initiate meiosis.  In addition, all the 
studies to date have been exclusively conducted using mouse models and so it cannot 
be ruled out that alternative mechanisms operate in other species. 
 
1.4 Paracrine signalling molecules in the testis 
1.4.1 Activin  
Activin is a member of the TGFβ family.  The biologically active form of activin 
consists of two subunits covalently attached by a single disulphide bond.  To date 
there are five isoforms of the β subunit that have been identified, but only βA and βB 
have been shown to dimerize, giving rise to three forms of activin: activin A, activin 
B and activin AB.  The βA and βB subunits can also form heterodimers with an α 
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Figure 1-16 Diagram showing α and β subunit peptides.  Initially the precursor forms 
undergo maturation to allow release of the mature C-terminal.  Once mature, the β 
subunit can associate with an α subunit to form inhibin A or inhibin B. Alternatively 
the β subunits can dimerize to form activin A, B or AB.  From Ethier and Findlay, 2001 
Activin signals through membrane bound serine-threonine kinase receptors.  Activin 
initially binds to a type II receptor (Figure 1-17 [1]), which recruits a type I receptor, 
(activin receptor IA) (Alk4) (Figure 1-17 [2]).  A receptor complex forms (Figure 
1-17 [3]) and the type I receptor undergoes phosphorylation (Figure 1-17 [4]), this 
then phosphorylates a receptor-regulated Smad, either Smad2 or Smad3 (Figure 1-17 
[5]) (Massague, 1998).  Once the receptor-regulated Smad is phosphorylated, it can 
dimerize with Smad4 (Figure 1-17 [6]), and undergo translocation to the nucleus 
(Figure 1-17 [7]).  The Smad complex forms an association with a DNA binding 
partner (Figure 1-17 [8]), and binds to specific enhancers within target genes (Figure 
1-17 [9]) (Massague, 1998; Massague and Chen, 2000). 
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Figure 1-17 Overview of TGFβ signalling system (Massague, 1998) 
In the human fetal ovary, activins may play an important role in germ cell survival 
(Martins da Silva et al., 2004), where it appears to act upon the somatic cell (Coutts 
et al., 2007a), and studies in immature mice and rats suggest that activin may play a 
role in Sertoli cell and germ cell survival and proliferation in the testes (Meehan et 
al., 2000).  In a study where prepubertal rats were administered Activin A, the Sertoli 
cells underwent increased proliferation (Boitani et al., 1995), while in vitro data 
suggests that activin may act as a regulator of germ cell proliferation (Mather et al., 
1990).  Immunohistochemical staining for the activin subunits in the human fetal 
testis suggest that the Sertoli cells, PTM cells and Leydig all have the potential to 
produce activins (Majdic et al., 1997; Anderson et al., 2002).  Cells in the human 
fetal testis also express activin receptors: ACTRIIA has been immunolocalised to the 
interstitium, as well as the gonocytes and some Sertoli cells; while ACTRIIB was 
found to be expressed in the interstitium, the gonocytes and the Sertoli cells, as well 
as the PTM cells (Anderson et al., 2002).  This suggests that within the human fetal 
testis, activins have the potential to be made, and ellicit a cellular response, but as yet 
no specific mechanisms affected by activin have yet been identified. 
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1.4.2  Androgen signalling 
In the developing testis, androgens are produced by the Leydig cells.  These 
androgens are important for the masculinisation of the developing reproductive tract 
and external genitalia (Wilson et al., 2002).  Some cells within the fetal testis express 
the androgen receptor (AR).  
 
Testosterone can be converted to the more potent metabolite dihydrotestosterone 
(DHT) by the 5α-reductase enzyme  (Russell and Wilson, 1994), of which there are 
two isoforms.  Both testosterone and DHT exert their effects by binding the AR.  The 
AR belongs to a nuclear receptor superfamily of ligand activated transcription 
factors.  DHT binds AR with a higher affinity than testosterone and induces a greater 
response (Deslypere et al., 1992).  In the unliganded state, AR primarily resides in 
the cytoplasm, but upon ligand binding, AR undergoes a conformational change 
allowing it to translocate to the nucleus (Figure 1-18).  Within the nucleus the 
activated AR binds to androgen response elements (AREs) within the response 
elements of target genes to cause up or down regulation of gene expression (Shaffer 
et al., 2004b)  
 
Figure 1-18 Overview of AR signalling.  Modified from Wilson, 1999  
In the adult testis both Sertoli cells and Leydig cells express AR, but previous work 
on the fetal rat (Majdic et al., 1995) and fetal human (Gaskell et al., 2004; Murray et 
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al., 2000) have not detected AR in either of these cell types.  Instead AR is 
abundantly expressed in interstitial fibroblasts and PTM cells (Gaskell et al., 2004; 
Murray et al., 2000).  Although androgen specific targets have not yet been identified 
in these cell types, the presence of the AR suggests that they may be important 
targets for the high concentrations of testosterone synthesised by the fetal Leydig 
cells. 
 
1.5 Methods for studying germ cell development in vitro 
Investigations into the molecular control of germ cell development would be 
enhanced if early germ cells could be obtained and reliably cultured in vitro in a 
differentiated state.  Recent advances, such as the derivation of germ cells from 
embryonic stem (ES) cells, and the derivation of proliferative pluripotent embryonic 
germ cells from human fetuses are promising.  Establishment of somatic cell cultures 
in order to study germ cell-somatic cell interaction would also be useful.   
1.5.1 Embryonic stem cell derived germ cells  
ES cells are pluripotent cells derived from the inner cell mass of the blastocyst 
(Evans and Kaufman, 1981; Thomson et al., 1998) (Figure 1-19).  They undergo self-
renewal in vitro, and when they are allowed to differentiate, they form a large variety 
of cell types from all 3 germ layers (ectoderm, endoderm and mesoderm).   
 
Several groups have now reported the derivation of germ cells from ES cells for both 
the mouse and human.  Interestingly, a variety of methods have now been used for 
obtaining these cells, and each method appears to present a different result.  A 
number of laboratories have employed the use of genetically modified reporter cell 
lines to enhance the study of germ cell-derived ES cells.  
 
Hubner et al (2003) were the first to report the in vitro differentiation of germ cells 
from ES cells.  They used a mouse ES cell line where expression of GFP was driven 
by the Oct4 promoter.  These ES cells were allowed to differentiate as a monolayer.  
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After 8 days of differentiation, around 40% of the cells were found to be Oct4 
positive, and also expressed both Kit and Mvh and were therefore classified as germ 
cells.  After a few weeks of culture, aggregates were found to break away from the 
colonies, and these aggregates were maintained in suspension for another few weeks.  
Within the cultures, follicle-like structures which contained cells thought to be 
‘oocytes’ were found.  These cells were surrounded by a zona pellucida (Hubner et 
al., 2003).  Although, in a more recent analysis of a number of meiosis specific 
markers in germ cell-like ES cells, found that although Sycp3 was expressed, the 
nuclear distribution was highly abnormal, while other meiotic markers such as 
SYCP1 and REC8 were absent (Novak et al, 2006). 
 
In the same year differentiation of ES cells down the male germ cell lineage was also 
described.  Toyooka et al in 2003 used mouse ES cell lines where GFP expression 
was driven by the Mvh promoter.  In their culture system ES cells were allowed to 
form embryoid bodies.  Initially the cultures were negative for Mvh, but after several 
days, a number of GFP positive cells could be detected.  Additionally, the number of 
GFP positive colonies was found to be enhanced by supplementing the cultures with 
BMP4.  These cells were then aggregated with embryonic gonadal tissue and 
transplanted into a host, resulting in the production of haploid spermatids that were 
positive for the Mvh-GFP transgene. 
 
Another group has shown that the formation of ES cell-derived germ cells can be 
enhanced by supplementing the media with RA.  Geijsen et al (2004) allowed 
embryoid bodies to form in vitro for 5 days, and were then able to isolate SSEA1 
positive cells; SSEA1 is expressed by undifferentiated ES cells and early germ cells. 
These putative germ cells were then cultured in the presence of RA, resulting in the 
in vitro expansion and they were subsequently characterised as alkaline phosphatase 
positive with motile characteristics, suggestive of migratory PGCs and displayed 
signs of imprinting erasure, similar to PGCs.  These cultures were found to be 
capable of supporting the maturation of PGCs into haploid male gametes, which 
could form blastocyts when injected into oocytes.  Within the cultures no oocytes-
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specific genes could be detected, suggesting that this culture system could not 
support the generation of female germ cells.  
 
One group has reported the production of live mice from ES cell-derived germ cells 
using mouse ES cell transfected with Stra8 fused to a GFP reporter (Nayernia et al., 
2006).  GFP positive cells were isolated by flow cytometry and then cultured in the 
presence of RA.  The cells were then transfected with a second fusion reporter gene, 
Protamine 1-ds red, in order to identify post-meiotic cells.  These red cells were then 
isolated from the cultures and injected intracyoplasmically into mouse oocytes 
resulting in the production of some live offspring which died prematurely probably 
as a result of imprinting defects.  As yet these experiments have not been repeated by 
any other groups. 
 
As germ cell-derived ES cells develop, a niche may be important for their survival 
and differentiation.  Studies have shown that the formation of male germ cells 
requires embryoid body differentiation and the use of a 2D culture system only 
results in the formation of female germ cells (Hubner et al., 2003; Kerkis et al., 
2007).  It has been reported that within the differentiating embryoid body, male germ 
cells tend to form on the surface, while female germ cells form inside the embryoid 
body (Kerkis et al., 2007).  Directed differentiation of male germ cells has also been 
reported.  Successful derivation of developing male germ cell occurs when ES cells 
are allowed to differentiate in the presence of both RA and testosterone (Silva et al., 
2008) or from testicular cell conditioned media containing cytokines such as BMP4 
and GDF-9 (Lacham-Kaplan et al., 2006).    
 
Only one group thus far has reported the differentiation of human ES cells into germ 
cells (Clark et al., 2004).  When human ES cells are induced to form embryoid 
bodies, the expression of OCT4 and other pluripotency genes declines, while mature 
germ cell markers such as VASA and PUMILIO2 increase. 
Chapter 1 Literature Review 53 
1.5.2 Embryonic germ cells  
In addition to ES cells, another in vitro pluripotent cell line derived from germ cells 
has also been described.  When PGCs are cultured under very tightly regulated 
culture conditions, they will form embryonic germ (EG) cells (Figure 1-19).  These 
cells, like ES cells, are highly proliferative cells which express alkaline phosphatase, 
and other pluripotency markers such as Oct4 and Nanog.  They can also give rise to 
all three germ layers in a similar manner to ES cells.  The derivation and long-term 
culture of mouse EG cells has been relatively unproblematic (Durcova-Hills et al., 
2006; Matsui et al., 1992; Resnick et al., 1992; Rich, 1995; Rohwedel et al., 1996; 
Shim et al., 2008 Durcova-Hills et al., 2001).  This is in comparison to the derivation 
and maintenance of human EG cell lines, where since the initial cultures were 
reported by Shamblott et al., in 1998, only a handful of other groups have reported 
their derivation and successful culture (He et al., 2007; Liu et al., 2004; Park et al., 




Figure 1-19 Cartoon depicting the derivation of human embryonic stem cells from the 
inner cell mass of a blastocyst and the derivation of human embryonic germ cells 
from PGCs.  From Turnpenny et al., 2006 
The derivation of human EG (hEG) cells involves the enzymatic and mechanical 
dispersion of embryonic gonads at 5-9 weeks post-ovulation, followed by their 
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culture in the presence of feeder layers, such as STO fibroblasts or mouse embryonic 
fibroblasts (MEFs).  The hEG cells have been cultured in the presence of the anti-
apoptotic stem cell factor (SCF), Leukaemia Inhibitory Factor (LIF), fibroblast 
growth factor 2 (FGF2) and forskolin.   A recent study has describes the successful 
derivation of hEG cells on fibroblast-like cells derived from the gonadal ridges and 
dorsal mesenteries of 1st trimester fetuses, which endogenously expressing FGF2 and 
LIF (He et al., 2007).  EG cells have been shown to be capable of forming embryoid 
bodies (He et al., 2007; Shamblott et al., 1998) and their therapeutic potential was 
demonstrated when Kerr et al. (2003) reported the introduction of differentiated 
hEGs into the cerebral spinal fluid of paralysed mice, resulting in their distribution 
throughout the spinal cord where they produced factors that aided the recovery of 
motor neurons.   
 
EG cells have been shown to express the characteristic pluripotent cell surface 
markers, stage specific embryonic antigens SSEA-1 and SSEA4, and most groups 
report the expression of the tumour rejection antigens, TRA1-60 and TRA1-81 
(Turnpenny et al., 2006).  The EG cells have been shown to be capable of 
maintaining a normal karyotype for around 10 passages (reviewed in Turnpenny et 
al., 2006).   
 
Park et al in 2004 reported the culture of hEG cells for up to a year.  However 
subsequently, others have reported difficulty in maintaining the pluripotency of the 
hEG cells long-term. It has been reported that levels of OCT4 decrease with long-
term passage, and with repeated freeze-thawing (Liu et al., 2004; Turnpenny et al., 
2003).  Although the expression of OCT4 and NANOG has been demonstrated, other 
genes, normally expressed at high levels in human ES cells, such as SOX2, FGF4 
and FRAGILIS, have never been detected (Turnpenny et al., 2006).  As SOX2 does 
not appear to be expressed in human PGCs (Perrett et al., 2008), and given that 
expression of OCT4, NANOG and SOX2 are all essential for the establishment of ES 
cell lines (Avilion et al., 2003), questions have been asked as to whether the absence 
of SOX2 hinders the long-term maintenance of hEG cells (Perrett et al., 2008).  A 
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recent report also shows that there is a correlation between the number of OCT4 
positive cells and the number of EG colonies, suggesting that the age of the fetus 
from which the cells are derived is critical (Kerr et al., 2007). 
 
1.5.3 Models for studying somatic cells/germ cell interactions in the 
developing testis 
Primary cultures of Sertoli cells, PTM cells and gonocytes have been established 
from a variety of species (Fritz et al., 1975; Majumdar et al., 1998; Tung and Fritz, 
1980; Van Dissel-Emiliani et al., 1996).  However these cultures are only maintained 
short-term and normal cellular interactions between differing cell types such as 
Sertoli cell and PTM cell cannot be achieved (Tung and Fritz, 1980).  Cellular 
architecture and function is better maintained when testicular tissue is cultured on a 
reconstituted basement membrane (Hadley et al., 1985; Noguchi et al., 2006; Gassei 
et al., 2006).  A number of laboratories have already used organ culture as a 
technique for studying human fetal testis and the effects of various molecules such as 
RA (Lambrot et al., 2006a) and environmental pollutants (Lambrot et al., 2006b 
Hallmark et al., 2007).  But these cultures can only be maintained for a few days, 
before cell death occurs and the tissue architecture becomes compromised.  A more 
promising model system for studying cellular interactions within the developing 
testis is xenografts.  For example, when neonatal and prepubertal testicular tissue is 
transplanted subcutaneously into an immunodeficient host tissue function is 
maintained and can result in the successful completion of spermatogenesis.  This 
technique has now successfully been performed in a variety of species, such as the 
mouse, rat, hamster and monkey (Gassei et al., 2006; Honaramooz et al., 2002; 
Schlatt et al., 2003; Schlatt et al., 2002;.  This system could be a valuable model for 
studying germ cell-somatic cell interaction. 
1.6 General aims 
The overall aim of this thesis was to study germ cell development and the influence 
of the somatic cells.  For this study, human fetal gonads were obtained during the 1st 
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and 2nd trimester, and additionally mouse embryonic stem cell lines were used as an 
in vitro model for the study of germ cell gene expression. 
 
The general aims of this thesis are: 
 
• To further characterize germ cells in the human fetal testis, by studying their 
pattern of protein expression during the 1st and 2nd trimester.  
• To determine whether a similar model leading to the meiotic induction of 
germ cells in the developing ovary and inhibition of meiosis in the fetal testis 
operates in the human fetal gonads as has been proposed in the mouse. 
• To establish cultures of human fetal testicular somatic cells that maintain a 
differentiated phenotype, in order to provide a model system to further 
understand gene expression in the 2nd trimester human fetal testis. 
• Culture and differentiate mouse ES cells in order to understand further germ 
cell gene expression and Kit signalling in both wild-type ES cells, as well as 
cell lines mutant for the Kit receptor. 
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2 General materials and methods 
2.1 Recovery of human fetal gonads 
Human fetal testes and ovaries were obtained following elective termination of 
pregnancy during the first (50-65 days gestation) and second (13-20 weeks gestation) 
trimesters, as dated from last reported menstrual period.  Women gave informed 
consent in accordance with national guidelines (Polkinghorne, 1989.). Ethical 
approval was obtained from Lothian Pediatrics/Reproductive Medicine Research 
Ethics Committee.  No terminations were for reasons of fetal abnormality, with all 
fetuses used appearing morphologically normal. Termination of pregnancy was 
performed by medical and nursing staff at the Brunstfield Suite within the Simpson’s 
Centre for Reproductive Health, Edinburgh Royal Infirmary. Terminations were 
induced with mifepristone (200mg, orally) followed by misoprostol (Pharmacia, 
Surrey UK; 200mg every 3 hours per vaginam).  Gestational age was determined by 
ultrasound and for second trimester samples this was confirmed by direct 
measurement of foot length.  The sex of first trimester fetal gonads was determined 
by PCR for the SRY gene.  Testes and ovaries were carefully dissected free from the 
abdominal cavity and either snap frozen and stored at -80oC prior to extraction of 
total protein or RNA, fixed for immunohistochemistry or dissociated for cell culture. 
2.2 Tissue fixation and processing  
Testes and ovaries were divided into two parts, and fixed in Bouins solution 
(Triangle Biomedical Sciences, Lancashire, UK) for 2-3 hours, transferred to 70% 
ethanol (Fisher Scientific) and embedded in paraffin wax by the histology support 
service.  An automated Leica TP1050 processor (Leica Microsystems, Milton 
Keynes, UK) was used for processing the tissue and dehydrating through a series of 
graded alcohols on a 17.5 hour cycle.  Processed tissue was saturated and embedded 
by hand in liquid paraffin wax and cooled. 
 
Sections (5µm) were cut using a hand operated microtome (Leica RM2135), placed 
in a 42oC water bath (Lamb RA, model E/65), and were mounted onto positively 
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charged microscope slides (BDH, Lutterworth, UK).  They were dried overnight in a 
50oC oven (Lamb, RA, model E28.5), before being dewaxed in xylene (Triangle 
Biomedical Sciences), and rehydrated through a series of different concentrations of 
ethanol (95%-70%). 
 
2.3 Tissue staining and Immunohistochemistry 
2.3.1 Haematoxylin and eosin staining 
Following dewaxing and rehydration, sections were then immersed in Harris’s 
haematoxylin (Triangle Biomedical Sciences) for 4-5 minutes, which stains the 
nuclei blue.  Sections were washed in tap water, immersed in 1% acid alcohol to 
remove nonspecific cytoplasmic staining and then rinsed again in tap water.  Sections 
were then immersed in Scott’s tap water for 30 seconds to allow the blue colour to 
develop.  Sections were then immersed in eosin Y (1% aqueous solution mixed with 
1% alcohol solution at a ratio of 3:1 - Triangle Biomedical Sciences) for 30 seconds 
to stain the cytoplasm pink, before being rinsed in tap water.  Sections were then 
dehydrated in a series of alcohols.  Slides were cleaned with xylene (2x5 minutes) 
and mounted with coverslips (VWR, Poole, UK.) using Pertex (Cell Path, Hemel 
Hempstead, UK). 
2.3.2 Immunohistochemistry 
Immunohistochemistry is the process whereby a specific antigen within tissues or 
cells is recognised by an antibody raised to an epitope within the protein of interest.  
The protein of interest is detected by binding of a specific primary antibody, which is 
then bound by a secondary antibody conjugated with a biotin molecule.  Streptavidin 
horseradish peroxidise (HRP) binds the biotin and the complex is visualised by 3,3-
diaminobenzidine tetrahydrochlorine (DAB) that turns brown in the presence of the 









Figure 2-1 Summary of immunohistochemical detection method used   
 
2.3.3 Antigen Retrieval 
The fixation process can mask a number of antigens, due to the cross linking of a 
number of amino acids, and this can reduce binding by the primary antibody.  By 
exposing the tissue to high levels of heat and altering the pH, epitopes can be 
exposed, allowing the antibody to bind the antigen (Shi et al., 1997).  Heat-induced 
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antigen retrieval was performed by placing slides in a pressure cooker in 0.01M 
citrate pH6 for 5 minutes on full power, with 20 minutes standing time prior to 
cooling.  First trimester tissue was pressure cooked for 3 minutes with 10 minutes 
standing time. 
2.3.4 Methanol peroxide block 
In order to block endogenous peroxidase activity, which would otherwise interfere 
with horseradish peroxidise amplification, tissues were incubated in 3% H2O2 (BDH 
laboratory supplies) in methanol for 30 minutes.  After the 30 minutes, slides were 
washed by being placed in Tris-buffered saline (TBS) solution (section 2.7) for 5 
minutes. 
2.3.5 Serum block 
Non-specific binding of secondary antibodies was prevented by incubating with the 
appropriate non-immune block.  Serum was used from the species in which the 
secondary antibody was raised.  For example, if the secondary antibody was raised in 
rabbit, tissue was incubated in TBS containing 20% normal serum (e.g rabbit) 
(Diagnostics Scotland, Carluke, UK) and 5% BSA (Sigma, Poole, Dorset, UK) for 30 
minutes. 
2.3.6 Avidin-biotin block 
Some tissues have high levels of endogenous biotin, making them prone to binding 
high levels of the streptavidin-HRP without the addition of the biotinylated 
secondary antibody.  An avidin-biotin blocking step was used to block endogenous 
biotin, which can cause non-specific binding.  Immediately after the serum blocking 
step, tissues were incubated with avidin-D (Vector Laboratories, Peterborough, UK, 
0.01M) for 15 minutes.  After 2x5 minute washes in TBS, slides were incubated with 
biotin for 15 minutes (Vector Laboratories, Peterborough, UK). 
2.3.7 Primary antibodies 
Details of primary antibodies used are listed in Tables 3-2, 4-1 and 5-1.  All primary 
antibodies were diluted in the appropriate normal serum, and incubated overnight at 
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4oC.  Negative controls were included in each run where the primary antibody was 
replaced with a non-immune block.  After the overnight incubation, the slides were 
then washed in TBS (2x5 minutes). 
2.3.8 Secondary antibodies 
Biotinylated secondary antibodies were diluted in their appropriate normal serum and 
incubated on tissue sections for 30 minutes at room temperature.  Secondary 
antibodies used are listed in Table 2-1. 
2.3.9 Developing, counterstaining and mounting 
Streptavidin-HRP (DAKO, Cambridge, UK) was used, diluted 1:1000 and incubated 
with slides for 30 minutes at room temperature.  Slides were washed for 2x5 minutes 
in TBS, then incubated with DAB substrate (DAKO), for 1-5 minutes, until 
immunopositive staining (brown) was observed.  DAB produces an insoluble stable 
dark brown substance at the sites of antibody localisation.  DAB is an electron donor 
that oxidises in the presence of peroxidise, resulting in a colour change.  Slides were 
then immersed in water, counterstained with haematoxylin for 2-5 minutes, 
rehydrated and dewaxed, before being mounted in pertex. 
2.3.10 Fluorescent immunohistochemistry 
Double label fluorescent immunohistochemistry is frequently used for the cellular 
and subcellular colocalisation of independent antigens.  Primary antibodies for 
double labelling should be derived from independent species.  In order to use two 
antibodies from the same species, monovalent secondary antibodies with FAB 
fragments were used (Lewis Carl et al., 1993). 
 
Fluorescent immunohistochemistry was performed in the same way as the DAB 
immunohistochemistry up until the secondary antibody stage, with the exception of 
the washes being performed in PBS 0.5% Tween (Sigma) followed by PBS for 5 
minutes.  Biotinylated, peroxidase or direct fluorescent conjugated secondary 
antibodies were used.  Peroxidase and biotinylated labelled antibodies were diluted 
in normal serum, and direct conjugate antibodies were diluted in PBS.  Peroxidase 
Chapter 2     General Materials and Methods 62 
labelled and direct fluorescent conjugates were incubated for 1 hour at room 
temperature.  The biotinylated antibodies were incubated on the sections for 30 
minutes, followed by either streptavidin 488 or 546 diluted 1:200 in PBS for 1 hour. 
The peroxidase antibodies were incubated for 1 hour followed by tyramide-Cy 3 or 
tyramide-enhanced fluorescein (PerkinElmer, Massachusetts, USA) diluted in 
tyramide buffer (1:5 dilution) for 10 minutes.  Information regarding secondary 
antibodies used is listed in Table 2-1.  Nuclear counterstaining was performed using 
DAPI (Sigma) diluted 1:1000.  Slides were mounted using permaflour (Immunotech, 
Marseille, France). 
Table 2-1 Summary of secondary antibodies used for immunohistochemsitry 
Host Target Conjugate Source Catalogue 
number 
Dilutions 
Goat  anti-mouse biotinylated Sigma B6649 1:500 
Chicken  anti-rabbit biotinylated SCruz1 Sc-2986 1:500 
Goat  anti mouse peroxidase Dako PO447 1:200 
Goat  anti-rabbit (Fab)-
biotinylated 
AbCam2 Ab7055 1:600 
Rabbit  anti-mouse biotinylated Dako E0464 1:500 
Goat  anti rabbit biotinylated Dako E0432 1:500 
Chicken  anti-mouse biotinylated SCruz1 Sc-2985 1:500 
Chicken  anti-goat peroxidase SCruz1 Sc-2953 1:200 
Rabbit  anti-goat peroxidase Sigma A5420 1:200 
Goat  anti-rabbit alexa 488 Molecular 
probes3 
A11034 1:200 
Goat  anti-rabbit alexa 546 Molecular 
Probes3 
A11035 1:200 
1Santa Cruz Biotechnology, CA, USA 
2R+D Systems, MN, USA 
3Molecular Probes, Leiden, The Netherlands 
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2.3.11 Imaging 
Non-fluorescent images were photographed using a PROVIS microscope (Olympus 
Optical, London, UK) and a Canon DS126131 camera.  Images were obtained using 
Canon EOS image capture software (Canon, Woodhatch, Surrey, UK). 
 
Fluorescent images were visualized using a LSM 510 Meta-Confocal (Carl Zeiss, 
Hertfordshire, UK).  Photographs were compiled using Adobe Photoshop 7.0 (Adobe 
Systems Inc, CA, USA.). 
 
2.4 RNA analysis 
2.4.1 RNA extraction from tissues and cells 
RNA extraction was performed using reagents supplied in the RNA mini extraction 
kit (Qiagen, Crowley, UK).  For RNA extraction from tissues, tissue was lysed by 
either grinding in liquid nitrogen or using a Qiagen Tissue Lyser.  Lysates were spun 
through a Qiagen shredder spin column placed in a 2ml collection tube.  RNA 
extraction was performed using a mini column, following manufacturer’s 
instructions.  On-column DNase treatment, to prevent DNA contamination, was 
performed (Qiagen).  RNA extraction was completed by eluting RNA in a volume of 
RNAse-free H20 (30µl-60µl).  
2.4.2 RNA quantification 
RNA concentration was determined using a Nanodrop-1000 (Labtech International, 
East Sussex, UK).  This is a spectrophotometer which allows accurate and 
reproducible quantification of RNA.  The concentration of RNA was adjusted to 
100ng/µl in RNAse free H20. 
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2.5 TaqMan® reaction 
2.5.1 Principles of reaction 
Quantitative PCR is a modified form of PCR, which allows quantification of the 
amount of RNA present in a sample.  PCR should amplify the DNA exponentially, 
doubling the number of molecules present within each amplification cycle.  
Therefore, the amount of a specific cDNA present in the sample can be calculated.  
Real-time PCR allows a measure of the amount of DNA after each cycle of PCR, by 
the use of fluorescent markers.   
 
Figure 2-2 Principle of TaqMan® reaction with probe intact 
In the TaqMan® reaction fluorescent probes are used, and upon melting of the DNA, 
the probe will bind to the complementary sequence in the region of interest in the 
template DNA, along with the primers.  Once taq polymerase becomes activated, the 
polymerase starts writing the complementary strand to the primed single strand DNA 
(Figure 2-2).  The polymerase has 5’-3’ exonuclease activity, as it reaches the probe 
the reporter and quencher separate, resulting in an increase in fluorescence (Figure 
2-3).  As the reaction progresses, more and more fluorescent reporter is liberated, 
allowing an accurate quantification of the final, and thus the initial, quantity of DNA, 
through measurement of the amount of fluorescence. 
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Figure 2-3 TaqMan® reaction following release of fluorescence 
2.5.2 Universal probe library 
The Roche Universal Probe Library™ (Roche, West Sussex, UK) consists of 165 
short hydrolysis probes.  The probes have the duplex stabilising DNA analogue 
locked nucleic acid (LNA), which allow the probe size to maintain short, while 
maintaining specificity and a melting temperature permitting hybridization of the 
probes.  Probes are labelled 5’ terminal with fluorescien (FAM) and the 3’-proximal 
terminal is labelled with a dark quencher dye.  As they only bind to 8-9 nucleotides, 
each probe can recognize target sequences which occur frequently in the 
transcriptomes.  
 
The design software at Roche Applied Science Assay Design centre 
(https://www.roche-appliedscience.com/sis/rtpcr/upl/) for each assay suggests an 
optimal set of PCR primers and one probe.  Primers and probes used are listed in 
tables 4-2, 5-2 and 6-1.  
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2.5.2.1 Preparation of cDNA using random hexamers. 
A cDNA mastermix was prepared, and each reaction was set up at 20μl.  Reagents 
per reaction (all Applied Biosystems, California, USA) were used at the following 
concentrations:  PCR buffer I (1x), MgCl2 (5mM), dNTPs (1mM), RNase inhibitor 
(1μg/μl), Multiscribe reverse transcriptase (2.5μg/μl), random hexamers (2.5μM), 5μl 
of H2O and 400ng of RNA.  In every run, a positive, negative and no RT control was 
included.  The reaction was run on a Biometra PCR machine set at 25oC for 10 
minutes, 42oC for 1 hour, 99oC for 5 minutes and 5oC for 5 minutes. 
2.5.2.2 TaqMan reaction 
Each TaqMan® reaction was performed in triplicate and on a Microamp Fast Optical 
96 well reaction plate (Applied Biosystems).  During the course of the studies 2 sets 
of reagents were used.  Each well was set to contain either of the following reagents:   
• Universal mastermix (Applied Biosystems) (2x)  7.5μl 
• 18S primer (0.02μM) primer/probe mix (0.08μM)  0.225μl 
(Applied Biosystems) 
• Forward Primer (200nM)     0.15μl 
• Reverse Primer (200nM)     0.15μl 
• Target probe (100nM)      0.15μl 
• H20        5.325μl 
•  cDNA        2μl 
OR: 
• 2x faststart master mix (Roche)    10μl  
• Rox dye (6μM) (Roche)     1.5μl 
• Forward Primer (20μM)     0.2μl 
• Reverse Primer (20μM)     0.2μl 
• Probe (10μM)       0.1μl 
• 18S (0.08μM probe 0.02μM primer)    0.3μl 
•  H20         5.7μl  
• cDNA.        2μl  
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2.5.3 Analysis of results 
Relative quantification was performed using the ABI Prism sequence detection 
system.  Real-time PCR reactions are characterised by the point in time during 
cycling when amplification of the target reaches a threshold rather than by the 
amount of target which has accumulated by the end of the reaction.  The earlier that a 
target becomes detectable therefore means the more cDNA present.  The results of 
the TaqMan reaction are presented in an amplification plot, displaying the amount of 
reporter dye generated during amplification and relative to the quantity of PCR 
product formed, which is related to the levels of expression of the target gene.  The 
threshold level is defined as the point at which an increase in signal is associated 
with an exponential increase in PCR product.  The threshold cycle (Ct) indicates the 
fractional cycle number at which the amount of amplified target reaches a fixed 
threshold (Figure 2-4).  The FAM Ct value corresponds to the cycle number where 
the fluorescence generated crosses the threshold level.  Samples are normalised 
against the amount of DNA present for a stably expressed ‘housekeeping’ gene, such 
as 18S.  The 18S ribosomal RNA is a measure of the total RNA content in the 
sample, and allows for sample variation. 
 
The results were analysed using the comparative ct method, whereby the fold change 
in gene expression is made relative to a reference sample (e.g control).  The initial 
step in the analysis was to calculate the ΔCt, this is the difference between FAM Ct 
and 18S Ct.  The mean ΔCt for the triplicates was calculated and used to determine 
the ΔΔCt.  The ΔΔCt is the difference between the ΔCt of the experimental sample 
compared to that of the control sample.  The amount of amplified target is given the 
value 2-ΔΔCt , which is based on the mathematical equation that describes the 
exponential amplification of a PCR: 
 
Xn=X0 x (1+Ex)n 
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Where Xn=number of target molecules at cycle n of the reaction, where X0 is the 
number of target molecules, Ex is the efficiency of target amplification and n is the 
number of cycles.   
 
The selected reference or control sample is given the value 2-ΔΔCtof 1 
 
Figure 2-4  A typical amplification plot, after a successful PCR reaction 
2.5.4 Primer/Probe validation 
The amplification efficiencies of the target and reference must be approximately 
equal for the 2-ΔΔCt calculation to be valid.  In order to asses whether two amplicons 
have the same efficiency, it should be determined how ΔCt varies with template 
dilution.  An example is shown in Figure 2-5, where a series of RNA dilutions were 
amplified using primers and probes for SOX9 and 18S.  The average Ct was 
calculated for both SOX9 and 18S, and the ΔCt determined.  A plot of log RNA 
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dilution versus ΔCt was then made.  If the absolute value of the slope is close to zero 
(in the case of SOX9 it was -0.0166), the efficiencies of the target and reference are 
similar and the ΔΔCt calculation can therfore be used for relative quantification. 
.  
Figure 2-5 SOX9 validation with log ng RNA plotted against ΔΔCT. 
2.6 Western Blotting 
Western blotting is a technique where electrophoresis is used to separate proteins by 
size, the proteins are then transferred onto a membrane, allowing for detection of 
proteins of interest using specific primary antibodies.  Visualisation is performed 
with secondary antibodies combined with either chemical or fluorescent detection 
systems.  The LiCor system (LiCor Biosciences, Lincoln Nebraska) is a two colour 
detection system, whereby two fluorescently labelled secondary antibodies can be 
detected simultaneously with a fluorescent filter. 
2.6.1 Protein extraction from tissues and cells 
Protein was extracted from human fetal testes and ovaries of the 1st and 2nd trimester.  
Testes and ovaries from the 1st trimester were placed in 50μl of RIPA Buffer (section 
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2.7) containing a protease inhibitor cocktail (Roche).  2nd trimester testis were halved 
and placed in 200μl of RIPA buffer. They were homogenised using a rotorstator 
homogenizer or with a Qiagen Tissue Lyser.  Cells were lysed directly in RIPA 
buffer. Homogenates were incubated for 1 hour on ice and then centrifuged for 20 
minutes at 2500 rpm, the supernatant was kept and the pellet discarded. 
2.6.2 Protein quantification 
A Biorad DC Protein Assay Kit (Hemel Hempstead, Herts, UK) was used for 
quantification of proteins, by comparing the amount of protein in diluted samples to 
a series of controls containing a known concentration of protein Bovine Serum 
Albumin (BSA) (0.125mg/ml-1.5mg/ml).  The standards and samples of an unknown 
concentration were subjected to an assay based on the Lowry method for protein 
quantification.  The first step involves a reaction between the protein and copper in 
an alkaline medium, while the second step involves the reduction of Folin reagent by 
the copper treated protein.  The protein causes a reduction of the follin reagent and 
results in the production of a reduced species with a characteristic blue colour. 
Briefly, in accordance with manufacturer’s instructions, 25μl of reagent S was added 
to each ml of reagent A.  The assay was performed in a flat bottom 96 well plate.  To 
each well, 5μl of sample/standard and 25μl of reagent A (+S) and 200μl of reagent B 
in duplicate for each well.  This was mixed and incubated at room temperature for 15 
minutes.  Samples were then read on a spectrophotometer (Labsystems Miltiskan Ex, 
VWR) at 690nm.  A standard curve from the solution of known concentration was 
drawn to obtain the equation of the line.  This was used to calculate the value of 
protein in each sample. 
 
2.6.3 Poly-acrylamide gel electrophoresis 
Protein samples were separated using NuPage® Novex Bis-Tris ready made 
polyacrylamide gels (4-12%) (Invitrogen, paisley, UK) using NuPage® MOPS SDS 
running buffer (Invitrogen).  Protein samples were ran on a NuPage® Novex 4-12% 
Bis-Tris readymade polyacrylamide gel (Invitrogen, paisley, UK) with 1X MOPS 
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running buffer (Invitrogen). 20μg of protein was loaded onto each well on the gel, 
samples were diluted to this concentration in PBS, 5μl of bromophenol loading 
buffer and 2μl of reducing agent (both Invitrogen) were added to the protein samples 
prior to loading.  The samples were heat denatured for 5 minutes at 70oC.  Protein 
was kept on ice before loading onto gel; 7μl of SeeBlue plus-2 pre-stained 
multicoloured molecular weight marker (Invitrogen) was loaded, in a parallel lane on 
each gel.  This marker runs down the gel, along with protein and displays bands of a 
known molecular weight, allowing the size of the samples to be identified.  The gel 
was run at 120 volts for 2 hours.  Electrophoresis was stopped when the 
bromophenol blue dye reached the bottom of the gel. 
 
2.6.4 Protein transfer  
The protein from the gel was transferred onto a PVDF Immobin FL membrane  
(Millipore UK, Watford, UK), using an electrophoresis unit (Hoefer Scientific 
Instruments) with 1X transfer buffer (Invitrogen), supplemented with methanol, in 
accordance with manufacturer’s instructions.  The electrophoresis unit was set up to 
contain 2 porous pads, 6 pieces of Whatman paper, all soaked in 1x NuPage Transfer 
Buffer (Invitrogen).  The nitrocellulose membrane (Immobilin P, Millipore, Bedford, 
UK) was rehydrated in methanol for 30 seconds and then washed in transfer buffer.  
The transfer tank was set up with the membrane on the positive side of the electrode, 
the arrangement is shown in Figure 2-6.  The tank was filled with the above transfer 
buffer and the blot was transferred at 40 volts for 4 hours or at 20 volts overnight.  
During this time proteins migrated out of the gel towards the positive electrode and 
became trapped in the membrane. 
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Figure 2-6 Orientation of a Western blot transfer tank.  From the negative electrode 
there is a sponge, followed by 3 pieces of Whatmann paper (P), the gel (G), the 
membrane (M), 3 pieces of Whatman (P), a sponge (S) and then a positive electrode 
 
2.6.5 Probing the membrane  
After transfer to the membrane, non-specific binding was blocked by incubation for  
1 hour in Odyssey blocking buffer (LiCor), diluted 1:1 in PBS.  Primary antibodies 
were incubated overnight at 4oC.  Details of antibodies used, their concentration, 
species and source can be found in Tables 3-1, 6-2, 5-5. 
 
After 4x5 minute washes in PBS 0.1% Tween (Sigma), secondary antibodies were 
added, diluted 1 in 10,000 in Odyssey blocking buffer. The secondary antibodies 
used are described in Table 2-2.  Secondary antibodies were incubated for 1 hour. 
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Table 2-2 Summary of secondary antibodies used for Western blotting 
Antibody Source Detection 
Goat anti-rabbit  Rockland, USA 800nm 
Goat anti-mouse  Molecular Probes, Leiden, The 
Netherlands 
680nm 
Donkey anti-goat  Invitrogen, Paisley, UK 680nm 
 
2.6.6 Protein expression analysis  
Finally, 4x5 minute washes in PBS 0.1% Tween were performed, the membrane was 
washed further in PBS to remove any residual Tween 20, and visualised using the 
LiCor system. 
2.7 Commonly used solutions 
 
RIPA lysis Buffer 
• 25mM tris 
• 1% triton 
• 0.05% sodium deoxycholate 
• 0.1% SDS 
• 150mM NaCl 
Tris Buffered Saline (TBS) 
• 60.5g Tris  
• 87.6g NaCl  
• 300mls HCL 
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Tris-Acetate EDTA buffer 
• 242g Tris base  
• 57.1ml  Acetic acid  
• 100ml 0.5M EDTA  
Add ddH2O to 1 liter and adjust pH to 8.5.  
Modified Davidsons fixative 
 
• 37-40% Formaldehyde  
• 15% Ethanol 
• 5% Glacial Acetic Acid  




Embryonic stem cell medium 
 
• 340 mls UHP H2O 
• 40mls of 10x Glasgow Minimal Essential Media  
• 13.2mls of Sodium Bicarbonate (7.5% stock solution)  
• 4mls of non essential amino acids  
• 8mls of glutamine/pyruvate  
• 400μl mercaptoethanol  
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TVP 
• 2.5 ml trypsin  
• 0.078g EDTA 
• 2.5ml Chick serum 
• 245ml PBS 
 
Glutamine/pyruvate 
• Sodium pyruvate 100mM  
• L-glutamine 200mM 
 
2-mercaptoethanol 
• 100μl of mercaptoethanol in 14.1ml sterile water 
 
Human fetal testis somatic cell medium 
• Dulbecco’s Modified Eagles Medium  
Supplemented with: 
• 10% HI foetal calf serum 
• 1% non essential amino acids  
• 1% D-(+)-Glucose (45% solution)  
• 1% 2mM L-Glutamine  
• 1% Penicillin-Streptomycin  
• 1% Fungizone  
 
T9 retinoic acid reporter cells medium 
• Dulbecco’s Modified Eagles Medium  
Supplemented with: 
• 20% charcoal stripped foetal calf serum  
• 1% non essential amino acids  
• 1% 2mM L-Glutamine 
• 1% Penicillin-Streptomycin  
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3 Protein expression patterns in germ cells of the human 
fetal testis 
3.1 Introduction 
Primordial germ cells (PGCs) arise from a population of cells within the proximal 
epiblast (Lawson and Hage, 1994) they migrate to the genital ridge (Kaufman, 1992), 
arriving by the 5th week of gestation in the human (Wartenberg, 1981) (Chapter 1, 
section 1.3.1.7).  In the male, upon entry to the developing gonads, the germ cells 
become enclosed by the developing Sertoli cells thus forming the testicular cords, 
this is complete by the 8th week of gestation (Wartenberg, 1981).  
 
Early germ cells express a number of characteristic pluripotency markers, such as the 
transcription factors OCT4 and NANOG.  In the rodent, both Oct4 and Nanog have 
been shown to be expressed in PGCs throughout the migratory period and in the 
initial gonocyte population that colonise the genital ridge (Rosner et al., 1990; 
Yamaguchi et al., 2005).  The germ cells of the rodent then differentiate in a 
synchronized manner, with all germ cells switching on mouse vasa homologue (Mvh) 
upon entry to the genital ridge (Toyooka et al., 2000), followed by the subsequent 
downregulation of Oct4 before birth (Ferrara et al., 2006; Zayed et al., 2007).  
Studies in the 1970s suggested that unlike the mouse, germ cells of the human fetal 
testis appear as a heterogenous population of cells within one single testis cord 
(Fukuda et al., 1975; Wartenberg, 1976).  Fukuda et al (1975) used histological 
analysis to identify 3 different subpopulations of human fetal germ cells, which were 
termed gonocytes, intermediate cells and prespermatogonia (Chapter 1, section 
1.3.2.2).  The gonocytes have been shown to express OCT4 and the tyrosine kinase 
receptor KIT, and have low levels of the melanoma associated antigen, MAGE-A4.  
The prespermatogonia display little to no expression of OCT4 and KIT, but express 
high levels of MAGE-A4 protein.  An intermediate population of cells with low to 
negative levels of OCT4 and no KIT or MAGE-A4 has also been identified (Gaskell 
et al., 2004).  The gonocytes are the predominant cell type in the 1st trimester testis 
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and by the 2nd trimester, gonocytes, intermediate cells and prespermatogonia are all 
present, with the number of prespermatogonia increasing towards the end of the 2nd 
trimester. 
 
Understanding germ cell differentiation in the human fetal testis may be key to 
understanding mechanisms leading to testicular germ cell tumours (TGCT) in adults 
(Chapter 1, section 1.3.2.3).  TGCTs arise from a common precursor lesion called 
carcinoma in situ (CIS).  CIS cells bear close morphological similarity with human 
fetal germ cells (Nielsen et al., 1974) and it is widely speculated that CIS cells arise 
from a failure of fetal germ cells to undergo the normal maturation process, instead 
they are believed to persist in the testis and undergo malignant transformation post-
pubertally (Skakkebaek, 1972).  This theory is supported by the fact that CIS cells 
express a large number of proteins in common with embryonic germ cells.  Among 
the proteins detected in both fetal germ cells and CIS are the pluripotency markers 
OCT4 (Looijenga et al., 2003) and NANOG (Hart et al., 2005), as well as mature 
markers such as: M2A, a glycosylated monomeric sialoglycoprotein, which has an 
unknown function (Giwercman et al., 1988); the RNA-binding protein DAZL 
(LitSchitz-Mercer, 2002); the RNA helicase VASA (Honecker et al., 2004; Zeeman 
et al., 2002) and the transcription factor AP2γ (Hoei-Hansen et al., 2004; Pauls et al., 
2005). 
 
A number of genes have been implicated in the development and maturation of germ 
cells.  One such gene is DAZL, a member of the deleted in azoospermia (DAZ) 
family of proteins that has two further family members DAZ and BOULE, both of 
which are expressed in the adult human testis (Xu et al., 2001).  Dazl knock-out mice 
are infertile (Ruggiu et al., 1997).  In female mice, germ cells were lost at e17.5 
having failed to complete meiotic prophase, while in males germ cells were reported 
to be lost as they progressed through the zygotene stage during the first 
spermatogenic wave, at the time of puberty.  Taken together these data suggested that 
Dazl is important for progression through meiotic prophase in both male and female 
germ cells (Saunders et al., 2003).  Studies in Dazl−/− mice of C57BL/6 background 
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suggested that Dazl may have an earlier role, as germ cells in these mice were lost 
during embryonic development, between e12.5 and e13.5 (Lin and Page, 2005). 
 
Another gene with a well characterized role in germ cell development in the mouse is 
Mvh, a member of the DEAD-box protein family, initially identified as a key 
regulator of germ cell development in Drosophila (Lasko and Ashburner, 1988).  
Mvh was reported to be germ cell specific (Fujiwara et al., 1994) and Toyooka et al 
(2000) showed that Mvh was expressed by both male and female germ cells 
immediately after colonization of the genital ridge through to post-meiotic stages.  
Loss of Mvh resulted in germ cells in the male failing to pass through the zygotene 
stages of meiosis (Tanaka et al., 2000).  In the human, VASA has been shown to be 
expressed in fetal germ cells of the testis where it localized to OCT4 negative cells of 
a 21 week of fetus (Honecker et al., 2004). 
 
Another RNA binding protein, nanos was originally identified as a maternal effect 
gene in Drosophila (Wang and Lehmann, 1991), where it is necessary for the 
migration and development of germ cells in Drosophila embryos (Forbes and 
Lehmann, 1998; Kobayashi et al., 1996), mediating its effects through interaction 
with the pumilio protein (Abe et al., 1996; Forbes and Lehmann, 1998).  In the 
mouse the Nanos gene has been cloned, as have 2 homologues (Nanos 2 and 3) 
(Tsuda et al., 2003).  In the human NANOS1 may have a role in germ cell 
development, as it has been shown to bind to human PUMILIO2, both of which are 
co-expressed in spermatogonia (Jaruzelska et al., 2003). 
 
3.1.1 Aims of chapter 
The aim of this study was to further characterize germ cells in the human fetal testis, 
by studying their pattern of protein expression during the 1st and 2nd trimester, using 
double fluorescent immunohistochemistry to determine protein expression in specific 
germ cell types and Western blotting to compare total protein expression.  
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3.2 Materials and methods 
3.2.1 Collection of human fetal testes 
Human fetal testes were obtained following termination of pregnancy as outlined in 
section 2.1 
 
3.2.2 Testicular germ cell tumour tissue 
Testicular germ cell tumour samples were collected by the pathology departments at 
Edinburgh Royal Infirmary and Edinburgh Western General.  Ethical approval was 
obtained from Lothian Local Research Ethics Committee (REC ref:07/51101/8). 
 
3.2.3 Western blotting 
Western blotting was performed on human fetal testes of the 1st trimester and 2nd 
trimester.  Testes were halved and lysed in RIPA buffer (section 2.6.1).  Protein was 
quantified using a Biorad protein assay kit (section 2.6.2).  Details of Western 
blotting are outlined in section 2.6.  Information regarding the primary antibodies 
used is listed in Table 3-1.  Quantification of Western blots was performed using the 
Odyssey software, where the values of the proteins of interest were divided by the 
values for the loading control. Values were then made relative to one of the 9.3 day 
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Table 3-1  Summary of primary antibodies used for Western blotting 
Antigen  
 
Host Species  Source  Dilution 
AP2γ Mouse Santa Cruz 1.200 
DAZL Mouse Serotec 1.500 
NANOG Goat R and D systems 1.500 
NANOS1 Rabbit AbCam 1.500 
OCT4 Goat Santa Cruz 1.500 
VASA Rabbit AbCam 1.500 
β-TUBULIN Rabbit Santa Cruz 1.1000 
β-TUBULIN Mouse Sigma 1.1000 
  
3.2.4 Haematoxylin and eosin staining 
Details of the haematoxylin and eosin procedure are outlined in section 2.3.1. 
3.2.5 Immunohistochemistry 
3.2.5.1 DAB 
The immunohistochemical procedure used is outlined in section 2.3.2. Information 
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Table 3-2 Summary of primary antibodies used for immunohistochemistry 
Antigen Source Species Dilution Citrate 
Retrieval 
AP2γ Santa Cruz Mouse 1.20 Yes 
DAZL Serotec Mouse 1.300 Yes 
Ki67 AbCam Rabbit 1.200 Yes 
Ki67 Vector  Mouse 1.100 Yes 
M2A AbCam Mouse 2 drops/slide Yes 
NANOG R+D 
systems 
Goat 1.50 Yes 
NANOS1 AbCam Rabbit 1.500 Yes 
OCT4 Santa Cruz Goat 1.50 Yes 
VASA AbCam Rabbit 1.500 Yes 
 
3.2.5.2 Immunofluorescence 
Immunofluoresent immunohistochemistry was performed as described in section 
2.3.10.  The protocols for double fluorescent immunohistochemistry using specific 
primary antibodies are outlined in Table 3.3. 
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Table 3-3 Summary of primary and secondary antibodies, and fluorescent labels used 
for co-localisation 
ABBREVIATIONS 
GAM-b: Goat anti-mouse biotinylated  ChAM-b:Chicken anti-mouse biotinylated 
GAR-488:Goat anti-rabbit alexaflour 488  ChAG-p:Chicken anti-goat peroxidase 
RAG-p:Rabbit anti-goat peroxidase   GAR-546:Goat anti-rabbit alexafluor 546 
ChAR-b:Chicken anti-rabbit biotinylated  GAR (fab)-b:Goat anti-rabbit FAB-biotinylated 
RAM-b: Rabbit anti-mouse biotinylated  TyrCy3: Tyramide Cy3 
Strep488:Streptavidin 488    TSA (tyramide signal amplification)  
Strep546: Streptavidin 546 
 
 
3.2.6 Proliferation index 
Ki67 immunohistochemistry was used to identify proliferating germ cells. Fetal 
testes were divided into groups of early 2nd trimester (14-15 weeks, N=4), mid 2nd 
trimester (16-17 weeks, N=5), and late 2nd trimester (18-19 weeks, N=4).  Fetal 













DAZL 1.500 GAM-b Strep 546 VASA 1.300 GAR -488        - 
VASA 1.300 ChAR-b Strep 488 OCT4 1.200 ChAG-p Tyr cy 3 
AP2γ 1.60 GAM-p Tyr cy 3  VASA 1.200 GAR-b Strep 488 
VASA 1.200 GAR 
(Fab)-b 
Strep 488 NANOS1 1.60 GAR 
(Fab)-b 
Strep 546 
VASA 1.200 GAR-b Strep 488 OCT4 1.50 ChAG-p Tyr cy 3 
DAZL 1.500 RAM-b Strep 546 OCT4 1.200 RAG-p TSA plus 
fluorescein 
VASA 1.300 GAR-b Strep 488 M2A 2 drops 
per slide 
GAM-p Tyr cy 3 
Ki67 1.100 ChAR-b Avidin 
488 
OCT4 1.200 ChAG-p Tyr cy 3 
M2A 2 drops 
per slide 
ChAM-b Strep 488 OCT4 1.200 ChAG-p Tyr cy 3 
Ki67  1.100 ChAM-b Strep 488 VASA 1.200 GAR-546         - 
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testicular cords.  Counting was performed using a 40x objective fitted to an Olympus 
BH2 microscope with Hitachi HVC20 camera and images were analysed using 
Imagepro-plus version 4.5.1 with Stereology Pro 5.0 (Media Cybernetics, 
Wokingham, Berkshire, UK); 30 fields were randomly selected and counted.  The 
proliferation index was calculated by dividing the number of Ki67 positive germ 
cells by the total number of germ cells counted.  Statisitical analysis was performed 
using a one-way analysis of variance (ANOVA). 
3.3 Results 
3.3.1 Western analysis of 1st and 2nd trimester human fetal testes 
Total protein expression of putative germ cell markers in extracts of testes of the 1st 
and 2nd trimester were determined using Western blot analysis.  The microtubular 
protein β-tubulin was used as a loading control.  OCT4 (39kD), NANOG (37kD), 
AP2γ (50kD), NANOS1 (35kD) and DAZL (33.5kD) were all detected in both 1st 
and 2nd trimester samples (Figure 3-1).  VASA (76kD) protein was found to be 
absent in testes of the 1st trimester, but present throughout the 2nd trimester (Figure 
3-1).   
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Figure 3-1 Western blots for OCT4, NANOG, AP2γ, DAZL, VASA and NANOS1 in 
human fetal testes of the 1st (9.3 days) and 2nd trimester (14, 15 and 19 weeks). β-
tubulin (51KD) is the loading control for each of the proteins, L is the protein ladder, 
relative to second trimester testes. 
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Quantification of proteins revealed that all proteins tended to increase in the 2nd 
trimester compared with the first (Figure 3-2).  The increased expression of these 
proteins in the 2nd trimester relative to the 1st trimester could be attributed to 
increased numbers of germ cells expressing these proteins, increased expression per 
germ cell or increased proportion of germ cells in the testis relative to somatic cells.  
Therefore to further analyse the expression patterns of these proteins, 
immunohistochemistry was performed. 
 
 
Chapter 3    Protein expression patterns in germ cells of the human fetal testis 86 
 
Figure 3-2 Quantification of Western blots OCT4, NANOG, AP2γ, DAZL, VASA and 
NANOS1 in 1st (N=2) and 2nd (N=3) trimester testes.  Mean ± sem. 
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3.3.2 Immunohistochemical analysis of OCT4, NANOG, AP2γ, and M2A  
The expression of OCT4, NANOG, AP2γ and M2A was further investigated using 
immunohistochemistry.  All proteins were expressed in testes of the 1st and 2nd 
trimester (Figure 3-3 and Figure 3-4).  All proteins were localized to the germ cells, 
identifiable as large round cells with a prominent nucleus.  In the 2nd trimester germ 
cells were located within the testis cords, separated from the interstitium.  OCT4, 
NANOG and AP2γ were restricted to the nuclei of the germ cells.  M2A was 
expressed on the germ cell membrane.  All identifiable germ cells were 
immunopositive for OCT4, NANOG, AP2γ and M2A in the 1st trimester.  In testes of 
the 2nd trimester, a number of negative germ cells could be identified (Figure 3-4, 
asterisks) 
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Figure 3-3 Immunohistochemistical staining for OCT4, NANOG, AP2γ, and M2A in 
testes of the 1st and 2nd trimester (In = Interstitium). Bar =100µm, applies to all 
images.  Inset shows negative control 
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Figure 3-4 High power images of human fetal testes immunohistochemically stained 
for OCT4, NANOG, AP2γ, and M2A at both the 1st and the 2nd trimester.  Bar = 50µm, 
applies to all images.  Asterisks show immunonegative germ cells 
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3.3.3 Immunohistochemical analysis of DAZL, NANOS1 and VASA 
Protein expression of DAZL was demonstrated in testes sections of the 1st and 2nd 
trimester (Figure 3-5, Figure 3-6).  In testes of the 1st trimester, germ cells displayed 
weak DAZL staining in the nucleus and cytoplasm of germ cells.  In the 2nd 
trimester DAZL staining was more intense and remained in both nuclear and 
cytoplasmic compartments.  NANOS1 staining was found at low intensity in germ 
cells of the 1st trimester (Figure 3-5, Figure 3-6).  In the testis of the 2nd trimester 
NANOS1 staining was stronger, where it predominantly was found in the nuclear 
periphery (Figure 3-5).  VASA protein expression was not detectable in testis of the 
1st trimester, but was found in the cytoplasm of germ cells in 2nd trimester testis 
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Figure 3-5 Immunohistochemistry for DAZL, NANOS1 and VASA in testes of the 1st 
and 2nd trimester.  Bar=100 µm.  Inset shows negative control 
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Figure 3-6 High power images of DAZL, VASA and NANOS1 in 1st and 2nd trimester 
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3.3.4 Immunoexpression of OCT4 and VASA 
Immunofluorescent co-staining for OCT4 and VASA was performed on 1st and 2nd 
trimester testes.  In testes of the first trimester all OCT4 positive germ cells were 
VASA negative.  In the 2nd trimester, germ cells with high levels of OCT4 staining 
tended to have low levels of VASA (Figure 3-7, arrowhead).  Conversely cells which 
stained positive for VASA had low intensity of OCT4 staining (Figure 3-7, arrows).  
Germ cells could also be identified which displayed low staining of both OCT4 and 
VASA (Figure 3-7, asterisks), but these were infrequent. 
 
 
Figure 3-7 Immunofluorescent co-staining for OCT4 (red) and VASA (green) in testes 
of the 1st trimester a) 65 days and the 2nd trimester b) 14 weeks c) 16 weeks and d)19 
weeks. Arrowheads point to OCT4 positive cells, arrows show VASA positive cells.  
Asterisks show cells with low levels of OCT4 and VASA staining.  Bar=50µm 
 
Chapter 3    Protein expression patterns in germ cells of the human fetal testis 94 
3.3.5 Immunoexpression of AP2γ and VASA 
Co-staining for AP2γ and VASA in second trimester testis revealed that AP2γ 
positive cells were low/negative for VASA, while VASA positive cells were 
low/negative for AP2γ (Figure 3-8).  Arrowheads identify the VASA positive cells, 
while arrows identify the AP2γ positive cells. 
 
 
Figure 3-8  Fluorescent immunohistochemistry for AP2γ (red) and VASA (green) in 
2nd trimester testes at  a) 16 weeks and b) 18 weeks.  Arrows point to AP2γ 
expressing germ cells and arrowheads indicate to germ cells expressing VASA only.  
Bar=50µm 
 
3.3.6 Immunofluorescent co-staining for OCT4 and M2A  
Immunofluorescent co-staining for OCT4 and M2A (Figure 3-9) was performed on 
1st and 2nd trimester testis.  Both OCT4 and M2A were restricted to the same cell 
type in both a 65 days and 17 week testis.  There was a marked decrease in 
expression of both proteins by 17 weeks possibly as a result of reduced numbers of 
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Figure 3-9 Fluorescent immunohistochemical staining for OCT4 (red) and M2A (green) 
in a) testis of the first trimester at 65 days and b)  2nd trimester at 17 weeks.  Cells 
stained positively for OCT4 also tended to stain positively for M2A.  In a ) Bar=50 µm 
and in b) Bar=20 µm 
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3.3.7 Immunofluorescent staining of M2A and VASA 
Immunofluorescent staining for M2A and VASA was performed on 1st and 2nd 
trimester testis.  VASA positive cells had low/negative levels of M2A (arrowheads), 
while M2A positive cells showed little VASA staining (arrows) (Figure 3-10). 
 
Figure 3-10 Immunohistochemical staining for M2A (red, as indicated by arrowheads) 
and VASA (green, as indicated by arrows) in testes of the 2nd trimester at a) 17 week 
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3.3.8 Co-localisation of OCT4 and DAZL  
DAZL immunopositive cells were found to be generally restricted to the germ cells 
which were OCT4 positive.  DAZL was immunolocalised to the cytoplasm and 




Figure 3-11 Fluorescent immunohistochemistry showing the localisation of OCT4 
(green) and DAZL (red) in 2nd trimester testes at a) 15 weeks and b) 19 weeks.  
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3.3.9 Immunoexpression of DAZL and VASA  
Immunofluorescent co-staining for VASA and DAZL revealed that both were 
generally restricted to separate cell types, although there was some degree of overlap.  
Cells with the highest levels of VASA staining were generally negative for DAZL.  
In a number of the DAZL positive/VASA negative cells, DAZL was 
immunolocalized to the nucleus (Figure 3-12, asterisks). 
 
 
Figure 3-12 Immunofluorescent staining for VASA (green) and DAZL (red) in 2nd 
trimester testis at a) 15 weeks b) 17 weeks c) 16 weeks. Arrows point to germ cells 
expressing VASA only.  Arrowheads point to DAZL positive/VASA negative cells. 
Asterisks identify cells with high nuclear DAZL staining.  In a) bar=50 µm, in b and c) 
bar=20 µm. 
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3.3.10 Immunoexpression of OCT4 and NANOS1 in 2nd trimester human 
fetal testes 
 
NANOS1 was primarily detected in the nuclei of germ cells (Figure 3-13, arrows), 
where it was found to be expressed in germ cells which were low for OCT4 (Figure 
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Figure 3-13 Fluorescent immunohistochemistry for NANOS1 (green) and OCT4 (red) in 
testes of the 2nd trimester a) 16 weeks b) 16 weeks and c) 17 weeks. Arrowheads 
identify OCT4 positive cells, arrows indicate OCT4 positive cells and asterisks show 
cells with some co-localisation.  In a) bar=50 µm in b) bar=20 µm. 
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3.3.11 Immunofluorescent co-staining for NANOS1 and VASA  
Both NANOS1 and VASA were found to be restricted to the same cells types in 
germ cells of the 2nd trimester.  NANOS1 was found to be immunolocalised to the 





Figure 3-14 Immunoflourescent staining for NANOS1 (green) and VASA (red) in 2nd 
trimester human fetal testes a) 15 weeks b) 16 weeks c) 18 weeks.  Cells which stained 
positive for NANOS1 also tended to stain positive for VASA. In a bar=50 µm and 
applies to c also and in b bar=20 µm 
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3.3.12 Morphological analysis of TGCT samples 
TGCT samples were examine for morphological abnormalities and tubules 
containing CIS were identified, these cells with large prominent nuclei and 
resembled fetal germ cells (Figure 3-15). 
 
 
Figure 3-15  a and b) Haematoxylin and eosin staining of TGCT samples containing 
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3.3.13 Immunofluorescent staining for OCT4 and VASA in TGCT 
samples 
CIS cells were detected within the tubules of TGCT tissue sections (Figure 3-16 a-d).  
OCT4 positive cells were present but no OCT4 positive cells could be detected in 
adjacent ‘normal’ tubules (Figure 3-16 e).  Within the tubules containing CIS, VASA 
immunopositive cells were also present, but these cells did not appear to be 
immunopositive for OCT4 (Figure3-16 a-d). 
 
Figure 3-16 Immunofluorescent staining of OCT4 (red) and VASA (green) in adult 
testicular germ cell tumour samples a) tubule containing CIS cells b) staining of CIS 
cells from a different TGCT sample c) high power image of b) d) another tissue sample 
containing CIS and e) a normal tubule containing no CIS.   Arrows point to OCT4 
positive cells, while arrowheads point to VASA positive cells.  In e bar=50 µm and 
applies to a also, and in c, bar=20 µm and applies to b and d also. 
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3.3.14 Germ cell proliferation 
Ki67 positive germ cells were identified based on their morphology and their 
location within the cords (Figure 3-17a).  Quantification of the number of Ki67 
positive germ cells showed that throughout the early and mid 2nd trimester, germ 
cell proliferation occurred in a relatively high proportion of germ cells, with more 
than half of the cells proliferating, although the number of proliferating cell tended to 
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Figure 3-17 Ki67 proliferation in germ cells of the human fetal testis (HFT) a) 
Immunostaining for Ki67 in 2nd trimester testis.  Bar=100µm b) proliferation indices for 
germ cells in early (14-15 weeks, N=4), mid (16-17 weeks, N=5) and late (18-19 week, 
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3.3.15 Immunoflourescent co-staining of Ki67 with OCT4  
Using co-staining for Ki67/OCT4, a high number of germ cells in the 1st trimester 
were Ki67 positive (Figure 3-18 a and b).  In the 2nd trimester some OCT4 
immunopositive germ cells were also found to express Ki67 (Figure 3-18 c-d, 
asterisks), while other cells were positive for OCT4 but negative for Ki67.   
 
 Figure 3-18 Immunofluorescent staining of Ki67 (green) with OCT4 (red) in 1st and 2nd 
trimester human fetal testes a) 65 days b) high power image of 65 days c) high power 
image of 16 week testis d) 15 week testis e) 17 week testis.  Asterisks identify co-
localisation.  In b, bar=20 µm and applies to c also, in e bar=50 µm and applies to a 
and d also. 
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3.3.16 Immunoflourescent costaining of Ki67 with VASA  
Ki67/VASA co-staining showed that some cells positive for VASA were also 
positive for Ki67 (Figure 3-19, asterisks) and some VASA positive/Ki67 negative 
cells were also observed. 
 
 
Figure 3-19 Immunofluorescent staining of Ki67 (red) with VASA (green) in 2nd 
trimester human fetal testis at 15 week and 17 week.  Bar=20 µm for 15wk and bar=50 
µm for 17 week. 
3.4 Discussion 
A mixed population of germ cells in the human fetal testis, apparently at differing 
stages of maturation, have been identified (Fukuda et al., 1975), a situation that 
appears in contrast to the rodent where germ cells develop in a synchronous fashion.  
Along with the varying morphological alterations that occur in the germ cells as they 
mature, there are key changes in protein expression.  This study has further 
characterized the changes in protein expression as germ cells undergo the transition 
from gonocytes to prespermatogonia.  
3.4.1 OCT4 positive gonocytes express AP2γ, DAZL, NANOG and M2A 
The transcription factor AP2γ is highly expressed in the OCT4 positive gonocyte 
population in 1st and 2nd trimester testis.  AP2γ appears to be downregulated at 
around the same time as expression of OCT4 declines, as the VASA positive germ 
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cells displayed low/negative levels of AP2γ and OCT4 in germ cells of the 2nd 
trimester testis.  Ap2γ is a member of the AP2 family of transcription factors.  
Studies in the mouse suggest that AP2γ has potential roles in proliferation, apoptosis 
and differentiation of cells (Jager et al., 2003). In Ap2γ knock-out mice 
trophoectodermal cells fail to proliferate (Auman et al., 2002) and AP2γ is 
upregulated in a variety of tumours, such as melanomas and breast cancer (Turner et 
al., 1998).  Another protein previously restricted to the gonocyte population, KIT 
(Gaskell et al., 2004) has been shown to contain putative AP2 binding sites in its 
promoter (Yamamoto et al., 1993). Our findings agree with a previous study that has 
localized AP2γ to both the gonocyte and the intermediate cell populations (Pauls et 
al., 2006).  The transcription factor NANOG acts synergistically with OCT4 to 
maintain pluripotency (Liang et al., 2008; Loh et al., 2006). Nanog is expressed in 
the early germ cells of the mouse (Yamaguchi et al., 2005). In this study, NANOG 
was detected in all germ cells of the first trimester, but by the second trimester 
NANOG negative germ cells could be identified.  Previous studies have shown 
NANOG to be highly expressed in CIS cells and also in germ cells of the fetal testes 
up until 20 weeks gestation, where it appears to be downregulated earlier than OCT4 
(Hart et al., 2005; Hoei-Hansen et al., 2005). 
 
In this study, the RNA-binding protein DAZL was detected in germ cells of the 1st 
and 2nd trimester, where it was located in either the nucleus or cytoplasm, or in some 
cases both.  This is consistent with previous studies that have shown DAZL to be 
present in the germ cell nuclei of a 17 week human fetal testis (Ruggiu et al., 2000), 
and others have described DAZL in both the nucleus and cytoplasm of human germ 
cells (Reijo et al., 2000). The change in subcellular location of DAZL during fetal 
germ cell maturation is intriguing considering its role as an RNA binding protein.  
The role of DAZL may be to activate silent mRNAs by recruiting poly A binding 
proteins, resulting in the expression of a subset of mRNAs during germ cell 
maturation (Collier et al., 2005).  The nuclear location of DAZL in immature human 
fetal germ cells may be a means of storing DAZL and rendering it inactive.  The 
Drosophila homologue of DAZL, boule, is initially found in the nucleus of 
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premeiotic germ cells and this translocates to the cytoplasm at the onset of meiosis 
(Cheng et al., 1998).  In the rodent Dazl has only been detected in the cytoplasm of 
the germ cells, the difference between the rodent and the human may be due to the 
DAZ gene cluster which is present on the Y chromosome of humans and higher 
primates (Cooke et al., 1996; Reijo et al., 1995).  The functions of DAZ have not 
been fully established but it has been shown to be capable of partial rescue of the 
DAZL mutant mouse (Slee et al., 1999). 
 
Previous studies have implicated Dazl in the regulation of Vasa, as Dazl knock-out 
mice display reduced levels of Mvh, while the 3’ UTR of Mvh contains various Dazl 
binding sites, and this is conserved among a variety of species (Reynolds et al., 
2005).  Our study would support this hypothesis given that DAZL is expressed 
earlier than VASA.  DAZL appears to be more of an intermediate marker, remaining 
expressed in VASA positive cells, although possibly changing from a nuclear 
location in gonocytes to the cytoplasm in prespermatogonia.  The slight increase in 
DAZL immunoexpression in 2nd trimester testis is in contrast to the situation in the 
ovary where there was a dramatic increase in DAZL expression in the second 
trimester at the time when germ cells enter meiosis (Anderson et al., 2007).   
 
The oncofetal marker M2A localizes to the membrane of OCT4 positive gonocytes 
and is expressed in a distinct population from the VASA positive germ cells.  Our 
findings are consistent with a previous study when M2A was described as an ‘early’ 
germ cell marker (Pauls et al., 2006).   
3.4.2 OCT4 negative prespermatogonia express VASA and NANOS1 
The NANOS1 protein was found to be germ cell specific in the human fetal testis.  It 
was found to be expressed at low levels in fetal testes of the first trimester, and in 
testes of the second trimester it was found to co-localize with the VASA positive 
germ cells.  In Drosophila, nanos is essential for the migration of PGCs (Wang and 
Lehmann, 1991). However in the mouse, knock-out of Nanos1 was shown to cause 
no disruption to germ cell development, while loss of Nanos2 and Nanos3 resulted in 
Chapter 3    Protein expression patterns in germ cells of the human fetal testis 110 
germ cell defects, with Nanos2 -/- mice characterised by a complete depletion of 
spermatogonia, and Nanos3 -/- mice exhibiting an earlier loss of germ cells at the 
PGC stage, in both males and females (Tsuda et al., 2003).  This is the first report of 
NANOS1 expression in the human fetal testis.  In our study, NANOS1 was 
immunolocalised mainly to the nuclear periphery of germ cells, however, the fact 
that Nanos1 appears to not be necessary for germ cell development in the mouse 
raises questions about its role in the human, although a previous group have reported 
the expression of NANOS1 in the germ cells in adult human testis, where it was also 
found to be expressed in a perinuclear location (Jaruzelska et al., 2003).  
 
VASA was not detected in human germ cells during the first trimester, this finding is 
in contrast to reports in the mouse where studies have shown that contact between 
germ cells and somatic cells within the gonadal ridge is enough to induce Mvh 
expression (Toyooka et al., 2000).  VASA was detected in 2nd trimester testis where 
it was found to be present in the germ cells that no longer expressed OCT4.  
NANOS1 appears to be expressed slightly before VASA as it was just detectable in 
first trimester gonads. 
 
3.4.3 OCT4 positive CIS cells have low/negative levels of VASA 
Immunofluorescent co-staining for OCT4 and VASA identified OCT4 positive CIS 
cells within the tubules of TGCT samples.  This is in agreement with previous 
reports that CIS cells express OCT4 (Looijenga et al., 2003; Rajpert-De Meyts et al., 
2004).  Other groups have reported the expression of VASA in CIS cells (Honecker 
et al., 2004; Zeeman et al., 2002).  Co-immunostaining for OCT4 together with 
VASA in CIS cells demonstrated for the first time that CIS cells within the abnormal 
tubules were negative for OCT4 and conversely that OCT4 positive cells were either 
VASA immunonegative or expressed the protein at very low levels.  There are 
several possible explanations for the mutually exclusive expression of OCT4 and 
VASA in CIS cells, one possibility is that CIS cells do not express VASA, and 
originate from the period in fetal life where germ cells are VASA negative (i.e. the 
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gonocytes) and that the VASA positive cells could be ‘normal’ germ cells located 
within the same tubule.  Alternatively, the VASA positive cells within the CIS 
tubules may also be CIS cells that do not express OCT4, possibly because some CIS 
cells are themselves capable of some form of limited differentiation.  Heterogeneity 
of CIS cells has previously been reported, where OCT4 expression was described at 
high levels in a number of cells, and other CIS markers such as C-KIT were 
expressed in only a subset of these cells (Rajpert-De Meyts et al., 1996).  We also 
have unpublished data showing that C-KIT and MAGE-A4 are not co-expressed. 
3.4.4 Germ cells proliferate throughout the 1st and 2nd trimester 
In this study, a high number of Ki67 positive germ cells were found in the 1st 
trimester, although this was not quantified.  Proliferation was found to continue 
throughout the second trimester, with a slight decrease towards the end of the second 
trimester.  This is consistent with work done by Murray et al (2000) who found that 
germ cells throughout the second trimester expressed the proliferation cell nuclear 
antigen (PCNA).  Previous studies have reported that germ cells proliferate 
extensively throughout the 1st trimester (Bendsen et al., 2006).   In the human, germ 
cell number has been found to increase exponentially from week 7 to week 19, with a 
doubling time of 12 days, resulting in an increase in the germ cell to Sertoli cell ratio 
(O'Shaughnessy et al., 2007).  This would explain the increase in protein expression 
in the second trimester compared with the first for the OCT4, DAZL, AP2γ and 
NANOS1 Western blots.  Honecker et al (2004) reported a decrease in the number of 
Ki67 positive germ cells throughout the second trimester, with a significant number 
of immunopositive gonocytes, and then a reduced number of positive cells, until the 
3rd trimester when the prespermatogonia become proliferative and remain so until the 
first weeks of life.  This data is consistent with the theory that germ cell proliferation 
in the human does not cease in the way that occurs in the rodent. For example studies 
analysing germ cell proliferation in  the rat have shown that that germ cell proliferate 
synchronously at e15.5, where proliferation then stops until the gonocytes form 
prespermatogonia at postnatal day 4-6 (Ferrara et al., 2006).  
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3.4.5 Conclusion 
In summary, these studies have further expanded the protein profiling of human fetal 
testicular subpopulations.  This chapter has demonstrated for the first time that the 
OCT4-positive (gonocyte) sub population almost exclusively express the proteins 
M2A, NANOG, AP2γ and DAZL, while the OCT4-negative prespermatogonia have 
been shown to express low/negative levels of M2A and AP2γ, while expressing some 
DAZL and high levels of VASA and NANOS1.  In addition, an intermediate 
population of cells, undergoing the transition form gonocyte to prespermatogonia 
was also identified.  These studies have also shown for the first time that 
proliferation is not restricted to either the gonocyte or prespermatogonial 
populations. These observations may be important for the studies on testicular germ 
cell tumours, as results in this chapter show that within tubules of adult testis 
containing CIS cells, populations of OCT4 positive/VASA negative and OCT4 
negative/VASA positive cells co-exist. 
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4 Retinoic acid signalling and the control of meiotic entry 
in the human fetal gonad  
4.1 Introduction 
During development, germ cells migrate into the gonad by e10.5 in the mouse and by 
the 5th week of gestation in the human (Wartenberg, 1981).  In the ovary, germ cells 
proliferate and form syncytial nests in close association with the somatic cells, and 
are surrounded by a network of stromal cells (McNatty et al., 2000).  In the mouse, 
germ cells enter meiosis at e13.5 (McLaren and Southee, 1997), then progress 
through meiotic prophase I, arresting at the diplotene stage of meiotic prophase by 
e17.5, forming primordial follicles (Hirshfield, 1992).  In the human fetal ovary, 
germ cells begin to enter meiosis at around 11 weeks gestation (9 weeks post-
conception) (Bendsen et al., 2006).  Unlike the mouse, germ cells in the human fetal 
ovary contain oocytes that are present at various stages of meiotic prophase I, with 
many oogonia continuing to proliferate, while others enter meiosis (Bendsen et al., 
2006; Gondos et al., 1986).  
 
In the fetal testis, germ cells become surrounded by the developing Sertoli cells, and 
once peritubular myoid cells (PTM) migrate into the testis, they surround the Sertoli 
cells that are organised together with the germ cells to form the testicular cords 
(Buehr et al., 1993).  The interstitial compartment that exists between the cords 
contains fetal Leydig cells, fibroblasts and blood vessels.  In the testis, germ cells do 
not enter meiosis until puberty, occurring many years after they first arrive in the 
gonad.  In the mouse testis at e13.5, germ cells all arrest in the G1 (G0) stages of the 
cell cycle as T-prospermatogonia, and then remain in mitotic arrest until one week 
after birth (McLaren, 1984).  In contrast, whilst germ cells in the human fetal testis 
initially all appear to exist as uniform OCT4+ germ cell population in the 1st 
trimester, by the 2nd trimester a mixed population of OCT4+ and VASA+ germ cells 
can be detected within individual cords (Anderson et al., 2007; Gaskell et al., 2004) 
(Chapter 3).  Additionally, unlike the mitotic arrest observed in the mouse testis, 
Chapter 4  RA signalling and the control of meiotic entry in the human fetal gonad             114
germ cells continue to proliferate throughout the 2nd trimester (Bendsen et al., 2006; 
Murray et al., 2000) (Chapter 3).   
 
Studies in the mouse ovary have shown that as germ cells enter meiosis, Oct4 
expression is downregulated in a caudal to rostral direction (Pesce et al., 1998; 
Menke et al., 2003; Bullejos and Koopman, 2004). As Oct4 expression is 
downregulated, genes associated with meiosis, such as stimulated by retinoic acid 8 
(Stra8) and the synaptonemal complex protein 3 (Sycp3), are upregulated (Menke et 
al., 2003; Bullejos and Koopman, 2004).  Studies in the human fetal ovary have 
shown that distinct OCT4 positive/VASA negative populations of cells can be 
identified, indicating that a similar maturation process occurs in the germ cells of the 
human fetal ovary as occurs in the fetal testis (Anderson et al., 2007; Stoop et al., 
2005)(Chapter 3), and suggests that the downregulation of OCT4 and upregulation of 
VASA in the human fetal ovary is not linked to meiotic entry.  The less mature 
OCT4 cells were found at the periphery of the ovary, while the more mature VASA 
positive cells, located within the germ cell nests, were found towards the centre of 
the gonad (Anderson et al., 2007).  Therefore, the maturation of germ cells and 
meiotic progression in the human fetal ovary may occur differently from the mouse 
ovary. 
 
The fate of the germ cells and the expression of factors controlling meiotic entry are 
regulated by the somatic cells of the gonad (refer to Chapter 1, section 1.3.2.5).  
Some recent progress has been made in understanding mechanisms controlling 
meiotic entry in the mouse.  In the female gonad, expression of Stra8 is upregulated 
one day before meiotic entry (Menke et al., 2003).  In Stra8-deficient ovaries, germ 
cells develop normally until e13.5, but then fail to initiate meiotic prophase, and 
deteriorate (Baltus et al., 2006).  Stra8 is a member of a gene family that has been 
shown to respond to retinoic acid (RA).   
 
RA is the biologically active derivative of retinol (Vitamin A) and has various effects 
on cells and tissue during development and differentiation (Mendelsohn et al., 1992; 
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Niederreither et al., 2002; Wendling et al., 1999).  The tissue distribution of RA is 
highly regulated by a group of RA producing and metabolising enzymes.  The 
retinaldehyde dehydrogenase enzymes (Aldh1a 1,2 and 3) are responsible for the 
oxidation of the RA precursors to produce RA (Maden, 2007; Reijntjes et al., 2005).  
RA signalling is negatively regulated by three RA degrading enzymes, Cyp26A1, 
Cyp26B1 and Cyp26C1, which metabolize RA into hydroxylated polar derivatives 
(Fujii et al., 1997) (Literature Review Section 1.3.5.2.1). 
  
Studies by Koubova et al (2006) found that the normal upregulation of Stra8 failed to 
occur when e11.5 ovaries were cultured for two days in the presence an antagonist 
for all retinoic acid receptors, BMS-204493.  In contrast when testes were cultured in 
the presence of RA, Stra8 was upregulated, specifically in the germ cells.  A further 
part of the jigsaw was provided by Bowles et al in 2006 who found that the RA 
metabolising enzyme Cyp26b1 was initially expressed in the gonads of both sexes, 
but at e12.5, it became male-specific.  This enzyme was demonstrated to be 
expressed in the testis cords, in the Sertoli cells, with maximal expression in the male 
at e13.5 (Koubova et al., 2006; Bowles et al., 2006).  In ovarian cultures, treatment 
with RA resulted in a decrease in Oct4 expression but an increase in Stra8; in 
contrast, incubation with the RA receptor antagonist AGN193109 resulted in a 
downregulation of meiotic genes, and a sustained expression of Oct4  (Bowles et al., 
2006).  Treatment with the cytochrome p450 inhibitor ketoconazole, increased 
expression of meiotic genes in the testis, and decreased expression of Oct4 (Bowles 
et al., 2006).  Furthermore, Cyp26b1 null testis had a 3-fold increase in RA levels 
and an abnormal number of apoptotic germ cells, with some cells appearing to have 
entered meiosis.  In addition, the enzymes Aldh1a2 and Aldh1a3, responsible for RA 
biosynthesis, were shown to be expressed within the mesonephroi, but not the 
gonads, from e10.5-13.5  and high levels of RA were demonstrated to be produced 
by the mesonephros (Bowles et al., 2006). 
 
A member of the Nanos family of RNA binding proteins also appears to play a role 
in the suppression of meiosis in the developing testis.  In the mouse and human, three 
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Nanos family members (Nanos 1,2 and 3) have been identified (Tsuda et al., 2003).  
Nanos2 is expressed specifically in germ cells of the embryonic mouse testis and is 
absent from the ovaries (Tsuda et al., 2003; Suzuki and Saga, 2008).  Nanos2 appears 
to play an indirect role in the suppression of Stra8 and therefore contributes to the 
mechanisms preventing male germ cells from entering meiosis after Cyp26b1 has 
been downregulated (Suzuki and Saga, 2008).  Moreover, Nanos2 may also have a 
role in committing male germ cells to the spermatogonial lineage, as ectopic 
expression of Nanos2 in female germ cells induced their differentiation down the 
male lineage (Suzuki and Saga, 2008).   
 
Despite the convincing evidence that RA may be the signal leading to the initiation 
of meiotic entry in the developing mouse ovary, there are a few questions which 
remain about the true function of RA.  For example, although other groups have 
previously reported RA as an important mitogen and survival factor for germ cells, 
they never described any germ cells displaying signs of meiotic entry (Koshimizu et 
al., 1995;  Morita and Tilly, 1999).   
 
Recently a novel transmembrane protein has been implicated in the commitment of 
germ cells to the male lineage.  Expression of Sdmg1 is specifically upregulated in 
the Sertoli cells of the embryonic testes at e12.5.  Any substance involved in 
committing the germ cells to the spermatogenic lineage may be secreted by the 
Sertoli cells at this time, aided by Sdmg1.  If secretion from the Sertoli cells is 
inhibited at e12.5, it results in germ cells undergoing male-to-female sex reversal, 
with some germ cells appearing to enter meiosis (Best et al., 2008).  
4.1.1 Aims of Chapter 
The aim of this study was to determine whether a similar system to that reported to 
control the meiotic progression of mouse germ cells, operates in the human fetal 
testis and ovary.  Expression of key genes documented to be important for entry or 
inhibition of meiosis were studied in male and female gonads from the 1st and 2nd 
trimester.  We aimed to determine whether enzymes responsible for the production 
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and degradation of RA were expressed in the ovary, testis and mesonephros, and 
ultimately whether or not the gonad produces RA. 
4.2 Materials and Methods  
4.2.1 Collection of human fetal gonads 
Human fetal testes and ovaries were obtained following termination of pregnancy 
during the 1st and 2nd trimester as outlined in section 2.1. 
4.2.2 Immunohistochemistry  
4.2.2.1 DAB  
Immunohistochemistry was performed and is detailed in section 2.2. Information 
regarding the primary antibodies used is listed in Table 4-1. 
 
Table 4-1 List of antibodies used for immunohistochemistry 
Antigen Species Source Antigen 
Retrieval 
Dilution 
RARα Rabbit SCruz No 1.50 
RARβ Rabbit Abcam Yes 1.100 
RXRα Rabbit SCruz Yes 1.100 
 
4.2.3 RNA Extraction  
Details on the extraction of RNA from tissue is described in section 2.4. 
4.2.4 Preparation of cDNA using random hexamers  
cDNA was prepared as outlined in section 2.5. 
4.2.5 TaqMan analysis  
The Roche Universal Probe Library was used for TaqMan analysis.  The procedures 
for the TaqMan reaction and analysis are detailed in section 2.5.  Primers and probes 
used are listed in Table 4-2.  TaqMan analysis was performed in triplicate on 1st 
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trimester (50-65 days), early 2nd trimester (14-15wks) and late second trimester (18-
19wks)  ovaries and testes (N=4 for each age group). 
 
Table 4-2 Summary of primers and probes used for the TaqMan reaction 
Gene name 5’ sequence 3’sequence Probe 
STRA8 ggccttagctgtgcaaacac ctcttcatcaacgggaaagg 4 
NANOS1 tgaaagaaaaggtgcatttcaa cctggctaagaaacattgtgc 51 
NANOS2 gtcttcgcaggctcacct ggcattgaaaggtgtcagc 58 
NANOS3 gcagggttacttgtctctgtga acaggtcaaaggtccccata 44 
RARα cagcaccagcttccagttagt agaactgctgctctgggtct 83 
RARβ cacctgtcatcggaggactt ggtgctctgtgtttcaattgtt 16 
RARγ cgctccatccaagagactg gagggaactgggccgtag 70 
RXRα aagcggatcccacacttct gaaggaggcgatgagcag 18 
RXRβ ggcggagaacaacaaacc gtctgggcttcgggagtc 36 
RXRγ tgtcatgggcatgaagagg cctcactctcagctct 82 
ALDH1A2 ccacagtgttttccaacgtc tcctgaacagggccaaag 63 
ALDH1A3 ctggatgccctgagtcgt ccctgtatccatcgtctcca 22 
CYP26A1 gcagccacatctctgatcact tgttgtcttgattgctcttgc 45 
CYP26B1 acatccaccgcaacaagc ggatcttgggcaggtaactct 41 
CYP26C1 gccctcgacctaatcattca gagctccacagccgactc 17 
SDMG1 cagctaggcttccctggag aggatccctgagacattactcatc 4 
 
4.2.6 Statistical analysis 
Statistical analysis was performed using a Student’s t-test and a one-way analysis of 
variance (ANOVA), followed by a Bonferonni multiple comparison test. 
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4.2.7 Retinoic acid reporter cells  
4.2.7.1 Culture of Retinoic acid reporter cells  
The RA reporter F9 teratocarcinoma transformed cell line was kindly donated by Dr 
Michael Wagner (SUNY Downstate Medical Center, Brooklyn, N.Y., USA).  These 
cells had been transfected with a plasmid reporter construct containing a single copy 
of the RA response element (RARE) upstream of the Ecoli LacZ gene (Wagner et al., 
1992).    Upon stimulation with RA, the RARE becomes activated leading to LacZ 
gene expression.  Cells were cultured on 0.1% gelatin coated plates and reached 
confluence every 2-3 days.  The recipe for the medium used for the RA cells is 
detailed in section 2.7 
4.2.7.2 Incubation of tissue with retinoic acid reporter cells 
Reporter cells were plated onto a 24 or 48 well plate at 70% confluency.  Gonadal 
tissues were isolated from human fetuses during the 1st and 2nd trimester or mouse 
embryos (C57BL/6) at e11.5 (N=4) and e13.5 (N=5).  For 1st trimester human fetal 
gonads and embryonic mouse testes, mesonephroi (N=2) were separated from the 
gonads.  Tissues were incubated with the reporter cells for 24 or 48 hours.  As a 
positive control, Ion-Exchange bead (Biorad) were loaded with 1x10-10M of RA (all 
trans, Sigma) for 1 hour, and then washed 3x10 minutes in PBS, before being 
incubated with the cells in a separate well for the same length of time as the tissues. 
4.2.7.3 βGalactosidase staining  
βGalactosidase (βGal) staining was performed to visualise the cells that expressed 
LacZ.  The βGal enzyme is encoded by the LacZ gene.  βGal cleaves the X-gal 
substrate yielding galactosidase and 5-bromo-4-chloro-3-hydroxyindole.  The latter 
is further oxidised to an insoluble blue product, 5,5’-dibromo-4,4’ dichloro-indigo.  
The βGal staining kit was obtained from Invitrogen and staining was performed in 
accordance with manufactures instructions (Invitrogen Cat # K1465-01).  Briefly, 
cells were washed in PBS, and fixed in the fixative solution provided for 10 minutes.  
Cells were then washed in PBS again and incubated with the X-gal containing 
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solution provided.  Cells were incubated overnight at 37oC. βGal positive cells 
displayed blue staining. 
4.2.7.4 Fluorescein di-β-D-galactopyranoside (FDG) 
Fluorescein di-β-D-galactopyranoside (FDG) is a sensitive alternative for βGal.  
FDG is hydrolyzed by β-gal, first to fluorescein monogalactoside and then to the 
highly fluorescent fluorescein.  Cells were washed in PBS and then incubated in 50% 
PBS, containing 1 mM FDG (Invitrogen, Cat # F1179) for 1 minute at 37°C.  This 
solution was removed, followed by incubation with ice-cold PBS for 1 hour on ice 
before being visualized using an Axiovert 200 (Carl Zeiss). 
4.3 Results 
4.3.1 Differential expression of STRA8 in male and female gonads  
To investigate the expression of STRA8 in the human fetal testes and ovaries, 
TaqMan quantitative PCR analysis was performed for RNA extracted from testes and 
ovaries of the 1st trimester (50-65 days), early 2nd trimester (14-15 weeks), and late 
2nd trimester (18-19 weeks).  STRA8 mRNA expression was low/negative in the 1st 
and 2nd trimester testes, but was expressed at high levels in the ovaries all the 
gestational ages examined.  STRA8 expression was significantly higher in 2nd 
trimester ovaries compared with testes in both the early and late stages (P<0.05) 
(Figure 4-1).  STRA8 expression in the early second trimester ovaries was 
significantly higher than in the first trimester ovaries (P<0.0001).  The expression of 
STRA8 was slightly lower in ovaries of the late second trimester compared with the 
early second trimester (P<0.05) (Figure 4-1). 
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Figure 4-1 STRA8 mRNA expression in male and female gonads during the 1st and 2nd 
trimester relative to early second trimester ovary.  A=Expression in 1st trimester 
ovaries was significantly lower than early 2nd trimester ovaries (P<0.05).  B=mRNA 
expression in early 2nd trimester ovaries were significantly higher than early 2nd 
trimester testes (P<0.0001). C=mRNA expression in late 2nd trimester ovaries was 
significantly higher than late 2nd trimester testes (P<0.0002).  Taqman was performed 
in triplicate for four independent fetuses in each group.  Mean ± sem 
4.3.2 Analysis of NANOS gene expression in male and female gonads 
To determine whether the NANOS family of genes were expressed in the fetal 
gonads, and if so, whether they were expressed in an age-specific or sex-specific 
manner, NANOS 1, 2 and 3 mRNA concentrations were analysed.  Analysis of 
NANOS1 mRNA expression in 1st and 2nd trimester ovaries and testes revealed that 
expression was relatively constant throughout the 1st and 2nd trimester, for both the 
testes and ovaries (Figure 4-2a). 
 
NANOS2 mRNA expression was barely detectable in 1st and 2nd trimester ovaries, 
and whilst mRNA concentrations were low in 1st trimester testes, concentrations 
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increased in the early 2nd trimester, and by the late 2nd trimester, levels were 
significantly higher than the ovaries (P<0.001) (Figure 4-2b).  NANOS3 mRNA was 
detectable at all time points examined in both male and female gonads.  NANOS3 
mRNA expression was always higher in the ovaries than the testes for each age 
group examined (Figure 4-2c).  There was therefore a large increase in NANOS2 
expression in the testis but not the ovary, while there was no significant difference in 
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Figure 4-2 mRNA expression of a) NANOS1 b) NANOS2 c) NANOS3 in human fetal 
gonads during the 1st and second trimester. N=4, relative to late 2nd trimester testis 
value. Taqman was performed in triplicate for four independent fetuses in each group.  
Mean ± sem 
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4.3.3 Expression of RARs and RXR in the human fetal ovaries and 
testes  
To determine whether the RA receptors were present in the male and female gonad, 
and to analyse any changes in gene expression which occurs with development, 
TaqMan analysis for the RARs and RXRs was performed.  mRNA expression of all 
of the RARs and RXRs could be detected in the 1st and 2nd trimester ovaries and 
testes.  RARα was expressed at relatively constant levels in both the male and female 
gonads throughout the developmental stages examined (Figure 4-3a).  RARβ mRNA 
levels were highest in the 1st trimester for both the ovaries and testes, but mRNA 
levels at this time were indistinguishable between the sexes.  In the 2nd trimester, 
expression declined compared with the first trimester; this was more marked in the 
ovaries compared with the testes (Figure 4-3b), but this also was non-significant.  
RARγ mRNA expression peaked during the early 2nd trimester in the ovaries, while 
expression in the testes tended to be higher in the 1st trimester (Figure 4-3c).   
 
RXRα mRNA was expressed in both the ovaries and testes at similar levels during the 
1st trimester, expression rose slightly in the ovaries during the early 2nd trimester in 
the ovaries, and then decreased towards the end of the 2nd trimester (Figure 4-3d).  
Messenger RNA levels for RXRβ were similar in both the testes and ovaries during 
the 1st trimester.  In the 2nd trimester testes, RXRβ mRNA remained at similar levels.   
In the 2nd trimester ovary, RXRβ mRNA levels increased (Figure 4-3e).  RXRγ 
mRNA levels were maintained at similar levels in both the male and female at all 
ages examined (Figure 4-3f). 
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Figure 4-3.  mRNA expression of RARs and RXRs in human fetal testis and ovaries a) 
RARα b) RARβ c) RARγ d) RXRα e) RXRβ f) RXRγ. N=4, all relative to 1st trimester 
testis. Taqman was performed in triplicate for four independent fetuses in each group.  
Mean ± sem 
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Figure 4-4 RARα immunoexpression in a) 16 week testis b) 14 week ovary c) 18 week 
testis d) 18 week ovary Bar = 50 μm.  In a) and c) black arrows point to 
immunopositive Sertoli cells.  Arrowheads point to immunonegative Sertoli cells, red 
arrows identify immunopositive PTM cells.  In b) arrowheads point to immunopositive 
somatic cells, N indicates nests of germ cells and in a, c and d) blue arrows show 
immunopositive germ cells. Inset shows negative control.  
To determine whether any protein for the RARs and RXRs were present, and if so, 
what their distribution within the cells of the ovary and testis was, 
immunohistochemical analysis was performed using antibodies directed against, 
RARα, RARβ and RXRα.  In the 2nd trimester human fetal testis RARα protein was 
immunolocalised to the nuclei of some but not all of the Sertoli cells (Figure 4-4 a 
and c, arrows), with a subpopulation being immunonegative (Figure 4-4 a and c, 
arrowheads).  Some PTM cells were also immunopositive for RARα (Figure 4-4 a 
and c, red arrows), as were cells within the interstitium.  Immunopositive germ cells 
could also be detected in the testis (Figure 4-4 a and c, blue arrows) In the 2nd 
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trimester ovaries RARα staining was present within the nests of germ cells, where it 
was immunolocalised to the nucleus and the cytoplasm Figure 4-4 b and d, blue 
arrows).  The nuclei of the somatic cells in association with the germ cells also 
stained positive for RARα (Figure 4-4b and d, arrowheads) 
 
 
Figure 4-5 Immunostaining for RARβ in 2nd trimester human fetal ovaries and testes.  
a) 14 week testis b) 18 week ovary c) 15 week testis  d) 18 week ovary. Bar = 50 μm.  
For a) and c) arrows point to immunopositive Sertoli cells, blue arrows identify 
immunopositive germ cells and I indicates the interstitium where immunpositive 
Leydig cells can be identified.  In b) and d) arrowheads point to immunopositive 
ovarian somatic cells, blue arrows indicate immunopositive germ cells and S 
indicates stromal cells. Inset shows negative control. 
Immunostaining for RARβ in 2nd trimester human fetal testis showed that a large 
number of cells within the interstitium were immunopositive for RARβ (Figure 4-4a 
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and c).  The majority of Sertoli cells were also immunopositive (Figure 4-4a and c, 
arrows) and a number of germ cells also displayed positive staining (Figure 4-4a and 
c, blue arrows).  PTM cells appeared to be largely immunonegative.  In the 2nd 
trimester human fetal ovary, a number of germ cells exhibiting positive staining 
could also be identified (Figure 4-4 b and d, blue arrows).  Immunostaining was 
found in both the nucleus and the cytoplasm of these cells.  
 
 
Figure 4-6.  RXRα immunostaining in 2nd trimester ovaries and testes.  a) 16 week 
testis b) 19 week ovary c)15 week testis d) 19 week ovary . Bar = 50 μm.  For a) and c) 
black arrows point to immunopositive Sertoli cells, and red arrows point to 
immunopositive PTM cells, blue  arrows denote immunopositive germ cells. For b) 
and d) N indicates nests of syncytial germ cells, S indicates stromal cells and blue 
arrows show immunopositive germ cells. Inset shows negative control. 
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Immunhistochemical staining of RXRα showed that in the 2nd trimester testis, the 
majority of Sertoli cells were immunopositive (Figure 4-6a, arrows), as were PTM 
cells.   RXRα staining was also identifiable in some of the germ cells (Figure 4-6 a 
and c) where it was found mainly in the cytoplasm.  In the ovary, RXRα was 
detected within the germ cell nests, where it appeared to be present within the 
cytoplasm and nuclei of some of the germ cells, and the interstitial cells were 
immunonegative (Figure 4-6 b and d). 
4.3.4 Expression of RA producing enzymes in the human fetal gonad 
and mesonephros  
To determine whether all or some of the enzymes involved in the production of RA 
were present within the gonad or mesonephros, TaqMan analysis was performed to 
examine the levels of transcripts for the ALDH1A2 and ALDH1A3 genes. Total 
concentrations of ALDH1A2 mRNA were lower in the mesonephros than in the 
gonads.  In 1st trimester testis, concentrations of ALDH1A2 mRNA were higher than 
in the testis recovered during the 2nd trimester.  In the ovary, mRNA concentrations 
were maintained at a similar level at all stages of gestation examined.  Expression in 
the 2nd trimester ovaries was higher than in the 2nd trimester testes (Figure 4-7a).  
ALDH1A3 mRNA levels were also lower in the mesonephros than the male and 
female gonads.  In the ovaries and testes during the 1st trimester and early 2nd 
trimester ALDH1A3 mRNA expression was similar (Figure 4-7b). 
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Figure 4-7 mRNA expression of ALDH1A2 and ALDH1A3 in human fetal mesonephroi 
and gonads (N=4). Both relative to mesonephroi. a) For ALDH1A2, A= mRNA 
expression in the mesonephroi was significantly lower than 1st trimester testes 
(P<0.01).  B= mRNA levels in 1st trimester ovaries were significantly lower than 1st 
trimester testes (P<0.05).  C= early 2nd trimester testes mRNA expression was 
significantly lower than 1st trimester testes.  D= late 2nd trimester testes was 
significantly lower than 1st trimester testes (P<0.05).  For b) A=ALDH1A3 mRNA levels 
in the mesonephroi was significantly lower than the late 2nd trimester testes (P<0.05).  
Taqman was performed in triplicate for four independent fetuses in each group.  Mean 
± sem 
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4.3.5 Analysis of human fetal mesonephroi and gonads for the 
production of retinoic acid using a retinoic acid reporter cell line 
Having detected the mRNA expression for the genes responsible for the production 
of RA, we next wanted to determine whether RA was actually being produced.  In 
order to establish whether human fetal mesonephroi or gonads produced RA, tissues 
were cultured on a layer of RA responsive cells and a βGal assay was performed.  




Figure 4-8 RA reporter cell assays.  a) βGal assay showing cells incubated with RA 
loaded ion-exchange bead b) βGal assay following incubation with human 
mesonephroi at 8 weeks gestation c) βGal assay for cells incubated with mouse 
mesonephroi at e13.5 d) FDG assay for ion exchange beads e) FDG assay for mouse 
mesonephroi at e13.5 following 24 hours of culture.   
Analysis of RA reporter cells following culture of tissues after 24 and 48 hours 
showed that no βGal positive cells could be detected in cultures containing mouse 
mesonephroi, or human mesonephroi, while βGal positive cells could be detected in 
cultures with beads containing 1x10-10M RA (Figure 4-8a-c).  To determine if a 
stronger response could be obtained from a more sensitive method, an FDG assay 
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was performed.  Cells cultured in the presence of RA containing ion exchange beads 
were positive for fluorescein, while cultures containing mouse mesonephroi were 
negative (Figure 4-8d and e), thus showing a similar response as with the βGal assay.  
In both assays only some of the RAR-LacZ cells appear to be responding when 
cultured in the presence of the RA containing ion exchange beads, this is unlikely to 
be the result of diffusion gradients and suggests that a heterogenous population of 
reporter cells are present with some cells having lost expression of the transgene. 
4.3.6 mRNA expression of Cytochrome 26 in the human fetal gonads  
To obtain an understanding of the expression pattern of the Cyp26 enzymes in the 
human fetal gonads, TaqMan analysis was performed for mRNAs encoded by the 
CYP26A1, CYP26B1 and CYP26C1 genes. Both CYP26A1 and CYP26C1 were 
undetectable in ovaries and testes examined, at all age groups.  But in the positive 
control, the human endometrial adenocarcinoma Ishikawa cell line, low levels of 
transcript could be detected (Figure 4-9 a and c).   
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Figure 4-9 mRNA expression of a) CYP26A1 in human fetal gonads and Ishikawa cells 
b) CYP26B1 expression in human fetal gonads, relative to 1st trimester testes c) 
CYP26C1 in human fetal gonads and Ishikawa cells.  Taqman was performed in 
triplicate for four independent fetuses in each group.  Mean ± sem 
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In both the 1st and 2nd trimester ovaries and testes, CYP26B1 mRNA levels were 
found to be similar.  mRNA levels then subsequently declined in the ovary toward 
the end of the 2nd trimester.  mRNA levels in the testes were maintained at a similar 
levels throughout the 2nd trimester (Figure 4-9) .  
 
 
4.3.7 Analysis of SDMG1 mRNA expression in human fetal ovaries and 
testes 
 
Analysis of SDMG1 mRNA expression in human fetal gonads was performed.  The 
overall expression of SDMG1 was higher in the testes than the ovaries, and in the 
testes there was a progressive increase in expression with gestational age, while in 
the ovary, the levels of expression did not change throughout the age-groups 
analysed (Figure 4-10).  In the late 2nd trimester testes mRNA levels were 
significantly higher than the early 2nd trimester (P<0.05), and mRNA levels in the 
late 2nd trimester testes were significantly higher compared with the late 2nd trimester 
ovaries (P<0.001) (Figure 4-10). 
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Figure 4-10 SDMG1 mRNA expression in human fetal gonads.  A=mRNA levels in late 
2nd trimester testes is significantly higher than early 2nd trimester testes (P<0.05).  
B=mRNA levels in late 2nd trimester ovaries is significantly lower than late 2nd 
trimester testes (P<0.001) (N=3, relative to early 2nd trimester testis).  Taqman was 
performed in triplicate for four independent fetuses in each group.  Mean ± sem 
 
 
4.4 Discussion  
4.4.1 Conserved expression patterns of NANOS2 and STRA8  
Expression of STRA8 mRNA was significantly higher in ovaries compared with 
testes.  In the female STRA8 mRNA was highest during the early 2nd trimester at a 
time when germ cells are actively entering meiosis.  STRA8 mRNA was almost 
undetectable in the testes at all gestational ages examined.  We believe that this is the 
first study that has examined the expression of STRA8 in the human fetal gonad.  
Stra8 was initially identified as a retinoic acid responsive gene, expressed 
specifically in premeiotic germ cells of the mouse (Miyamoto et al., 2002; Oulad-
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Abdelghani et al., 1996; Zhou et al., 2007).  This gene has since been shown to be 
required for germ cells to enter meiosis in both male and female mice (Baltus et al., 
2006).   
 
The Nanos gene family of RNA binding proteins were initially identified for their 
role in germ cell development in Drosophila, where nanos is necessary for the 
migration and development of germ cells in Drosophila embryos (Forbes and 
Lehmann, 1998; Kobayashi et al., 1996).  In the mouse the Nanos gene has been 
cloned, as have 2 homologues (Nanos 2 and 3) (Tsuda et al., 2003).   In this study the 
expression of mRNAs encoded by the Nanos genes was analysed.  NANOS1 was 
found to be expressed in both the male and female gonads.  The total concentration 
of mRNAs was similar for both sexes until the late second trimester, where the 
expression of NANOS1 increased in the male.  This supports the results found in 
Chapter 3 where NANOS1 was found to be specifically localised to the VASA-
positive prespermatogonia in the human fetal testis and the large increase can be 
attributed also to the increase in germ cell numbers with increasing gestation.  In the 
human NANOS1 may have a role in germ cell development, as it has been shown to 
bind to human PUMILIO2, which is also expressed in spermatogonia (Jaruzelska et 
al., 2003).  In the current study analysis, NANOS3 mRNA was also detected in male 
and female germ cells, where expression of NANOS3 was found to peak during the 
early 2nd trimester in both sexes.  In the mouse, Nanos3 is specifically expressed in 
the germ cells after e7.25 (Yabuta et al., 2006), while Nanos3-/- mice display a 
complete loss of germ cells in both males and female (Tsuda et al., 2003) and the 
protein appears to be necessary for the maintenance of the germ cell lineage through 
the suppression of apoptosis (Suzuki et al., 2008).  After birth, Nanos3 expression is 
restricted to the testis, where it has recently been shown to be important for 
maintaining the undifferentiated state of the spermatogonia via regulation of the cell 
cycle (Lolicato et al., 2008).  Our results would therefore suggest that as in the 
mouse NANOS3 may play a role in the maintenance of the germ cell population 
during fetal life in the human male gonad. 
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In this study, NANOS2 was sexually dimorphic with significantly higher mRNA 
levels in the fetal testes than in the female gonads during the 1st and 2nd trimesters.  
Nanos2 is expressed specifically in germ cells of the mouse testis (Tsuda et al., 2003; 
Suzuki and Saga, 2008), where it appears to contribute to the suppression of Stra8 
and therefore ensures male germ cells do not commit to meiosis after Cyp26b1 has 
been downregulated (Suzuki and Saga, 2008).  The male-specific upregulation of 
NANOS2 in the 2nd trimester testis suggests that the roles of NANOS2 may be 
conserved in the human and may be important for initiating and or maintaining 
development of testicular germ cells. 
 
Our studies so far have demonstrated the expression of STRA8 and the NANOS genes 
in the human fetal gonads, but have failed to localise the expression of any of these 
genes to particular cell types within the gonads.  Therefore in situ analysis or 
immunohistochemical analysis must be performed, firstly to demonstrate germ cell 
specificity, and secondly to determine which particular germ cells these genes are 
expressed in, in order to ascertain whether expression patterns of these genes are 
trully conserved between the mouse and human.  It is also important to localise the 
expression of STRA8 and the NANOS gene family to the cell types of the ovaries and 
testes, as germ cell number changes dramatically from the first trimester to the 
second trimester, and analysis of gene expression on RNA extacted from whole 
gonads is not sufficient to truly understand the changes that occur in gene expression 
with development. 
4.4.2 Both the testis and ovary express the RARs and RXRs during the 
first and second trimester  
In this study, measurements of the mRNAs for the RARs and RXRs in extracts of 
whole ovaries and testes revealed that all six receptors were present throughout the 
development stages examined.  The RARs are activated by all-trans RA and 9-cis 
RA, while the RXRs are only activated by 9-cis RA (Allenby et al., 1993).  In 
addition to forming heterodimers with the RARs, the RXRs are also capable of 
heterodimerizing to other nuclear receptors such as the peroxisome proliferator 
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activated receptors (PPARs) (Huang, 2008; Kliewer et al., 1992).  
Immunohistochemistry suggested that RARα was differentially expressed in the 
nuclei of the Sertoli cells and the germ cells of the testis in the 2nd trimester and was 
also present within the cells of the interstitium.  In the ovary, RARα was detected 
within the germ cells nests, where it was localised to both the nuclear and 
cytoplasmic compartments of the germ cells and also to the nuclei of the somatic 
cells.  RARβ protein was also detected in the cells of the testes and ovaries.  In the 
testes, the majority of Sertoli cells were found to express RARβ within the nuclear 
compartment and RARβ was also localised to both interstitial cells and germ cells.  
In the developing ovary, RARβ was localised to the germ cells.  In the 2nd trimester 
testes RXRα was expressed in the Sertoli cells, PTM cells, germ cells and interstitial 
cells, while in the ovary RXRα was localised to the somatic cells in close association 
with the germ cells.  The expression of a number of these receptors in the human 
fetal gonad makes the formation of different heterodimers a possibility within 
different cell types of the ovary and testis.  For example, in this study, germ cells of 
the human fetal ovary have been shown to display nuclear expression of RARα and 
RARβ, making it possible that they are acting as heterodimers. 
 
Expression of RARs and RXRs has been well documented in postnatal rodent testes 
(Dufour and Kim, 1999; Vernet et al., 2006).  The only study into the expression of 
the RA receptors on the fetal testis has been performed in the rat. Rarα and Rarβ 
were both reported to be expressed in the interstitial tissue from e14.5 and in the 
gonocytes from e20.5.  Rarγ was undetectable until after birth.  Rxrα was localised to 
the gonocytes from e13.5 and the Leydig cells at e16.5.  Rxrβ was detected in the 
Leydig cells throughout development and Rxrγ was expressed in a variety of cells 
from e20.5 (Boulogne et al., 1999).  A previous study has immunolocalised the RA 
receptors to the germ cells in the fetal mouse ovary (Morita and Tilly, 1999).  
Interestingly, the majority of the RARs were detected within the cytoplasm of the 
germ cells and upon in vitro treatment with RA, the RARs redistributed to the 
nucleus.  In this study, the nuclear localisation of some of these receptors in certain 
cell types suggests that the RA receptors may possibly be signalling within cells of 
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the gonad.  The fact that some of the receptors were found to be nuclear in germ cells 
of the human fetal testis may suggest that retinoids may be signalling within the 
germ cells.  This is in contrast to the findings of a study into retinoic acid receptor 
expression in the fetal and neonatal rat testis by Boulogne et al. in 1999, where the 
receptors were found predominately in the cytoplasm of the germ cells. 
 
The expression of these receptors within the human fetal ovary and testis suggests 
that RA may have the potential to signal within cell types of the testis, and alter gene 
expression.  The expression of the RA receptors in germ cells means that germ cells 
may be direct targets for retinoid action.   
 
The potential effects of RA may not only be confined to the germ cells. One previous 
study used explant cultures to show that RA stimulation results in an increase in 
steroidogenic function in human fetal 1st trimester testis, while having a negative 
effect on the number of germ cells (Lambrot et al., 2006a).  This study has localised 
RARα, RARβ and RXRα to the interstitium of the testis, and suggests that the 
Leydig cells, could be direct targets for RA signalling. 
4.4.3 Assessment of the ability for local RA production  
The enzymes ALDH1A1, 2 and 3 are responsible for the production of RA through 
the oxidation of retinaldehyde (Reijntjes et al., 2005; Maden, 2007).  This study has 
shown for the first time that both ALDH1A2 and ALDH1A3 mRNAs were detected in 
the human ovaries, testes and mesonephroi.   
 
In the mouse, Aldh1a2 and Aldh1a3 mRNAs have been detected in the mesonephroi 
of both males and females at e13.5 at a time when meiotic entry occurs in the female 
germ cells (Bowles et al., 2006).  In our study, the concentrations of both ALDH1A2 
and ALDH1A3 mRNAs were lower in the mesonephroi than in the gonads of either 
sex, suggesting that in the human the mesonephros may not be capable of secreting 
large concentrations of RA.  Bowles et al (2006) confirmed the synthesis and 
secretion of RA by the mouse mesonephros at e13.5 and proposed a model whereby 
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the mesonephric tubules, situated adjacent to the anterior pole of the gonad may be 
capable of secreting RA into the adjacent gonad, or producing cells that synthesise 
RA and then that migrate into the gonad.  This model agrees with the observation 
that meiosis is initiated at the cranial end close to the mesonephros (Bendsen et al., 
2006; Byskov, 1975) 
 
In our study, incubation of the human mesonephros on the same cell line did not 
result in activation of the RARE reporter.  However mouse mesonephroi recovered at 
e11.5 and e13.5 failed to induce a quantifiable response from these cells, suggesting 
that the methods which we used for this assay were not sufficient to induce an 
appropriate response.  For example there may have been slight differences in the 
procedures used by Bowles et al in either the mechanical dissociation of the 
mesonephroi or the volume of media used for the cultures.  Different mouse strains 
were also used, in our study C57Bl6 mice were used, while Bowles et al collected 
mesonephroi from the Quakenbush-Swiss strain.  Additionally the cells may not have 
been as responsive as previously reported (Bowles et al., 2006; Wagner et al., 1992).  
Ideally the experiments should be repeated again with the same mouse strain as used 
by Bowles et al, and with new reporter cells. 
 
Another question mark regarding the role of the mesonephros in providing signals 
that induce meiotic entry in the female through production of RA is prompted by the 
differences that exist between species in the timings of regression of the 
mesonephros.  In the human, the mesonephros is reported to begin its regression at 
10 weeks of gestation (Moritz and Wintour, 1999), at the time when female germ 
cells are beginning to enter meiosis.  The rodent mesonephros persists until relatively 
late in gestational development, regressing at e15.5 (Vazquez et al., 1998), by which 
time all oocytes have entered meiosis.  Therefore if RA is to influence meiotic entry 
in the human, it is more likely to be that RA producing cells are located within the 
human fetal gonad.  Although we have demonstrated ALDH1A2 and ALDH1A3 
enzymes are expressed in the human gonads, with higher levels of expression of 
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ALDH1A2 in the ovary than the testis, to date we have not been able to demonstrate 
production of RA, and therefore as yet this hypothesis is unproven. 
 
4.4.4 CYP26B1 is present in the ovary and testis during the 1st and 2nd 
trimester 
Analysis of the expression of CYP26B1 in the human fetal gonads revealed that this 
enzyme was expressed in both the testes and ovaries, and contrary to expectations, 
mRNA concentrations were higher in the ovary than in the testis during the early 
second trimester.  This is in contrast to the situation in the mouse where expression 
of Cyp26b1 is upregulated specifically in the testis at the time when germ cells in the 
ovary enter meiosis.  Additionally in the mouse, Cyp26b1 transcripts have been 
found to be specific to the somatic cells of the testis including the Sertoli cells 
(Bowles et al., 2006; Koubova et al., 2006).  Therefore, in the human, the cellular 
expression of CYP26B1 must be determined in the ovary and testis.  In this study, 
messenger RNAs for CYP26A1 and CYP26C1 could not be detected in either the 
developing human fetal ovaries or testes and neither of these are expressed in the 
mouse gonad (Bowles et al., 2006).  Studies have shown in cell lines, that stimulation 
by RA results in an upregulation in both Cyp26a1 and Cyp26b1 mRNA expression 
(White et al., 2000) and that the promoter region of Cyp26a1 contains a RARE 
(Loudig et al., 2000).  Additionally, Cyp26b1 expression can be upregulated by 
signalling through RARα (Reijntjes et al., 2005). 
4.4.5 SDMG1 is expressed at high levels in the 2nd trimester human 
fetal testis 
Expression of SDMG1 mRNA appeared higher in human fetal testis than in the 
ovary.  In the mouse, Sdmg1 is specifically upregulated in the Sertoli cells of 
embryonic testes at e12.5, where it is localised to the endosomes (Best et al., 2008).  
It is not expressed in the ovary until postnatal life.  Disruption to Sdmg1 resulted in 
membrane trafficking defects, and when secretion by the Sertoli cells was inhibited, 
it resulted in germ cells undergoing male-to-female sex reversal (Best et al., 2008). 
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In our study, SDMG1 total mRNA concentrations were highest in the human fetal 
testis during the 2nd trimester, so upregulation of this gene appears to occur in the 
human later than in the mouse and interestingly Sdmg1 was expressed in the human 
fetal ovary at low levels throughout the time points analysed. 
4.4.6 Conclusions 
The results presented in this chapter have shown for the first time that STRA8 mRNA 
expression is restricted to the human fetal ovary, at the time when germ cells are 
entering meiosis, and that NANOS2 is expressed at higher levels in the 2nd trimester 
human fetal testis than the ovary.  This is an exciting indication that the mechanisms 
of meiotic entry and germ cell commitment to their sex-specific fate are at least 
partially conserved between the mouse and human.  RA appears to be important in 
inducing germ cells to enter meiosis in the mouse, and the novel findings of this 
chapter that the RARs and RXRs are expressed in the human fetal ovaries and testis 
suggests that if RA is present it may act to regulate gene expression within the cells 
of the gonad.  Messenger RNA for two of the RA producing enzymes, ALDH1A2 
and ALDH1A3 were detected in the ovaries and testis and were found at lower levels 
in the mesonephroi, indicating differences between the mouse and human.  
Unfortunately, whether either the mesonephroi or gonads produce RA, was not 
determined.  Intriguingly, the results presented here, show that the enzyme 
responsible for RA break down, CYP26B1 was found to be expressed in both the 
ovary and testis, unlike data in the mouse, and given the spatial differences in 
meiotic progression between the mouse and the human it therefore appears that the 
model whereby RA induces meiotic entry of germ cells in the mouse is not 
completely applicable to the developing human gonad. 
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5 Dissociation and culture of the somatic cells from the 
human fetal testis 
5.1 Introduction 
In 1st trimester human fetal testes, germ cells are initially characterised as a uniform 
OCT4 positive/VASA negative population, but by the 2nd trimester a heterogeneous 
population exists as germ cells differentiate into OCT4 negative/VASA positive 
prespermatogonia (Anderson et al., 2007; Gaskell et al., 2004) (Chapter 3).  Germ 
cell maturation takes place in the seminiferous cords in close association with the 
Sertoli cells, and surrounded by the peritubular myoid cells (PTM) and interstitial 
cells, including the Leydig cells.  These somatic cells are thought to play an 
important role in regulating the maturation and differentiation of germ cells and in 
preventing male germ cells from entering meiosis during fetal life, as occurs in 
females.   
 
In the human, the genital ridges appear in the intermediate mesoderm in the fourth 
week of gestation, where they form as paired structures on the ventromedial sides of 
the mesonephroi.  Within the centre of the genital ridge coelomic epithelial cells 
begin to proliferate (Wartenberg, 1981).  The Sertoli cells polarise, aggregate 
together and enclose the germ cells, which migrate into the gonad by the fifth week 
of gestation (Wartenberg, 1981) (Chapter 1, section 1.3.1.7).  The Sertoli cells are 
themselves enclosed by the PTM cells; these are cells of mesenchymal origin, which 
express the myofibroblast markers α-smooth muscle actin (α-SMA) and desmin 
(DES) (Nishino et al., 2001).  PTM cells are thought to migrate into the genital ridge 
from the mesonephros (Martineau et al., 1997) (Chapter 1, section 1.2.3).  The 
recruitment of cells from the mesonephros is male-specific (Merchant-Larios et al., 
1993; Capel et al., 1999) and is necessary for the formation of the testis cords 
(Tilmann and Capel, 1999).  Cord formation occurs within only a few hours in the 
rodent, while in the human, it takes place over a number of weeks, and is not 
complete until around the 8th week of gestation (Wartenberg, 1981). 
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The interstitial compartments, situated between the cords contain the fibroblasts, 
Leydig cells and blood vessels (Brennan and Capel, 2004).  Mesonephric cell 
migration is thought to contribute a number of cells to the interstitium, bringing 
endothelial cells, perivascular cells and fibroblasts (Buehr et al., 1993; Martineau et 
al., 1997; Merchant-Larios et al., 1993).  Fibroblast cells express the intermediate 
filament protein vimentin (VIM) (Steinert et al., 1984).  In the fetal testis, the 
fibroblast cells within the interstitium, as well as PTM cells, express the androgen 
receptor (AR) (Gaskell et al., 2004; Majdic et al., 1995).   
 
Leydig cells are evident from around 9 weeks gestation in the human (Codesal et al., 
1990; Ostrer et al., 2007).  The primary function of the Leydig cells is the secretion 
of steroids.  Human fetal Leydig cells have been shown to express enzymes required 
for steroid synthesis such as, side chain cleavage p450 (SCCP450) and 3-β-
hydroxysteroid dehydrogenase (3βHSD) throughout the 2nd trimester (Murray et al., 
2000).  The development of the Leydig cells is at least partly dependent on the 
secretion of paracrine signalling molecules from the Sertoli cells.  The most well 
characterised Sertoli-cell derived signalling molecule is desert hedgehog (Dhh) this 
molecule acts upon the patched (Ptch) receptor expressed by the Leydig cells, and 
may lead to the upregulation of steroidogenic enzymes such as SCCp450 (Clark et 
al., 2000; Yao et al., 2002). 
 
In most mammals, the gene which initiates the cascade resulting in the development 
of the testis is located on the Y chromosome, referred to as the Sex-determining 
region of the Y chromosome (SRY) (Koopman et al., 1990; Lovell-Badge and 
Robertson, 1990).  SRY encodes a putative transcription factor that is expressed in 
cells within the interior of the genital ridge between e10.5 and e12.5 in the mouse 
(Hacker et al., 1995; Bullejos et al., 2001; Albrecht and Eicher, 2001).  The primary 
function of SRY is to trigger the differentiation of the Sertoli cells (Palmer and 
Burgoyne, 1991) (Chapter 1, section 1.2.2.1).  In the human testis, SRY mRNA is 
first detectable at about 6 weeks gestation (Hanley et al., 2000; Poulat et al., 1995), 
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and unlike the transient expression observed in the mouse, mRNA is still detectable 
in the human testis throughout fetal life (Hanley et al., 2000) and even into adulthood 
(Salas-Cortes et al., 1999). 
 
The only identified target of SRY thus far has been the HMG-box containing 
transcription factor SOX9 (Bishop et al., 2000; Vidal et al., 2001) (Chapter 1, section 
1.2.2.2).  Once gene expression is initiated, Sox9 continues to be expressed in the 
testis throughout development (Morais da Silva et al., 1996).  In the human SOX9 
mRNA is expressed in the human male genital ridge, where its expression pattern 
closely parallels that of SRY, with transcripts detectable as early as 44 days post 
ovulation (Hanley et al., 2000), and persisting throughout gestation in the testes.  
 
Also implicated in the regulation of Sox9 expression is the transcription factor Wilms 
Tumour 1 (WT1).  When WT1 is mutated, a host of genitourinary abnormalities 
occur, including sex reversal (Barbaux et al., 1997; Pelletier et al., 1991).  Mutations 
in Wt1 in the mouse result in a failure of the genital ridge to thicken at e10.5, and as a 
consequence no gonad forms (Kreidberg et al., 1993).  Sertoli cell specific ablation 
of Wt1 was shown to lead to a downregulation of Sox9 at e14.5 (Gao et al., 2006).  
WT1 has been shown to be highly expressed in the coelomic epithelium of the 
human at 6.5 weeks and after formation of the cords its expression becomes 
restricted to the Sertoli cells (de Santa Barbara et al., 2000; Hanley et al., 1999). 
 
The fetal Sertoli cells secrete the glycoprotein anti-mullerian hormone (AMH), 
which plays a critical role in stimulating the regression of the Mullerian ducts in the 
male (Jost et al., 1953), and may have other important roles within the testis (Ross et 
al., 2003).  Expression of  Amh is initiated in the developing Sertoli cells of the 
mouse at e12.5 (Munsterberg and Lovell-Badge, 1991) and in the human, AMH has 
been shown to be expressed in the fetal testis during the 7th week of gestation, just 
prior to cord formation (de Santa Barbara et al., 2000; Gaskell et al., 2004). AMH is 
expressed throughout fetal development at high levels, and expression is maintained 
after birth and is downregulated at puberty (Tran et al., 1987; Rey et al., 2003). 
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Another important transcriptional regulator important for testis differentiation is 
GATA4 (Tevosian et al., 2002).  GATA4 belongs to the GATA family of 
transcriptional regulators (Arceci et al., 1993) and is expressed in the somatic cells of 
the gonad where it has been localised to the Sertoli cells, Leydig cells and fibroblasts 
(Viger et al., 1998).  Mouse mutants of Gata4, and a knock-in mutation affecting the 
ability of Gata4 to interact with its co-factor Fog2, both display an identical 
phenotype, exhibiting decreased expression of Sry, decreased cellular proliferation 
and abnormal Sertoli cells and Leydig cell development (Tevosian et al., 2002).  A 
recent study suggests that in the absence of Gata4, Leydig cells cannot form 
(Bielinska et al., 2007). 
 
SF1 is an orphan nuclear receptor which acts to regulate the transcription of a 
number of target genes that control of the gonadal and adrenal development.  Sf1 
homozygous mutant mice display gonadal and adrenal agenesis (Lala et al., 1992; 
Luo et al., 1994).  At e11.5, Sf1 expression is found in both the pre-Sertoli cells and 
the pre-Leydig cell population, but thereafter Sf1 expression decreases in Sertoli cells 
and increases in differentiating Leydig cells (Hatano et al., 1996).  This pattern of 
expression appears to be mirrored in the human, where prior to formation of the 
cords, SF1 localises primarily to the developing Sertoli cells, while after the cords 
form SF1 is more abundant in the Leydig cells (Hanley et al., 1999; Majdic and 
Saunders, 1996). 
 
A number of paracrine signalling systems are thought to operate in the testis, one 
important group of signalling molecules are the activins.  Activins are members of 
the TGF-β family; they exist as dimers of 2 homologous protein B subunits, with 
homodimers of the activin subunit forming activin A (βAβA) or activin B (βBβB).  
Activins mediate their effect on cell function by binding to the type II receptor serine 
kinases, ACTRIIA or ACTRIIB, these then recruit and phosphorylate the type I 
activin receptor-like kinases ALK2 or ALK4, which in turn activate SMAD proteins 
(Mathews, 1994).  Phosphorylation of SMAD2 and SMAD3 enables them to 
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dimerize with SMAD4, and the SMAD complex then migrates to the nucleus where 
it induces transcriptional responses (Massague, 1998; Massague and Chen, 2000) 
(Chapter 1, section 1.4.1).  Sertoli cells, PTM cells and Leydig cells within the 
human fetal testis all have the potential to produce activins (Majdic et al., 1997; 
Anderson et al., 2002).  In the human fetal testis, ACTRIIA has been 
immunolocalised to the interstitium, as well as the gonocytes and some Sertoli cells, 
while ACTRIIB was found to be expressed in the interstitium, the gonocytes and the 
Sertoli cells, as well as the PTM (Anderson et al., 2002).  In the human fetal ovary, 
activins may have an important role in germ cell survival (Martins da Silva et al., 
2004), where it appears to act upon the somatic cell (Coutts et al., 2007a), and in the 
immature rat testis, activin A has been shown to stimulate proliferation of Sertoli 
cells (Boitani et al., 1995). 
 
Some progress has been made in establishing explant cultures of human fetal testes 
(Coutts et al., 2007b; Hallmark et al., 2007; Robinson et al., 2003).  Culture of 
isolated populations of somatic cells from postnatal human testis has been achieved, 
but with a limited success (Berensztein et al., 2000; Berensztein et al., 1992; Rivarola 
et al., 1995). 
 
5.1.1 Aims of chapter 
This study aimed to establish cultures of testicular somatic cells that maintain a 
differentiated phenotype in order to provide a model system to further understand 
gene expression in the 2nd trimester human fetal testis.  Cell-type specific expression 
of putative marker proteins was investigated using immunohistochemistry on fixed 
tissue sections.  Isolated populations of human somatic cells were maintained in vitro 
and gene expression was then analysed in these cell types.  Additional experiments 
aiming to optimise the dissociation procedure and culture conditions were also 
performed. 
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5.2 Materials and methods 
5.2.1 Collection of human fetal testes 
Human fetal testes were obtained following termination of pregnancy as outlined in 
Section 2.1 
5.2.1.1 Immunohistochemistry  
Immunohistochemistry on fixed tissue sections of testis was performed and is 
detailed in section 2.2.  Information regarding the primary antibodies used is listed in 
(Table 5-1). 
Table 5-1 Summary of primary antibodies used for immunohistochemistry 
Antigen Source Species Dilution Citrate 
Retrieval 
3βHSD Gift from Professor Ian Mason. 
University of Edinburgh 
Rabbit 1:1000 No 
AMH Santa cruz Goat 1:500 No 
AR Santa Cruz Rabbit 1:200 Yes 
DES Dako Mouse 1:200 Yes 
GATA4 Santa Cruz Goat 1:100 Yes 
SCCp450 Chemicon Rabbit 1:200 No 
SOX9 Chemicon Rabbit 1:200 Yes 
WT1 Dako Mouse 1:50 Yes 
α-SMA Sigma Mouse 1:200 No 
 
5.2.1.2 Fluorescent immunohistochemistry 
Fluorescent immunohistochemistry on tissue sections was performed following the 
procedure outlined in section 2.3.10.  For double staining of AR and SMA, AR was 
used at a dilution of 1:50.  Goat anti-rabbit biotinylated followed by streptavidin 546 
was used for detection of AR.  SMA was used at a dilution of 1:100, followed by 
goat anti-mouse alexa 488. 
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5.2.2 Dissociation of human fetal testes  
Testes were removed from male fetuses and placed in 4mls of Hanks Buffered Salt 
Solution (HBSS) (Gibco). Under a dissection microscope, a section of testis was 
removed and snap frozen for extraction of RNA or protein (time 0). The remaining 
testis was carefully pulled apart using a 40mm needle.  In a class II tissue culture 
hood, 500μl of collagenase type IV (Sigma) (0.01g in 1 ml HBSS) was added to the 
4mls of HBSS containing the tissue and incubated for 15 minutes, at 34oC on a roller.  
Thereafter, 50μl of DNase 1 (Sigma) (diluted 0.007g in 1ml HBSS) was added to the 
solution and the mixture was incubated for a further 5 minutes.  The resulting cell 
suspension was centrifuged for 5 minutes at 800 rpm, the supernatant was discarded, 
and the cell pellet was re-suspended in 4mls of HBSS (Gibco) to wash.  The washing 
step was repeated twice. 
 
In some cases, 1ml of trypsin/EDTA (Sigma) was then added to the cell suspension 
and incubated for 10 minutes.  Once a single cell suspension was obtained, 0.5ml of 
fetal calf serum was added to prevent any further action of trypsin.  The cells were 
filtered through a 70μm mesh filter and centrifuged at 800 rpm for 5 minutes, they 
then were resuspended in 1ml of media, and a cell count performed.   
5.2.3 Culture of human fetal somatic cells 
Cells were plated onto 0.01% gelatin (Sigma) coated plates, T25 flasks or chamber 
wells. The recipe of the medium used is listed in section 2.7.  Media was 
supplemented with dihydrotestosterone (DHT) (Sigma) at a concentration of      
1x10-8M.  Cells were passaged when confluent, normally every 4-6 days.  Passaging 
was performed by either using trypsin/EDTA or dispase (Sigma) (2 mg/ml).  
Medium was changed every 2nd day.  For activin experiments, activin A (R&D 
systems) was used at a concentration of 10 ng/ml (diluted in HBSS). 
5.2.4 RNA Extraction 
Details of the extraction of RNA from tissue and cells are as described in section 2.4. 
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5.2.5 Preparation of cDNA using random hexamers 
cDNA was prepared as outlined in section 2.5.2.1. 
5.2.6 TaqMan analysis  
TaqMan quantitative RTPCR was performed using the Roche Universal Probe 
Library.  Details of the TaqMan reaction and method of analysis are described in 
section 2.5.  Primers used, along with the corresponding probe number are listed in 
Table 5-2.  Data was expressed relative to positive control (pooled RNA from 3 
whole human fetal testes). 
5.2.7 Statistical analysis 
Statistical analysis was performed using a one-way analysis of variance (ANOVA) 
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Table 5-2 Summary of primers and probes used for TaqMan reaction 
Gene name 5’ sequence 3’sequence Probe 
number 
3βHSD cggaccagaattgagagagg gaatggctcatccagaatgtc 11 
ACTR IIB tgtcaagatcttcccactcca catgccaggtgtgctgaa 53 
ACTRIIA aaagcccagttgcttaacga tgccatgactgtttgtcctg 5 
ALK4 atattgggagattgctcgaaga ggcagctgatattcttcatgg 65 
ALK2 catgaatttggcttttggaga ctttggcagtgtgtgacgctta 1 
AMH cgcctggtggtcctacac gaacctcagcgagggtgtt 69 
AR gccttgctctctagcctcaa gtcgtccacgtgtaagttgc 14 
DES ggagattgccacctaccg ggtctggatggggagattg 55 
DHH gcaacaagtatgggttgctg cggaccgcagtgagtta 86 
GATA4 ggaagcccaagaacctgaat gggaggaaggctctcactg 17 
OCT4 gtggagagcaactccgatg tgcagagctttgatgtcctg 78 
SCCp450 aggaggggtggacacgac ttgcgtgccatctcataca 59 
SF1 gcaggtgcatggtcttcaa agttctgcagcagcgtcat 10 
SMA ctgttccagccatccttcat tcatgatgctgttgtaggtggt 58 
SMAD2 gcttctctgaacaaaccaggtc atgtggcaatccttttcgat 80 
SOX9 gtacccgcacttgcacaac tctcgctctcgttcagaagtc 61 
SRY gcttactgaagccgaaaaaatg tctctgtgcatggcctgtaa 79 
VASA cgccaaacccttatgttcag aaaaactctgcagccaacctt 6 
VIM gaccagctaaccaacgacaaa gaagcatctcctcctgcaat 39 
WT1 ggagccaccttaaagggagt gcccttctgtccatttcact 3 
 
5.2.8 Immunohistochemistry on cultured cells 
Cultured cells were seeded onto polyL lysine-coated CC2 chamber slides (Lab-Tek, 
Nalge Nunc International, Roskilde, Denmark).  Cells were either cultured for 3 
hours to allow attachment onto the slide or grown until confluent.  
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For DAB immunohistochemistry, cells were fixed in ice cold methanol for 10 
minutes at -20oC.  Cells were blocked in TBS containing 20% normal serum and 5% 
BSA, followed by the avidin-biotin blocking kit (refer to section 2.3.6), after which 
primary antibodies were added and incubated overnight at 4oC.  After 2x5 minute 
washes in TBS, cells were incubated with appropriate secondary antibodies for 30 
minutes.  Cells were then washed in TBS and incubated with Streptavidin-HRP for 
30 minutes, followed by DAB (refer to section 2.3.9) and counterstained with 
haematoxylin.  Primary antibodies used and their corresponding secondary 
antibodies are listed in Table 5-3. 
 
Table 5-3 Primary antibodies used for immunohistochemistry on cultured cells 
Antibody Supplier Dilution Secondary 
antibody 
DES Dako 1:200 GAM-b 
VIM AbCam 1:300 GAR-b 
 
For fluorescent immunohistochemistry, cells were fixed in Modified Davidson’s 
Fixative for 10 minutes at room temperature, followed by 2x5 minute washes in PBS.  
Cells were blocked in PBS containing 20% normal serum and 5% BSA, and then 
with the avidin-biotin blocking kit.  Primary antibodies were added and incubated 
overnight at 4oC and are listed in Table 5-4.  After 2x5 minute washes in PBS, cells 
were incubated with appropriate secondary antibodies.  Cells were then washed and 
the appropriate fluorescent molecules were added, diluted in PBS, following 2x5 
minute washes, Dapi (Sigma, diluted 1 in 1000) was incubated with the cells for 10 
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Table 5-4 Primary antibodies used for fluorescent immunohistochemistry on cultured 
cells 
Antibody Dilution Secondary antibody Flourescent Label 
GATA4 1:200 RAG-b Streptavidin-546 
SCCp450 1:100 RAG-b Streptavidin-546 
SMA 1:200 GAM-b Streptavidin-546 
SOX9 1:1000 GAR-b Streptavidin-546 
 
5.2.9 Western blotting 
Western blotting was performed on total protein extracted from human fetal testes 
obtained during the 1st trimester and 2nd trimesters.  Briefly, testes were halved and 
lysed in RIPA buffer (Section 2.6.1) and total concentration of protein was quantified 
using a Biorad protein assay (Section 2.6.2).  Full details of the Western blotting 
technique are outlined in Section 2.6.  Information regarding the primary antibodies 
used is listed in Table 5-5 





Source  Dilution 
SOX9 Rabbit Chemicon 1:500 
GATA4 Goat Santa Cruz 1:300 
SMA Mouse Sigma 1:500 
AR Rabbit Santa Cruz 1:300 
β-TUBULIN Rabbit Santa Cruz 1:1000 
β-TUBULIN Mouse Sigma 1:1000 
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5.3 Results 
5.3.1 Immunohistochemical staining for putative Sertoli cell specific 
proteins in human fetal testes  
Human fetal testis were immunopositive for SOX9 throughout the 2nd trimester and 
the protein was localised to the nuclei of all Sertoli cells (Figure 5-1 a and b).  AMH 
was immunolocalised to the cytoplasm of Sertoli cells throughout the 2nd trimester 




Figure 5-1 Immunoexpression of Sertoli cell markers in 2nd trimester human fetal 
testes.  SOX9 staining of human fetal testis at a) 16 weeks b) 17 weeks and AMH 
immunostaining of c) 17 week and d) 15 week human fetal testis.  I labels the 
interstitium, arrows point to immunopositive Sertoli cells and asterisks indicated 
immunonegative germ cells.  For a and c, bar=100μm, for b and d, bar=50μm. 
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5.3.2 Immunohistochemical staining of WT1 and GATA4 in the human 
fetal testis  
Sertoli cells were also immunopositive for WT1, which was localised to the Sertoli 
cell nuclei of 2nd trimester testis as well as some unidentified cells within the 
interstitium (Figure 5-2 a and b).  GATA4 was immunolocalised to the nuclei of the 
Sertoli cells, PTM cells, and some Leydig cells and interstitial fibroblasts (Figure 5-2 
c and d).   
 
Figure 5-2 Immunostaining of WT1 in 2nd trimester human fetal testis at a) 15 weeks 
and b) 19 weeks.  Immunostaining for GATA4 at c) 17 weeks and d) 19 weeks.  For a 
and b arrows show immunopositive interstitial cells, while arrowheads point to 
positive Sertoli cell nuclei.  For c and d arrows point to immunopositive Sertoli and 
PTM cells, arrowheads label GATA4 negative germ cells.  Bar=100 μm for a and c and 
50μm for b and d.   
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5.3.3 Immunohistochemical staining of Leydig cell markers in human 
fetal testis  
3βHSD was immunolocalised exclusively to cells within the interstitium of 2nd 
trimester human fetal testis, in cells presumed to be Leydig cells, where staining was 
confined to the cytoplasm (Figure 5-3, and b).  SCCP450 was also immunolocalised 
to these presumptive Leydig cells, with a non-uniform staining pattern consistent 
with its localisation to the microsomes (Figure 5-3, c and d). 
 
 
Figure 5-3 Immunostaining of Leydig cell markers in 2nd trimester human fetal testis.  
a) 3βHSD staining of 17 week human fetal testis b) 3βHSD staining of 16 week human 
fetal testis c )SCCp450 immunostaining of 16 week human fetal testis d) 15 week 
human fetal testis stained for SCCp450. Asterisks label the testicular cords and 
arrows point to immunopositive Leydig cells.  For a and c, bar=100μm, for b and d, 
bar=50μm.   
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5.3.4 Immunohistochemical staining of AR in the human fetal testis  
AR was immunolocalised to the nuclei of small interstitial cells (presumptive 
fibroblasts) and cells adjacent to the seminiferous cords i.e the PTM cells (Figure 
5-4.).  Note that both Sertoli cells and germ cells were immunonegative. 
 
Figure 5-4 Immunostaining of AR in 2nd trimester human fetal testis at a) 16 weeks and 
b) 18 weeks. Cells labelled with asterisks indicate AR immunonegative germ cells, 
while immunonegative Sertoli cells are labelled with a cross.  Arrows show 
immunopositive PTM cells, while arrowheads point to interstitial cells immunopositive 
for AR.  Bar=100 μm for a and 50μm for b. 
5.3.5 Immunohistochemical staining of PTM cells markers in the 
human fetal testis  
Both SMA and DES were immunolocalised to the cytoplasm of elongated flat cells 
found surrounding the testicular cords, identifiable as the PTM cells (Figure 5-5).  
Both SMA and DES were also immunolocalised to cells surrounding blood vessels 
(Figure 5-5).  DES immunopositive staining was detected in many more interstitial 
cells than SMA staining, the identity of these cells was not explored further, but they 
are likely to be fibroblasts (Figure 5-5 c and d).  
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Figure 5-5 Immunostaining of PTM markers in human fetal testis. a) and b) SMA 
immunostaining of 16 week human fetal testes; c) and d) immunostaining of DES in 16 
week human fetal testes.  Arrows point to immunopositive PTM cells and asterisks 
show DES immunopositive interstitial cells.  Bar=100μm, for b and d, bar=50μm. 
5.3.6  Immunohistochemical colocalisation of AR and SMA in human 
fetal testis  
In order to confirm that some of the AR-positive interstitial cells were PTM cells, 
sections were co-stained with antibodies directed against AR and SMA.  In 
agreement with the results of the single staining (Figure 5-5), SMA was localised to 
the cytoplasm of cells surrounding the testis cords and the blood vessels (Figure 5-6, 
green).  AR was detected in the nuclei of multiple cells within the interstitium 
(Figure 5-6, red nuclei), and PTM cells were identified as AR positive/SMA positive 
(Figure 5-6b, arrowheads). 
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Figure 5-6 Fluorescent immunohistochemistry showing co-localisation of SMA (green) 
and AR (red) in 2nd trimester human fetal testis at a) 18 weeks b) 16 weeks.  In a 
arrowheads show AR positive cells and arrows label cells that are immunopositive for 
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5.3.7 Morphology of dissociated and cultured 2nd trimester human fetal 
testis    
Once dissociated and placed in the culture dishes, the cells adhered to the gelatin-
coated plates quickly and began to divide within a few days.  The morphology of the 
cells in the cultures was not uniform, with smaller cells closely adherent to one 
another, as well as rounder cells and cells which appeared long and flat.  Cells were 
confluent normally within 4-6 days, although the time until confluency was reached 
decreased as the number of passages increased. As the passage number increased the 
number of long flat cells appeared to increase (Figure 5-7).  By passage 5 the 
morphology of the cells was less mixed, with more cells that were long and flat, 
 
 
Figure 5-7 Images of cells obtained from a 14 week fetus a) passage 1 b) passage 3 c) 
passage 5 
5.3.8 Expression of germ cell markers in cultures of dissociated 
testicular cells  
TaqMan qRTPCR analysis of cultures using primers specific for the gonocytes 
specific marker, OCT4 (Chapter 3) failed to detect the expression of the mRNA even 
in passage 1 cultures (Figure 5-8a).  Likewise VASA mRNA, a marker of the 
prespermatogonial cells (Chapter 3), was not detected in the cultures (Figure 5-8b).  
This data was taken as evidence that none of the adherent cells in the cultures were 
germ cell in origin, and therefore for the rest of this chapter, these cultures will be 
referred to as ‘somatic cell cultures’. 
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Figure 5-8 TaqMan analysis of germ cell markers on cultured human fetal testicular 
cells at time 0 (section of fetal testis taken prior to dissociation) and p1-p5, relative to 
positive control for a) OCT4 and b) VASA.  Taqman was performed in triplicate for 4 
independent cultures from fetuses obtained at 15, 17 and  2x18 weeks.  Mean ± sem 
5.3.9 Expression of Sertoli cell markers in somatic cell cultures 
Although AMH and DHH mRNAs were detected in the testes prior to culture, after 
dissociation the mRNAs were not detected in the cultured cells.  Expression of AMH 
was undetectable at P1 (Figure 5-9a) and was significantly reduced compared with 










Chapter 5   Dissociation and culture of somatic cells from the human fetal testis 162 
 
Figure 5-9 Expression of a) AMH and b) DHH mRNA for time 0, p1-5 in dissociated and 
cultured human fetal testis, relative to positive control (N=4; 15, 17, 2x18 week).  
Taqman was performed in triplicate for 4 independent cultures from fetuses obtained 
at 15, 17 and  2x18 weeks. Mean ± sem 
 
 
In contrast of SRY mRNA was detectable both in the 2nd trimester human fetal 
gonads prior to culture and in the dissociated cells throughout the culture period 
(Figure 5-10a).  SOX9 mRNA expression was also maintained throughout the culture 
period (Figure 5-10b).  The expression of SRY and SOX9 mRNAs decreased in 
parallel with each other with increasing passage number.  There were no statistically 
significant changes in SOX9 and SRY throughout the culture period. 
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Figure 5-10 mRNA expression for a) SRY b) SOX9 at  time 0 and p1-p5, relative to 
positive control (N=4; 15, 17, 2x18 week) .  Taqman was performed in triplicate for 4 
independent cultures from fetuses obtained at 15, 17 and  2x18 weeks.  Mean ± sem 
 
5.3.10 Expression of WT1, GATA4 and SF1 mRNA in human fetal 
somatic cell cultures.   
Expression of WT1 mRNA was also detected in cultures up to and including passage 
5 although it decreased as the passage number increased (Figure 5-10c).  In contrast, 
expression of GATA4 mRNA was maintained throughout the culture period (Figure 
5-11a), as was SF1 (Figure 5-11b), although the total amount of  SF1 mRNA relative 
to total mRNA appeared to decline as the number of passages increased, while the 
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expression of GATA4 appeared to be slightly more constant, even after repeated 
passage of the cells.   
 
Figure 5-11 a) WT1,  b) GATA4, c) SF1 mRNA expression for time 0, p1-p5.  All results 
are  given relative to positive control (N=4; 15, 17, 2x18 week).  Taqman was 
performed in triplicate for 4 independent cultures from fetuses obtained at 15, 17 and  
2x18 weeks.  Mean ± sem 
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5.3.11 Expression of Leydig cell markers in human fetal somatic cell 
cultures  
In order to determine whether any Leydig cells were present in the somatic cell 
cultures, qRTPCR analysis was carried out to determine the expression of two 
Leydig cell specific enzymes, SCCp450 and 3βHSD (Figure 5-12).  mRNA for both 
enzymes were detected at passage 1 but then rapidly declined.  SCCP450 mRNA 
levels were significantly reduced at P1 compared with time 0 (P<0.05), 3βHSD  was 
also significantly reduced by P1 (P<0.01).  Expression of 3βHSD appeared to be 
maintained slightly longer than SCCp450. 
 
Figure 5-12 3βHSD and SCCp450 mRNAs expression for time 0, p1-p5, relative to 
positive control (N=4; 15, 17, 2x18 week).  Taqman was performed in triplicate for 4 
independent cultures from fetuses obtained at 15, 17 and  2x18 weeks.  Mean ± sem 
 
 
5.3.12 Expression of PTM/fibroblast markers in human fetal somatic cell 
cultures  
As the number of passages increased, total expression of α-SMA mRNA appeared to 
increase compared to total concentrations in extracts from intact testes  (Figure 
5-13a).  α-SMA mRNA expression was significantly increased at P5 compared with 
P1 (P<0.05).  Expression of DES mRNA was also higher in the dissociated somatic 
cell cultures compared with the expression at time 0 (P<0.05) (Figure 5-13b).  Total 
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VIM mRNA  was similar to time 0 at passage 1 but thereafter increased as a 
population of total mRNA (Figure 5-13c). 
 
Figure 5-13 α-SMA, DES and VIM mRNA expression for time 0, p1-p5, relative to 
positive control (N=4; 15, 17, 2x18 week).  Taqman was performed in triplicate for 4 
independent cultures from fetuses obtained at 15, 17 and 2x18 weeks.  Mean ± sem 
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5.3.13 AR mRNA expression in human fetal somatic cell cultures  
Throughout the culture period mRNA for the AR was detectable, although as a 
population of total mRNA, it did decline with increasing passage (Figure 5-14). 
 
Figure 5-14 AR mRNA expression for time 0, p1-p5, relative to positive control (N=4; 
15, 17, 2x18 week).  Taqman was performed in triplicate for 4 independent cultures 
from fetuses obtained at 15, 17 and  2x18 weeks. Mean ± sem 
 
 
5.3.14 Activin receptor mRNA expression in human fetal somatic cell 
cultures 
Expression of mRNAs encoding the type II activin receptors ACTRIIA and ACTRIIB 
was detectable in cells throughout all five passages (Figure 5-15a and b).  The 
mRNAs for type I activin receptors, ALK2 and ALK4 were also expressed at 
concentrations that roughly paralleled those in the intact testis (time 0) and were 
sustained throughout the culture period (Figure 5-15c and d). 
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Figure 5-15 Expression of activin receptor mRNA for time 0 and p1-p5. a) ACTRIIA b) 
ACTR IIB c) ALK2 d) ALK4 (N=4; 15, 17, 2x18 week).  Taqman was performed in 
triplicate for 4 independent cultures from fetuses obtained at 15, 17 and  2x18 weeks.  
Mean ± sem 
 
5.3.15 Western analysis of human fetal somatic cell cultures  
Western analysis was used to detect expression of SOX9 (64kDa), GATA4 (46 kDa), 
α-SMA (42kDa) and AR (110kDa) protein (Figure 5-16).  β-TUBULIN (51kDa) was 
used as the loading control, for all N=1.  SOX9 and GATA4 protein expression was 
maintained throughout the cultures.  SMA protein was also present throughout the 
cultures, although total protein levels did not appear to show the gradual increase 
found with the mRNA data.   
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Figure 5-16 Western Blot for SOX9, GATA4 and SMA in cells from 17 week human 
somatic cell culture at time 0 and p1-p5. 
 
5.4 Immunohistochemical detection of somatic markers from human 
fetal somatic cell cultures.  
As TaqMan and Western analysis was only able to detect total levels of expression in 
the cell cultures, and the initial observations based on morphology suggested a 
mixture of cell types were present, additional analysis was carried out using 
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immunohistochemistry on the cell cultures at passage 1 to passage 3.  SMA was 
immunolocalised to the cytoplasm of a subpopulation of the cells in vitro.  It could 
be detected at the passages 1-3 analysed.  SOX9 immunostaining revealed positive 
nuclear staining in a subset of the cultured somatic cells and a similar result was 
obtained for GATA4.  SCCp450 was immunopositive in only the occasional cell at 
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Figure 5-17 Immunostaining of cultures established from 17 week human fetal testis at 
p1-p3, showing expression of  SOX9, GATA4, SCCp450 and SMA.  SOX9, GATA4. 
SCCp450 and SMA are all shown in red, while Dapi is shown in blue.  
 
Immunostaining for DES and VIM was also performed.  DES immunostaining was 
confined to a subset of the cells (Figure 5-18 a and b).  VIM immunostaining was 
more intense at passage 4 compared with passage 1, with a greater intensity per cell. 
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Figure 5-18 Immunostaining for DES in 18 week human fetal testis culture at a) 
passage 1 and b) passage 4.  Immunostaining for VIM c) passage 1 and d) passage 4.  
Bar=100 μm for a, c and 50μm for b. 
5.4.1 Activin treatment of human fetal somatic cell cultures 
Since expression of both the type I and type II activin receptor mRNAs was 
maintained throughout the 5 passages (Figure 5-15), additional cultures were 
performed with or without the addition of activin in order to determine what effects, 
if any, activin could have on the cells and their gene expression.  
 
The morphology or number of the cultured cells did not change in response to activin 
treatment (Figure 5-19). 
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Figure 5-19 Morphology of cells after 7 days of culture for a) treatment with HBSS 
control b) treatment with activin 
The expression of key genes required for activin signalling were maintained 
throughout the cultures (Figure 5-20). 
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Figure 5-20 Taqman analysis of cells cultured from p1-p5 following treatment either 
with or without activin for a)ACTRIIA b)ACTRIIB c)SMAD2.  Taqman was performed in 
triplicate for 2 independent cultures from fetuses obtained at 15 week and 17 weeks.  
Relative to dissociated 15 week testis control culture.  Mean ± sem 
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Inclusion of activin in the culture media did not prevent loss of expression of the 
Sertoli cell markers AMH and DHH or the Leydig cell marker SCCp450 during 




Figure 5-21 Taqman analysis for a) AMH mRNA expression b) DHH mRNA expression 
and c) SCCp450 mRNA expression following culture in the presence or absence of 
activin A, relative to 15 week control culture.  Taqman was performed in triplicate for 2 
independent cultures from fetuses obtained at 15 week and 17 weeks.   
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SOX9 and SMA mRNA were expressed in a similar manner to previous cultures with 
SOX9 declining with increasing passage, and SMA increasing as the cultures 




Figure 5-22 mRNA expression of a) SOX9 and b) SMA in human fetal somatic cells 
cultured in the presence or absence of activin A, relative to dissociated 15 week testis 
control culture  (N=2, 15 week and 17 week).  Taqman was performed in triplicate for 2 
independent cultures from fetuses obtained at 15 week and 17 weeks.   
5.5 The effect of trypsin/EDTA on human fetal somatic cell cultures  
Since the expression of mRNAs such as SOX9, SRY, WT1, SCCp450 and 3βHSD 
have been shown to decrease with repeated passage in these cultures, the effect of 
trypsin/EDTA on the cells was analysed. 
 
Testis were halved and dissociated as normal in the presence of Collagenase IV and 
DNAse1, half were then treated with trypsin/EDTA for 10 minutes, as had been 
performed for all previous experiments.  The other half were placed in culture 
without the trypsin dissociation step.  In testes that were dissociated in the absence of 
trypsin/EDTA a larger number of cells appeared to adhere and divide (Figure 5-23). 
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Figure 5-23 Images of cells from dissociated 14 week human fetal testis 2 days after 
culture when a) dissociated with trypsin/EDTA b) dissociated in the absence of 
trypsin/EDTA.   
 
TaqMan analysis for the Sertoli cell genes SOX9 and AMH showed increased 
expression after 7 days of culture when tissue was dissociated without 
trypsin/EDTA, as did the Leydig cell marker SCCp450.  A student’s t-test was 
performed but the difference between means were found to be non-significant for all 
three (P>0.05) (Figure 5-24). 
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Figure 5-24 mRNA expression for SOX9, AMH and SCCp450 in human fetal somatic 
cell cultures after 7 days of culture following dissociation either with or without 
trypsin/EDTA. N=3, Relative to cultures dissociated in the absence of trypsin/EDTA.  
Mean ± sem 
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Since the use of trypsin/EDTA during the initial dissociation procedure appeared to 
have an adverse effect on the survival of the cells and subsequent mRNA expression, 
this raised concerns about continuously passaging the cells with trypsin/EDTA also. 
Cultures were set up where cells were passaged with dispase instead of trypsin.  The 
effects of passaging with dispase on mRNA expression were then analysed. 
  
Analysis of cells dissociated in the absence of trypsin/EDTA and then subsequently 
passaged using dispase instead of trypsin/EDTA still resulted in a loss of expression 
of AMH and DHH mRNAs (Figure 5-25).   
 
 
Figure 5-25 Taqman analysis of human fetal testis dissociated in the absence of 
trypsin and passaged using dispase a) AMH b) DHH. Taqman was performed in 
triplicate for 3 independent cultures from fetuses obtained at 13 weeks and 2x17 
weeks. Relative to positive control.  Mean ± sem 
 
The mRNA expression of SRY, SOX9, and WT1 were all maintained throughout the 
cultures when passaged with dispase (Figure 5-26) and did not really differ from the 
expression when trypsin/EDTA was used (Figure 5-10 and Figure 5-11). 
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Figure 5-26 mRNA expression for a) SRY b) SOX9, and c) WT1 in human fetal testis 
dissociated without trypsin/EDTA and passaged using dispase, relative to positive 
control.  Taqman was performed in triplicate for 3 independent cultures from fetuses 
obtained at 13 weeks and 2x17 weeks.  Mean ± sem 
Chapter 5   Dissociation and culture of somatic cells from the human fetal testis 181 
 
Figure 5-27 GATA4 mRNA expression in testis dissociated without trypsin/EDTA and 
passaged using dispase, relative to positive control.  Taqman was performed in 
triplicate for 3 independent cultures from fetuses obtained at 13 weeks and 2x17 
weeks.  Mean ± sem 
 
GATA4 mRNA levels (Figure 5-27) were maintained as before and did not appear 
any higher or lower than when cells were passaged with trypsin/EDTA (Figure 5-11). 
 
Expression of SCCp450 mRNA at p1 was comparable to that at time 0, but was not 
maintained thereafter even if dispase was used in place of trypsin/EDTA (Figure 
5-28).  In addition to total amounts of α-SMA mRNA still increased as cells were 
passaged beyond passage 2 (Figure 5-29), although levels were not as high as when 
cell dissociation was performed with trypsin/EDTA. 
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Figure 5-28 mRNA expression of SCCp450 in testis dissociated in the absence of 
trypsin/EDTA and passaged using dispase. Relative to positive control.  Taqman was 
performed in triplicate for 3 independent cultures from fetuses obtained at 13 weeks 
and 2x17 weeks.  Mean ± sem 
 
 
Figure 5-29 mRNA expression of α-SMA in testis dissociated in the absence of 
trypsin/EDTA and passaged using dispase. Relative to positive control.  Taqman was 
performed in triplicate for 3 independent cultures from fetuses obtained at 13 weeks 
and 2x17 weeks.  Mean ± sem 
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5.6 Discussion  
Our ability to understand the regulation of gene expression in individual cell types 
within the human fetal testis would be enhanced if we were able to isolate them and 
culture them in vitro.  In this study human fetal testes were dissociated into a single 
cell suspension, maintained in vitro and passaged so as to determine whether somatic 
cells could a) be identified and b) maintain a differentiated phenotype.   Gene 
expression analysis was then performed on these cells for further characterisation. 
5.6.1 Protein expression of somatic cell markers in the human fetal 
testis  
Before commencing the studies with dissociated cells, immunohistochemical staining 
was used to identify the expression of specific cell markers for the Sertoli cell, 
Leydig cell and PTM cell lineages in the human fetal testis.  The transcription factor 
SOX9 was exclusively immunolocalised to the nuclei of Sertoli cells throughout the 
2nd trimester.  This is in agreement with a previous report which detected SOX9 in 
Sertoli cells of 1st and 2nd trimester testis (Hanley et al., 2000).  AMH was localised 
to the cytoplasm of the Sertoli cells throughout the 2nd trimester, as has been 
previously demonstrated (Gaskell et al., 2004; de Santa Barbara et al., 2000). The 
transcription factor, WT1 was expressed in the nuclei of the Sertoli cells in the 2nd 
trimester, consistent with previous studies (de Santa Barbara et al., 2000; Hanley et 
al., 1999). 
 
Interstitial cells in 2nd trimester testis were immunopositive for the steroidogenic 
enzymes 3βHSD and SCCp450.  Both enzymes are required for steroid biosynthesis 
during which SCCp450 converts cholesterol to pregnenolone (Lieberman et al., 
1984) and 3βHSD converts pregnenolone to progesterone (Simard et al., 2005).  In 
2004 Gaskell et al. reported the onset of 3βHSD expression in second trimester 
human fetal testis.  Several other groups have also reported the expression of these 
enzymes in the Leydig cells of the human fetal testis (Murray et al., 2000; Ostrer et 
al., 2007; Boukari et al., 2007) and the secretion of steroids during the 2nd trimester 
has also been demonstrated, with testosterone levels peaking between 14 and 18 
Chapter 5   Dissociation and culture of somatic cells from the human fetal testis 184 
weeks gestation (Voutilainen, 1992), coincidental with the time when Leydig cells 
are highly proliferative (Codesal et al., 1990). 
 
Immunohistochemical staining for GATA4 revealed that this protein was highly 
expressed in the Sertoli cells and PTM cells of the 2nd trimester human fetal testis, 
and some positive Leydig cells and interstitial fibroblasts were also observed.  No 
morphologically identifiable germ cells were found to be GATA4 positive.  GATA4 
expression has previously been reported in the Sertoli cells, Leydig cells and the 
germ cells of the human fetal testis (Ketola et al., 2000).  GATA4 and its co-factor 
FOG2 have been immunolocalised to human fetal testis from 7 weeks gestation, 
where FOG2 was cytoplasmic and GATA4 was nuclear (Ostrer et al., 2007).  
 
SMA and DES were both detected in the cytoplasm of PTM cells and presumptive 
myoepithelial cells surrounding the vasculature within the interstitium of the 2nd 
trimester testis.  Expression of SMA has recently been reported to occur in PTM and 
vascular cells of the human fetal testis from week 7 of development (Ostrer et al., 
2007) and our study is the first demonstration of DES expression in the human fetal 
testis.  One study examining PTM markers in the developing mouse testis, could 
detect neither Des or Sma within the PTM cells at e13.5 and e14.5, suggesting that in 
the mouse the PTM cells do not acquire a smooth muscle phenotype until later in 
development (Jeanes et al., 2005). 
 
Immunoexpression of AR revealed that protein expression was restricted to the PTM 
cells and interstitial populations.  In the adult testis both Sertoli cells and Leydig cells 
express the androgen receptor, but previous work on the fetal rat (Majdic et al., 1995) 
and fetal human (Gaskell et al., 2004; Murray et al., 2000) have not detected AR in 
either of these cell types.  The role of PTM cells in the fetal gonad is not fully 
understood, but the expression of AR in these cells suggests that they may be 
important targets for AR and establishment of a differentiated PTM cell culture to 
further understand these cells was one of the goals of this study and the reason that 
DHT was added to the media. 
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With the verification of the expression of these key proteins in the 2nd trimester 
human fetal testis, a comprehensive analysis and characterization of the cultured 
human fetal somatic cells could then be performed. 
 
5.6.2 Dissociation and culture of 2nd trimester human fetal testis leads 
to the differential survival of somatic cells in vitro 
Dissociation of second trimester human fetal testis into a single cell suspension and 
then their subsequent culture resulted in a population of cells that could be expanded 
in vitro.  Within each culture, cells displayed a mixture of sizes and morphology.   
Identification of cells based on morphology alone was not considered sufficient for 
identification of cell types and therefore gene expression analysis was performed. 
 
TaqMan analysis for the gonocyte marker, OCT4 and prespermatogonial marker 
VASA indicated that the adherent cell cultures did not contain germ cells.  This is not 
entirely surprising as maintaining and expanding germ cells in vitro is challenging 
and requires a number of cytokines and the support of feeder cells (Kanatsu-
Shinohara et al., 2005; Tu et al., 2007; Turnpenny et al., 2006). 
 
Analysis of the expression of AMH and DHH, both of which are secreted by Sertoli 
cells in vivo, revealed a loss of both markers from the cultures at a very early stage.  
Although DHH protein expression in the human fetal testis has not been studied, 
TaqMan analysis revealed high levels of mRNA in whole and positive control testis.  
Our inability to detect AMH and DHH mRNAs in the cultures beyond passage 1 
would imply that Sertoli cells did not maintain a differentiated phenotype in vitro, 
however the detection of several mRNAs and proteins for other Sertoli cell specific 
markers, such as SRY and SOX9 was at odds with this and suggested to us that Sertoli 
cells were present in the cultures, but with a phenotype that appears to be less 
differentiated and more primitive. 
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AMH is expressed in vivo throughout the 2nd trimester (Gaskell et al., 2004).  The 
expression of Amh has been shown to be unaffected by the absence of germ cells 
(Behringer et al., 1994) and there are four transcription factors, all with roles in early 
testis differentiation, also implicated in the control of AMH expression.  These are 
SF1 (Giuili et al., 1997; De Santa Barbara et al., 1998; Shen et al., 1994), SOX9 
(Arango et al., 1999), GATA-4 (Tremblay et al., 2001a) and WT1 (Nachtigal et al., 
1998).   
 
Sox9 has been shown to be required to bind to its specific response element within 
the Amh promoter for transcription of Amh (Arango et al., 1999).  In the 
undifferentiated mouse gonad, Sox9 is present in both sexes within the cytoplasmic 
compartment, but in the male upon sexual differentiation, it becomes nuclear (Morais 
da Silva et al., 1996).  This also appears to be the case in the human, where SOX9 
undergoes nuclear translocation prior to AMH expression (de Santa Barbara et al., 
2000).  SOX9 contains a nuclear export signal sequence that regulates 
nucleocytoplasmic translocation of SOX9 during sex determination, and in cultured 
mouse XX gonads when Sox9 nuclear export was inhibited, a sex-reversal phenotype 
resulted, accompanied by the expression of Amh (Gasca et al., 2002).  The nuclear 
receptor Sf1 may also have some degree of control over Amh transcription.  Male 
mice homozygous for a mutant Sf1 binding site on the Amh promoter initiated Amh 
transcription at a significantly reduced level.  Within the Sf1 proximal promoter there 
are Sox9 binding sites, and functional evidence that Sox9 upregulates Sf1 (Shen and 
Ingraham, 2002).  Both SOX9 and SF1 have been shown to localise to somatic cells 
in the human fetal testis prior to both cord formation and the expression of AMH (de 
Santa Barbara et al., 2000).   
 
The cooperative actions of SF1 and WT1 have been shown to be necessary for AMH 
upregulation (Nachtigal et al., 1998), while GATA4 has also been shown to 
transactivate the expression of AMH by interacting with SF1 protein (Watanabe et 
al., 2000) and a recent study has shown regulation of the AMH promoter by WT1 is 
enhanced by GATA4 (Miyamoto et al., 2008).  However, in the human the functional 
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relevance of GATA4 and WT1 in the upregulation of AMH can be called into 
question given that in the human fetal gonad, both appear not to be switched on until 
after the upregulation of AMH (de Santa Barbara et al., 2000). 
 
In the current study, analysis of the cultures suggested that the expression of the key 
genes believed to control AMH transcription were maintained, as was the only 
identified target of DHH, namely SF1.  For example SOX9, WT1, GATA4 and SF1 
were all expressed for several passages after AMH and DHH were lost.  The cultured 
cells were also found to maintain expression of SOX9 and GATA4 protein, where 
importantly, expression of both was restricted to the cell nucleus.  In order to 
evaluate whether the full transcriptional machinery necessary to maintain AMH 
expression exists, it will be necessary to perform further studies in order to ascertain 
whether expression of WT1 and SF1 proteins are also maintained within the cultured 
cells, and also if DAX1 and the GATA4 co-factor FOG2 are expressed.   
 
Alternatively the Sertoli cells may be transdifferentiating into fibroblasts as a 
consequence of their in vitro environment.  It is necessary to determine whether the 
SOX9 positive cells express SMA or other fibroblast markers.  One other possibility 
is that the Sertoli cells may be transdifferentiating into granulosa cells.  It would 
therefore be interesting to look at the expression of genes such as FOXL2 (Kalfa et 
al, 2008) to see if genes associated with the granulosa cell lineage are switching on 
within the cultures. 
 
The somatic cell cultures were also analysed for the expression of the Leydig cell 
markers, SCCp450 and 3βHSD.  mRNA expression of both was downregulated at 
passage 1 and was not detected thereafter. The pattern of expression of both of these 
enzymes suggests that at the early stages of the cultures there may have been 
functioning Leydig cells.  SCCp450 protein was detected in a small subset of the 
cultured cells in the initial passages.  The downregulation of these Leydig cell 
markers suggests that the cells failed to survive or proliferate within the cultures, or 
that perhaps the Leydig cells survived but lost their steroidogenic capacity.  As 
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Sertoli cells play a pivotal role in Leydig cell fate, perhaps the change in the 
phenotype of the Sertoli cells, and the loss of important paracrine signalling 
molecules such as DHH (Clark et al., 2000; Yao et al., 2002) and possibly platelet-
derived growth factor α  (PDGF-α) (Brennan et al., 2003) might have contributed to 
the loss/dedifferentiation of the Leydig cells. 
5.6.3 As the cultures progress the number of fibroblasts/PTM cells 
increase 
As the cells were passaged, the expression of α-SMA and VIM mRNAs continued to 
increase as a proportion of total mRNA, suggesting that the cells were undergoing 
phenotypic changes or that one population was increasing at the expense of another.  
An increase in the expression of these markers at passage 1 and 2 can be expected 
relative to whole fetal testes extracts because the cultures lack germ cells or 
significant numbers of Leydig cells.  On tissue sections α-SMA was localised to the 
PTM cells, and cells surrounding the blood vessels within the fetal testis.  
Furthermore immunohistochemical staining of α-SMA in the human fetal testis 
revealed no expression of α-SMA within the interstitial fibroblasts.  However 
previous reports have shown that fibroblasts from a number of tissues convert to a 
myofibroblast phenotype as a consequence of their in vitro environment (Dugina et 
al., 1998).  DES is another marker of myofibroblast cells (Bellin et al., 1999), while 
VIM is an intermediate filament protein that is characteristically expressed in 
fibroblast cells (Hay, 1995). The increasing expression of fibroblast markers relative 
to the total cell mRNA is consistent with the observed alterations in the morphology 
of the cells.  For example, with increasing passage the number of long flat cells 
increased.  Also with increasing numbers of passage the time until confluency was 
reached reduced, suggesting increasing numbers of rapidly dividing cells were 
overtaking the cultures.  Within primary tissue cultures, elimination of fibroblasts has 
proven difficult with even small numbers of fibroblasts rapidly overgrowing most 
other cell types, especially when cultured in the presence of serum (Singer et al., 
1989).  There are a number of methods for eliminating fibroblasts from culture, such 
as selective trypsinization (Schumann et al, 1988), culture in serum-free media or 
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isolation with the monoclonal antibody AS02 which binds specifically with human 
fibroblasts (Saalbach et al., 1997) but these can prove challenging and further studies 
will be needed to see if they can be used for human fetal testicular cultures (Halaban 
and Alfano, 1984; Saalbach et al., 1997). 
 
Throughout the five passages analysed, AR mRNA was present within the cultures.  
Despite the fact that the expression of fibroblast/PTM markers increased, AR 
expression decreased.  This is surprising since these are the cells in vivo that express 
AR.  This implies some loss in the differentiated phenotype in the PTM/fibroblast 
cells, suggesting that PTM cells may be transforming into cells with a myofibroblast 
cell phenotype.  
5.6.4 Activin treatment had no effect on human fetal somatic cells in 
vitro  
Previous studies have demonstrated the expression of activin subunits and receptors 
(Majdic et al., 1997; Anderson et al., 2002), suggesting a possible role for the 
activins in the control of human fetal testis development.  In these studies, somatic 
cell cultures were reported to express the type II activin receptors ACTRIIB and 
ACTRIIA, the Type I receptors ALK2 and ALK4 and the downstream signalling 
molecule SMAD2.  However in the current study treatment of dissociated human 
fetal testis with activin A at a concentration of 10 ng/ml had no effect on the 
morphology or survival of the cells or any of the Sertoli cell or Leydig cell mRNAs 
analysed.  The expression of the activin receptor proteins within the cultures was not 
analysed and phosphorylation of SMAD2 was not studied to establish whether the 
cells were responsive to activin, and further experiments are therefore required to 
ensure that the signalling machinery remains intact.  Previous reports suggest that in 
some models, cells responding to activin significantly upregulate SMAD2 mRNA 
(Coutts et al., 2007a), but no upregulation following activin treatment was found in 
this study.  No specific function of activin has been demonstrated in the human fetal 
testis, and it is necessary to elucidate the functions of activin receptor signalling 
further in the fetal testis to understand whether or not it has a role.   
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5.6.5 Trypsin has an adverse effect on the survival of human fetal 
testicular somatic cells in vitro  
When human fetal testes were dissociated without trypsin, an increased number of 
cells survived, and larger primary colonies formed.  The initial dissociation of the 
tissue with collagenase IV and DNase 1 and without trypsin/EDTA lead to a non-
significant increase in the expression of some Sertoli cell and Leydig cell specific 
mRNAs, when compared with tissue dissociated with trypsin/EDTA, suggesting that 
trypsin/EDTA may be detrimental to the in vitro survival of Sertoli cells and Leydig 
cells.  Trypsin is a pancreatic serine protease with specificity for peptide bonds 
involving the carboxyl group of basic amino acids: arginine and lysine (Brown and 
Wold, 1973).  Dispase is a neutral protease that hydrolyses N-terminal peptide bonds 
of nonpolar amino acid residues (Kitano and Okada, 1983). Studies suggest that 
dispase is less harsh than trypsin (Kohnert and Hehmke, 1986; Gragnani et al., 2008). 
However continuous passage with dispase resulted in no real improvements to gene 
expression, suggesting that the method of dissociation was not a key factor in the 
observed changes in gene expression. 
5.6.6 Conclusions 
A method for the in vitro culture of human fetal somatic cells has been established, 
there are currently no reports in the literature of the culture of somatic cells from the 
human fetal testis.  The novel findings of this thesis have demonstrated that the long-
term culture of these cells results in the downregulation in expression of mRNAs 
specific for Sertoli cells and Leydig cells, suggesting that these cells either did not 
survive or thatalterations occurred to their phenotype.  But this system may be able to 
be used as a model system for studying Sertoli cell development.  If studies are to be 
carried out on cell signalling or cell-cell interactions using this culture system, they 
must be done within a short-time period, i.e within the initial 1-2 passages.   
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6 Expression of germ cell associated genes in mouse 
embryonic stem cells 
6.1 Introduction 
The early stages of germ cell specification and development have been extensively 
studied in vivo in the mouse (Chapter 1, section 1.3.1.1).  Another model system for 
studying germ cell commitment and differentiation may be through the use of 
embryonic stem (ES) cells.  ES cells are pluripotent cells derived from the inner cell 
mass (ICM) of the blastocyst (Evans and Kaufman, 1981).  ES cells undergo self-
renewal in vitro, and are capable of differentiating into cell types from all three 
primary germ layers (ectoderm, endoderm and mesoderm) thus with the potential to 
differentiate into all tissue types.   
 
Several studies have now shown that ES cells can give rise to cells that appear to 
belong to the germ cell lineage (Hubner et al., 2003; Toyooka et al., 2003; Geijsen et 
al., 2004).  Different methodologies have been used to generate ES cell-derived germ 
cells (refer to Chapter 1, section 1.5.1).  For example, Hubner et al  in 2003 reported 
the formation of follicle-like structures which contained oocytes following the 
differentiation of ES cells on a monolayer, while in the same year, Toyooka et al 
reported the generation of ES cell-derived haploid spermatids, after the 
differentiation of ES cells in suspension culture, and the subsequent aggregation of 
putative germ cells with mouse gonadal tissue. Geijsen et al (2004) utilised an 
alternative approach with Oct4-GFP reporter ES cells, which were allowed to form 
embryoid bodies for around three weeks in the presence of retinoic acid (RA).  These 
embryoid body-derived germ cells expressed early germ cell markers and 
approximately 0.01% resembled post-meiotic male germ cells.  Haploid spermatids 
were isolated by flow cytometry and when injected intracytoplasmically into mouse 
oocytes, blastocysts expressing GFP were reported to develop.  More recently, the 
production of live mice from ES cell -derived germ cells has been reported (Nayernia 
et al., 2006), although as yet no other groups have repeated this.   
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Although ES cells are often assumed to most closely resemble pluripotent epiblast 
cells derived directly from the inner cell mass (ICM) of the blastocyst, there are 
several genes which are expressed by undifferentiated ES cells and are also 
expressed highly in the developing germ cells.   
 
For example, early germ cells express key pluripotency-associated proteins such as 
Oct4, the homeodomain-containing protein Nanog and high mobility group (HMG) 
domain-containing family member, Sox2 (Chapter 1, section 1.3.1.5).  All three 
genes are highly expressed in undifferentiated ES cells and are required to maintain 
pluripotency (Nichols et al., 1998; Chambers et al., 2003; Avilion et al., 2003).  In 
the embryo, initially Oct4 is expressed throughout the epiblast but it becomes 
restricted to the PGC cluster by e7.5 (Scholer et al., 1990; Yeom et al., 1996).  PGCs 
continue to express Oct4 as they are proliferating and migrating to the genital ridge.  
Oct4 may have an important role in the survival of PGCs, as its germ cell specific 
ablation results in germ cell loss by apoptosis (Kehler et al., 2004).  Nanog is also 
expressed in mouse PGCs, but although it is expressed in the epiblast, it cannot be 
detected in PGCs of e6.5-e7.5 embryos.  Instead it is upregulated in PGCs between 
e7.75-e12.5, and is then later downregulated in female germ cells at e13.5-e14.5, and 
male germ cells 1-2 days later (Yamaguchi et al., 2005).  Sox2 which also expressed 
in the inner cell mass of the blastocyst and neural progenitor cells (Foshay and 
Gallicano, 2008), is expressed in the mouse germ cell lineage e6.75 (Yabuta et al., 
2006) and lost at e14.5 (Western et al., 2005; Perrett et al., 2008). 
 
Other genes expressed by the early germ cell lineage include, B-lymphocyte-induced 
maturation protein-1 (Blimp1/Prdm1) (Vincent et al., 2005), Fragilis (Ifitm3) and  
Stella/PGC7 (Dppa3) (Sato et al., 2002; Saitou et al., 2002) (Chapter 1, section 
1.3.1.4).  In addition its’ roles in a number of other tissues, Blimp1 has been 
described as a master regulator of germ cell fate and downregulates genes associated 
with the somatic cell lineage such as the Hox genes (Yabuta et al., 2006) (Chapter 1, 
section 1.3.1.6).  Once within the genital ridge, germ cells also express the RNA 
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binding protein Dazl (Seligman and Page, 1998) and the RNA helicase, mouse vasa 
homologue (Mvh/Ddx4) (Toyooka et al., 2000). 
 
The expression of both Stella (Dppa3)  and Fragilis (Ifitm3) have been demonstrated 
in undifferentiated ES cells (Geijsen et al., 2004; Pain et al., 2005).  Some groups 
have reported the absence of Mvh in undifferentiated ES cell lines (Toyooka et al., 
2003), while others have found it to be present in the undifferentiated state (Kerkis et 
al., 2007) and the RNA-binding protein Dazl has also been reportedly expressed in 
undifferentiated mouse ES cells (Geijsen et al., 2004; Kerkis et al., 2007) . 
 
The tyrosine kinase receptor, Kit is also expressed in both germ cells and ES cells 
(Palmqvist et al., 2005), despite being absent form the ICM (Horie et al., 1991; 
Matsui et al., 1990).  The Kit receptor is activated by the Kitl (or stem cell factor) 
(Chapter 1, section 1.3.1.7).  In the mouse in the absence of both Kit and Kitl, germ 
cells die by apoptosis (Mintz and Russell, 1957; Chabot et al., 1988; Nocka et al., 
1989; Matsui et al., 1990; Pesce et al., 1993).  Additionally Kitl has been shown to be 
required for the successful in vitro culture of PGCs (De Felici and Dolci, 1991; Dolci 
et al., 1993; Matsui et al., 1991).  The Kit/Kitl signalling pathway acts to promote the 
survival of many progenitor cells; in addition to its role in germ cells, it plays an 
important role in maintaining haematopoietic, neuronal and melanocytes stem cells 
(Kent et al., 2008; Wehrle-Haller, 2003).   
 
Within ES cells, Kit signalling appears to be important as they undergo 
differentiation.  Bashamboo et al (2006) have generated mouse ES cell lines carrying 
null alleles of Kit (WlacZ), these mutant cells underwent apoptosis when they were 
differentiated upon withdrawal of LIF, suggesting that Kit/Kitl signalling is required 
as the cells differentiate.  Interestingly, preliminary data from gene profiling 
suggested that the expression of several germ cell genes was reduced within the Kit 
null ES cell line (Bashamboo and Forrester, unpublished). 
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6.1.1 Aims of Chapter 
This study firstly aimed to investigate germ cell gene expression in mouse ES cells in 
order to understand further the overlap in gene expression between germ cells and 
embryonic stem cells.  The expression of germ cell genes was analysed in the three 
wild-type ES cell lines (CGR8, E14 and EFC1) in order to determine whether they 
were expressed and if so what degree of variability there was between the cell lines.  
RNA extracted from mouse testes at e13.5 or adult, were included to allow a direct 
comparison with levels of expression in vivo.  The second aim of this study was to 
determine whether Kit signalling had an influence on germ cell gene expression in 
mouse ES cells.  Germ cell gene expression was analysed in ES cell lines that had 
undergone immunomagnetic bead sorting, using an antibody directed against Kit, in 
order to obtain Kit ‘low’ and Kit ‘high’ populations of cells.  Additionally germ cell 
gene expression was also analysed in mutant ES cell lines that were heterozygous 
and null for the Kit receptor. 
 
6.2 Material and Methods  
6.2.1 ES cell culture  
6.2.1.1 ES cell lines 
E14 (Hooper et al., 1987), CGR8 (Mountford et al., 1994), and EFC1 (Nichols et al., 
1990) embryonic stemES cell lines were cultured in feeder- free culture conditions in 
the presence of LIF (10ng/ml) (Sigma).  Additional cultures were prepared using the 
Kit null cell line (Kit w-lacz/Kit w-lacz) and the heterozygous cell line (Kit w-lacz/Kit +), 
both of which were derived from the parental cell line E14 (Bashamboo et al., 2006). 
6.2.1.2 Cell thawing 
Cells were thawed rapidly by placing them in a water bath at 37oC.  Media was then 
added and cells were then centrifuged at 1200 rpm for 3 minutes.  The supernatant 
was removed and the cells were resuspended in media (section 2.7); cells were 
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placed in a 25cm flask, precoated with 0.01% gelatin.  Media was changed after a 
few hours. 
6.2.1.3  Passaging ES cells 
Following a wash with PBS, confluent cells were subjected to 2 ml of trypsinization 
(TVP) (section 2.7) and incubated for 3-5 minutes.  The cells were removed and 
placed in a centrifuge tube with 8mls of media, and centrifuged at 1000 rpm for 5 
minutes. Thereafter, cells were resuspended in 10 ml of media, supplemented with 10 
ng/ml of LIF and a cell count was performed; 1-1.5 x106 cells were added to a T25 
flask, which had been pre-coated with 0.1% gelatin.  Cells were normally confluent 
after 2-3 days of culture.  
6.2.2 Embryoid body formation  
Confluent undifferentiated ES cells were harvested and then placed in suspension 
culture at a density of 1-2 million cells/ml in a 35mm bacterial grade petri dish in 
with GMEM containing 10% FCS without LIF. 
6.2.3 Immunomagnetic bead sorting  
E14 and EFC1 cells were grown to confluency and harvested for immunomagnetic 
bead sorting.  Cells were washed in PBS and centrifuged at 800 rpm for 5 minutes.  
This was repeated twice.  Cells were resuspended in PBS with 0.1% BSA to obtain 
10 x106 cells/ml.  10% sheep serum was added and incubated for 10 minutes.  A 
sample of unsorted cells was taken, and lysed for RNA extraction.  Sheep anti-rabbit 
Dynabeads were vortexed and the required volume was transferred into an 
eppendorf.  The tube was placed in the magnet for 2 minutes, and then the 
supernatant was removed.  The tube was removed from the magnet and an excess 
volume of wash buffer was added (PBS+0.1% BSA) and the beads were 
resuspended.  This wash step was repeated twice. 
 
The cells were then incubated with the primary antibody (Rabbit anti-Kit, Santa 
Cruz); this was added in excess to block all antigen binding sites on the cell surface.  
The cells were incubated in 2μg of primary antibody per 107 cells for 30 minutes at 
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4oC on a rocking platform.  After incubation, the cells were centrifuged at 1000 rpm 
for 10 minutes, the supernatant with the unbound immunoglobulin was discarded, 
and the cells were resuspended in PBS containing 0.1% BSA, this step was repeated 
twice.  
 
The cells were then incubated with 1x 107 Dynabeads per ml of sample to give 
approximately 4 beads per target cell.  The washed beads were added to the antibody 
covered cells and incubated for 30 minutes at 4oC on a rocking platform.  After the 
incubation period, the cell/Dynabead suspension was placed in a Dynal MPC-L 
magnet (Dynal A.S, Oslo. Norway) and allowed to stand for 2 minutes.  The 
supernatant was removed, centrifuged at 1000 rpm for 10 minutes and the cells lysed 
for RNA extraction.  Cells bound to the beads were also lysed immediately for RNA 
extraction. 
6.2.4 RNA extraction from tissues and cells  
RNA extraction was performed as outlined in section 2.4 
6.2.5 Preparation of cDNA using random hexamers 
cDNA was prepared as detailed in section 2.5 
6.2.6 TaqMan® analysis  
TaqMan® analysis was performed using the Roche Universal Probe Library.  Details 
of the TaqMan® reaction and analysis are detailed in section 2.5.  Primers used and 
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Table 6-1 Summary of primers and probes used for TaqMan reaction 
Gene Name 5’ sequence 3’ sequence Probe 
Oct4 gaggctacaggacacctttc gtgccaaagtggggacct 6 
Nanog agcctccagcagatgcaa ggttttgaaaccaggtcttaacc 25 
Sox2 tccaaaaactaatcacaacaatcg gaagtgcaattgggatgaaaa 63 
Blimp1 tgcggagaggctccacta gttgctttccgtttgtgtga 80 
Fragilis tggtctggtccctgttcaa ccatcttccgatccctagact 27 
Stella gatgcacaacgatccagattt tggaaattagaacgtacatactccaa 73 
Dazl gctgatattttgcccaatgaa atgcttcggtccacagactt 78 
Mvh aagcagagggttttccaagc gcctgatgcttctgaatcg 83 
Kit gatctgctcgtcgtcctgtt cttgcagatggctgagacg 15 
Kitl agcgctgcctttccttatg tccttggttttgacaagaggat 68 
Stra8 accgtggtggccttaaaga atcatcactgggttggttgc 80 
Hoxa1 aaaagaaaccctcccaaaaca tgaagtggaactccttctccag 100 
 
For the TaqMan® analysis, data was always made relative to a selected E14, bound, 
wild-type or undifferentiated value.  Statistical analysis was performed using either a 
Student’s t-test or a one-way ANOVA, followed by a Bonferroni’s multiple 
comparison test. 
6.2.7 Western Blotting 
Western blotting was performed on protein extracted from cultured ES cells.  Cells 
were lysed in RIPA buffer (section 2.6.1) and protein was quantified using a Biorad 
protein assay (section 2.6.2).  Details of Western blotting are outlined in section 2.6.  
Information regarding the primary antibodies used is listed in Table 6-2. 





Source  Dilution 
Mvh Rabbit AbCam 1:500 
β-Tubulin Mouse Sigma 1:1000 
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6.3 Results  
6.3.1 mRNA analysis of germ cell markers in  undifferentiated wild-type 
ES cell lines   
6.3.1.1 Expression of Kit and Kitl 
Analysis of the mRNA expression of the Kit receptor and Kitl was performed in ES 
cell lines and adult mouse testis.  Kit mRNA was expressed in all cell lines 
examined, although at a lower level than adult mouse testis.  Kitl mRNAs were 
detectable in all the cell lines examined (Figure 6-1), although at lower levels than in 
the adult mouse testis.  
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Figure 6-1 mRNA analysis of a) Kit and b) Kitl in undifferentiated E14 cells, EFC1 cells, 
CGR8 cell lines and positive control adults mouse testis, relative to E14 cells (N=4).  
Taqman was performed in triplicate for 4 independent cultures for each cell line.  
Mean ± sem 
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6.3.1.2 Expression of pluripotency markers  
TaqMan analysis was performed to evaluate the levels of expression of pluripotency 
genes in the three ES cell lines.  Expression of Oct4, Nanog and Sox2 mRNAs were 
higher in undifferentiated E14, EFC1 and CGR8 cell lines than in total embryonic 
mouse testes (Figure 6-2 a, b and c respectively).  The amount of Oct4, Nanog and 
Sox2 mRNAs were not significantly different between the three cell lines.   
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Figure 6-2 mRNA analysis for a) Oct4  b) Nanog and c) Sox2 in undifferentiated E14 
cells, EFC1 cells and CGR8 cell lines and e13.5 mouse testis positive control, relative 
to a selected E14  (N=4).  Taqman was performed in triplicate for 4 independent 
cultures for each cell line.  Mean ± sem 
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6.3.1.3 Expression of early germ cell markers  
The expression of early germ cell marker in ES cells was analysed, as was the 
expression in e13.5 mouse testis.  The amount of Blimp1 mRNA was 
indistinguishable between the three ES cell lines examined (Figure 6-3a).  Likewise, 
Fragilis mRNA was expressed in all three ES cell lines, although expression was 
significantly different between EFC1 and CGR8 cells (P<0.05).  Stella mRNA was 
expressed in E14, EFC1 and CGR8 cells, although in the EFC1 cell line, expression 
of Stella was significantly higher than E14 and CGR8 cells (P<0.05).   
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Figure 6-3 mRNA analysis of a) Blimp1  b) Fragilis and c) Stella in undifferentiated E14 
cells, EFC1 cells and CGR8 cell lines and e13.5 mouse testis, relative to E14 cells 
(N=4).  For Fragilis, EFC1 was significantly different from E14 cells (P<0.05).  For Stella 
EFC1 was significantly different from E14 cells (P<0.05).  Taqman was performed in 
triplicate for 4 independent cultures for each cell line.  Mean ± sem 
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6.3.1.4 Expression of late germ cell markers  
The expression of later germ cell markers was analysed in the wild-type cell lines 
and adult mouse testis.  Dazl and Mvh mRNAs were detectable in the three ES cell 
lines analysed at lower levels than in adult mouse testis (Figure 6-4).  Both of these 
later germ cell markers were therefore expressed at far higher levels in the adult 
mouse testis compared with the undifferentiated cell lines.  
 
Figure 6-4 mRNA analysis of a) Mvh and b) Dazl  in undifferentiated E14 cells, EFC1 
cells, CGR8 cell lines and positive control adult mouse testis, relative to E14 cells 
(N=4). Taqman was performed in triplicate for 4 independent cultures for each cell 
line.  Mean ± sem 
 
 
The amount of Stra8 mRNA expressed by all three the cell lines although levels were 
lower than in the adult mouse testis (Figure 6-5).  Stra8 mRNA concentrations were 
slightly higher in CGR8 cells than in E14 and EFC1. 
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Figure 6-5 mRNA analysis of Stra8 in undifferentiated E14, EFC1 and CGR8 cell lines 
and adult mouse testis, relative to E14 cells (N=4).  Taqman was performed in 
triplicate for 4 independent cultures for each cell line.  Mean ± sem 
6.3.1.5 Expression of Hoxa1 
Hoxa1 mRNA was expressed in all three ES cell lines at fairly similar levels, 
although at lower levels than in adult mouse testis (Figure 6-6). 
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Figure 6-6 mRNA analysis of Hoxa1 in E14, EFC1 and CGR8 cell lines and adult mouse 
testis, relative to E14 cells (N=4). Taqman was performed in triplicate for 4 
independent cultures for each cell line.  Mean ± sem 
6.3.2 mRNA analysis of germ cell markers in day 5 embryoid bodies  
E14 ES cells were allowed to grow in suspension culture, in the absence of LIF, to 
promote the formation of aggregates or embryoid bodies.  After 5 days of culture, 
mRNA expression analysis was performed in order to measure germ cell and 
pluripotency markers.  The expression of Oct4 and Nanog decreased significantly 
(P<0.01 for Oct4 and P<0.05 for Nanog) in embryoid bodies compared with the 
undifferentiated cells.  There was also some decrease in expression of Blimp1 and 
Fragilis, while Stella mRNA levels were significantly reduced (P<0.05).  The 
expression of both Kit and Kitl decreased with differentiation. (Figure 6-7a), and 
there was also a slight decrease in the expression of Stra8 mRNA, (Figure 6-7a).  
Notably expression of Mvh and Dazl mRNAs were higher in day 5 embryoid bodies 
compared with undifferentiated ES cells.  There was a slight decrease in the 
expression of Stra8 mRNA, while Hoxa1 mRNA expression appeared to increase 
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Figure 6-7 Relative changes in gene expression following ES cell differentiation (day 5 
embryoid bodies).  Relative to a selected undifferentiated ES cell values (N=4). a) 
mRNAs that decrease upon differentiation b) mRNAs which increase with 
differentiation.  Taqman was performed in triplicate for 4 independent cultures for 
each cell line.  Mean ± sem 
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6.3.3 Analysis of protein expression in E14, EFC1 and CGR8 cell lines 
Western analysis for total protein concentrations revealed that Mvh (76kD), was 
present in E14, EFC1 and CGR8 cell lines; overall levels concentrations appeared 





Figure 6-8 Western analysis of total Mvh protein in ES cell lines.  β-tubulin is loading 
control.  Lane L is the ladder, lane  a and b are E14 cells, c and d, are EFC1 cells and e 
and f are CGR8 cells  
6.3.4 mRNA analysis of germ cell markers in ES cells sorted into Kit 
high and Kit low populations using immunomagnetic beads  
 
To separate ES cells into two populations of cells, one which expressed high levels 
of Kit and one which expressed low levels of Kit, immunomagnetic bead sorting was 
performed using an antibody directed against Kit 
6.3.4.1 Expression of Kit and Kitl   
Immunomagnetic bead sorting resulted in a significantly higher expression of Kit 
mRNA in the bound fraction of the sorted cells for both E14 (P<0.05) and EFC1 
cells (P<0.05) (Figure 6-9), revealing that both of these cell lines did not express Kit 
uniformally in all cells. 
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Figure 6-9 mRNA analysis for Kit expression in sorted and unsorted EFC1 and E14 
cells, relative to bound cells (N=4).  Taqman was performed in triplicate for 4 
independent cell sorts.  Mean ± sem 
 
 
6.3.4.2 Expression of pluripotency genes  
Expression of Oct4, Nanog and Sox2 mRNA did not vary between the bound and 
unbound fraction of cells and this was consistent for both E14 and EFC1 cell lines 
(Figure 6-10) and suggests that there are no differences in the expression of these 
genes would be consistent with the lack of any difference in these cell markers in the 
E14 Kit ‘high’ and Kit ‘low’ populations.  In general the expression of pluripotency 
genes does not appear to be different in Kit ‘high’ or Kit ‘low’ populations and thus 
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Figure 6-10 mRNA expression for a) Oct4 b) Nanog and c) Sox2 in bound (Kit ‘high’) 
population and unbound (Kit ‘low’) population for EFC1 and E14 cell lines, relative to 
bound population (N=4).  Taqman was performed in triplicate for 4 independent cell 
sorts.  Mean ± sem 
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6.3.4.3 Expression of early germ cell markers 
Expression of Blimp1 mRNA was significantly lower in the unbound (kit ‘low’) 
population of cells for both EFC1 (P<0.01) and E14 populations (P<0.01) (Figure 
6-11a).  Expression of Fragilis mRNA was tended to be lower in the unbound 
population (kit ‘low’) EFC1 cells, but this was non-significant (Figure 6-11b).   
Expression of Stella mRNA levels were non-significantly different in the unbound 
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(Kit ‘low’) population for both EFC1 and E14 cells (Figure 6-11c).  
 
Figure 6-11 mRNA expression for a) Blimp1 b) Stella and c) Fragilis in Kit positive and 
negative population of EFC1 and E14 cell lines.  Taqman was performed in triplicate 
for 4 independent cell sorts.  Mean ± sem 
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6.3.4.4  Expression of late germ cell markers  
Mvh and Dazl mRNA levels did not vary between the bound and unbound fraction 
(Figure 6-12).  So within the Kit ‘low’ and Kit ‘high’ populations the expression of 
late germ cell markers does not vary in undifferentiated ES cells. 
 
 
Figure 6-12 mRNA expression for Dazl and Mvh in Kit positive and negative 
population for EFC1 and E14 cell lines.  Taqman was performed in triplicate for 4 
independent cell sorts.  Mean ± sem 
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6.3.4.5 Expression of Hoxa1 
Hoxa1 mRNA levels were slightly higher in the unbound fraction of cells although 
there were no significant differences between the bound and unbound populations of 
EFC1 and E14 cells (Figure 6-13).   
 
Figure 6-13 mRNA expression of Hoxa1 mRNA in Kit positive and negative 
populations of EFC1 and E14 cell lines.  Taqman was performed in triplicate for 4 
independent cell sorts.  Mean ± sem 
 
6.3.5 mRNA analysis of germ cell markers in undifferentiated wild-type, 
heterozygous (Kit w-lacz/Kit +) and null cells (Kit w-lacz/Kit w-lacz)  
 
Gene profiling analysis suggested that the Kit null cell expressed reduced 
concentrations of germ cell mRNAs compared with parental cells (Bashamboo and 
Forrester, Unpublished). The heatmap in Figure 6-14 shows the expression of 
selected genes in the two null cells generated by Bashamboo et al, FKBLacZ and 
LacZLacZ.  For both Kit null cell lines in the presence of LIF (plus), there was a 
decrease in the early germ cell genes, Blimp1, Stella and Fragilis.  Gene expression 
in other lineages was also analysed.  Genes associated with the cardiomyocyte 
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lineage such as the NK2 transcription factor related, locus 5 (Nkx2.5), the myocyte 
enhancer factor 2C, Mef2c; the neuronal markers nestin (Nes) and the neuronal cell 
adhesion molecule L1 Cam; the smooth muscle specific alpha actin (Acta2); and the 
adipocyte associated gene, peroxisome proliferator-activated receptorγ (Pparγ) 
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Figure 6-14  Heatmap generated from array performed by Bashamboo and Forrester. 
Obtained from Functional Genomics in Embryonic Stem cells (Fungenes).  
http://www.bioinf.ebc/ee/fungenes.  Pink bands indicate the conditions where the cells 
have been cultured in the presence of LIF. 
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Quantitative RTPCR was carried out to compare mRNA expression E14 wild-type, 
the heterozygous (Kit w-lacz/Kit +) and the null cells (Kit w-lacz/Kit w-lacz) in order to 
confirm or expand upon these findings.   
6.3.5.1 Expression of Kit and Kitl 
Consistent with the genotype of the cells, Kit mRNA was undetectable in the null 
cells and was reduced in the heterozygous cells compared with the wild-type cells 
(Figure 6-15a).  Notably the reduced expression of the receptors had no impact on 
expression of Kitl mRNA and these were comparable between wild-type, 
heterozygous and null cells (Figure 6-15b), thus the null cells maintain expression of 
Kitl in the absence of Kit. 
 
 
Figure 6-15 mRNA analysis for Kit and Kitl in wild-type, heterozygous and null cells, 
relative to wt  (N=4).  Taqman was performed in triplicate for 4 independent cultures 
for each cell line.  Mean ± sem 
 
 
6.3.5.2  Expression of pluripotency genes  
Oct4, Nanog and Sox2 mRNAs were all detectable in wild-type, heterozygous  and 
null undifferentiated E14 ES cells, with expression of all three mRNAs at relatively 
similar levels (Figure 6-16), suggesting that Kit signalling is not required for 
expression of these genes. 
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Figure 6-16 mRNA analysis of a) Oct4 b) Nanog and c) Sox2 in wild-type (wt), 
heterozygous (het) and null cells, relative to selected wt value (N=4).  Taqman was 
performed in triplicate for 4 independent cultures for each cell line.  Mean ± sem 
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6.3.5.3 Expression of early germ cell markers  
Expression of Blimp1 mRNA was significantly lower in heterozygous (P<0.01) and 
null cells (P<0.001) than wild-type cells (P<0.05) (Figure 6-17a).  Expression of 
Fragilis was significantly lower in the null cells compared with wild-type cells 
(P=0.05) (Figure 6-17b).  Expression of Stella was significantly reduced relative to 
wild-type cells (P<0.05), with heterozygous cells also displaying slightly lower 
levels of mRNA expression compared with wild-type cells (Figure 6-17c).  These 
confirm the array data, where early germ cell gene expression does seem to vary 
between the Kit cell lines.  The Kit null cells express significantly lower levels of all 
of these germ cell genes. 
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Figure 6-17 mRNA analysis of a) Blimp1 b) Fragilis and c) Stella in wild-type (wt), 
heterozygous (het) and null cells, relative to wt (N=4).  Taqman was performed in 
triplicate for 4 independent cultures for each cell line.  Mean ± sem 
6.3.5.4 Expression of late germ cell markers  
The expression of both Dazl and Mvh mRNAs were similar in the null, wild-type and 
the heterozygous cells (Figure 6-18 a and b).  Therefore there are no significant 
differences in late germ cell marker gene expression between the wild-type, 
heterozygous and null cells. 




Figure 6-18 mRNA analysis for a) Mvh and b) Dazl in wild type wt, heterozygous and 
null cells, relative to wt (N=4).  Taqman was performed in triplicate for 4 independent 
cultures for each cell line.  Mean ± sem 
6.3.5.5 Expression of Hoxa1 
Hoxa1 mRNA was significantly higher in null cells relative to wild- type cells 
(P<0.01).  Expression in heterozygous cells was also slightly increased compared 
with wild-type cells (Figure 6-19). 
 
Figure 6-19 mRNA analysis for Hoxa1 in wild type, heterozygous and null cells, 
relative to wt (N=4).  Taqman was performed in triplicate for 4 independent cultures for 
each cell line.  Mean ± sem 
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6.4 Discussion  
6.4.1 Expression of germ cell genes in undifferentiated ES cell lines  
The three wild-type ES cell lines (EFC1, E14 and CGR8) examined all expressed 
high levels of Oct4, Nanog and Sox2 consistent with previous reports that these 
genes are highly expressed in ES cells (Nichols et al., 1998; Chambers et al., 2003; 
Avilion et al., 2003).  Sox2 and Oct4 have been shown to act together to drive the 
expression of a number of genes, the expression of which is associated with the 
maintenance of pluripotency (Okumura-Nakanishi et al., 2005), and they have been 
shown to heterodimerize and bind to the Nanog promoter (Rodda et al., 2005).  Sox2, 
Oct4 and Nanog are also expressed in early mouse germ cells (Scholer et al., 1990; 
Yeom et al., 1996; Yamaguchi et al., 2005; Yabuta et al., 2006; Western et al., 2005; 
Perrett et al., 2008).  Data from a recent study by Chambers et al. in 2007 in which 
chimeric mice were created from a mix of wild-type and Nanog -/- ES cell revealed 
that although the Nanog -/- cells were initially recruited to the germline, by e11.5 
germ cells were lost.    
 
In the current studies, the expression of both Oct4 and Nanog mRNAs decreased 
significantly when cells were differentiated after five days of embryoid body 
formation, although expression was not completely lost, consistent with results 
reported in a previous study (Geijsen et al., 2004).  After 5 days of differentiation, it 
has been proposed that the Oct4 and Nanog positive cells may be the developing 
germ cells (Geijsen et al., 2004). 
 
All three ES cell lines examined expressed Fragilis, Blimp1 and Stella mRNAs at 
reasonably high levels compared with total tissue extracts from embryonic mouse 
testis.  Other groups have reported expression of Stella and Fragilis in 
undifferentiated ES cells (Geijsen et al., 2004, Pain et al., 2005), and two studies 
have described the heterogeneous expression of Stella in ES cells (Payer et al., 2006; 
Carter et al., 2008).  Stella expression has also been shown to be downregulated upon 
differentiation of human ES cells (Clark et al., 2004; Payer et al., 2003).  The 
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expression of Fragilis, Blimp1, and Stella all decreased with five days of 
differentiation, suggesting that they are all genes associated with the pluripotent 
state.  Expression of Blimp1 has not previously been reported in undifferentiated ES 
cells but it is expressed in a large number of embryonic tissues (Vincent et al., 2005).   
 
In this study all ES cell lines examined expressed Mvh in the undifferentiated state, 
although at far lower levels than the adult mouse testis.  Interestingly, Mvh protein 
was easily detectable on Western blots prepared with extracts from all three ES cell 
lines.  One group has also reported the mRNA and protein expression of Mvh in 
mouse ES cell (Kerkis et al., 2007), while others have found undifferentiated ES 
cells to be Mvh negative (Toyooka et al., 2003), although differing cell lines and 
culture conditions could explain the variability in expression. Dazl mRNA has also 
been reported in undifferentiated mouse ES cells (Geijsen et al., 2004; Kerkis et al., 
2007) and Dazl protein has been immunolocalised to human ES cells (Clark et al., 
2004).    
 
Stra8 mRNA was expressed at low levels in the undifferentiated ES cell lines 
examined, and has previously been reported to be expressed in mouse ES cells 
(Kerkis et al., 2007), although expression did decrease after five days of 
differentiation.  All three ES cell lines also expressed Kit mRNA, Kitl mRNA and 
Hoxa1 at low levels.  Previous studies have reported that the expression of Hoxa1 
increases as ES cells differentiate (Atkinson et al., 2008), and our results mirrored 
these findings. 
 
Therefore the expression of genes associated with the germ cell lineage such as 
Blimp1, Fragilis and Stella has been demonstrated in ES cells.  The expression of 
later germ cell markers Mvh and Dazl has also been shown in undifferentiated ES 
cells, despite their absence from the ICM.  Additionally mRNAs for Kit and Kitl 
have both been shown to be expressed in ES cells. 
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6.4.2 Kit null cell express low levels of Blimp1, Fragilis and Stella  
One hypothesis of this chapter was that Kit signalling may be important for the 
expression of germ cell genes in undifferentiated mouse ES cells.  Microarray 
analysis revealed that Kit null cells, cultured in the presence of LIF, expressed 
several genes associated with the germ cell lineage at a lower level than the wild-
type (Bashamboo and Forrester, unpublished).  Results in this chapter confirmed that 
Blimp1, Fragilis and Stella mRNAs were all expressed at lower concentrations in the 
Kit null cell line compared with control E14s.  Notably concentrations of Oct4, 
Nanog and Sox2 mRNAs were indistinguishable between wild-type, heterozygous 
and null cells, in agreement with previous findings (Bashamboo et al., 2006).  
Heterozygous cells also displayed a significant reduction in Blimp1 mRNA.  
However, the low levels of Blimp1 expression in heterozygous cells appears not to be 
related to levels of Kit expression in the Kit heterozygous cells, as Kit mRNA is 
expressed in the heterozygous cells at comparable levels to the wild-type cells. This 
suggests that the significant reduction in Blimp1 expression observed in the null cells 
may also not be related to the loss of Kit.  This raises potential doubts about the role 
of Kit signalling on Blimp1 expression. 
 
The function of Blimp1 is not fully understood, but it may have a role in epigenetic 
reprogramming of germ cells as it has been shown to interact with Prmt5, an arginine 
specific histone methyltransferase in mouse germ cells (Ancelin et al., 2006).  
Blimp1 is thought to commit germ cells to the germ cell lineage by suppressing the 
expression of somatic genes, and inducing the upregulation of Stella and Sox2 
(Saitou et al., 2002; Yabuta et al., 2006; Kurimoto et al., 2008) (Chapter 1, 1.3.1.6).   
 
The expression of Hoxa1 was increased in the null cell line compared with the wild-
type cells.  This increased expression could be the result of loss of Kit or the 
reduction may be as a consequence of the reduced Blimp1 expression observed in the 
null cells.  Previous studies suggest that in germ cells, the Hox genes are 
downregulated as they become committed to the germ cell lineage and that Blimp 1 
may be involved in this (Saitou et al., 2002; Ohinata et al., 2005).   However, in the 
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heterozygous cells, although Blimp1 is significantly downregulated, Hoxa1 
expression is not upregulated, weakening the argument for a relationship between 
Blimp1 and Hoxa1 expression. 
 
Ideally further analysis has to be performed to determine if any other lineages are 
affected in the Kit null cells, other than just the germ cell lineage.  Although the 
array analysis of early cardiomyocyte, neuronal and adipocyte markers doesn’t 
suggest that there are any changes in these lineages, a more comprehensive analysis 
would be useful, as Kit signalling may simply act by controlling the aberrant 
expression of a number of transcripts in ES cells. 
 
Immunomagnetic bead sorting of the wild-type E14 and EFC1 cell lines using an 
anti-Kit antibody, resulted in a significant reduction Kit expression in the cells bound 
to the beads than those that were bound. This in agreement with the finding of others, 
that undifferentiated ES cells express Kit in a heterogenous manner (Lu et al., 2007).  
RNA analysis of these two cell populations in both cell lines showed that expression 
of Oct4, Nanog and Sox2 did not vary between the Kit ‘low’ and Kit ‘high’ 
populations.  However in a previous FACS sorting study by Lu et al. (2007), the Kit 
low/negative population have been shown to express significantly lower levels of 
Nanog.  In this study the expression of Blimp1 mRNA was significantly lower in the 
Kit ‘low’ population for both the E14 and EFC1 cells.    
6.4.3 ES cells may contain a germ cell niche 
Further study of the spatial distribution of germ cell gene expression in 
undifferentiated ES cells is required to understand the regulation of germ cell gene 
expression in ES cells.  Payer et al (2006) used Stella-GFP reporter ES cells and 
found that the Stella positive cells occurred in distinct subpopulations, possibly 
indicating that within an ES cell colony there are germ cell-like ES cells (Aflatoonian 
and Moore, 2006; Payer et al., 2006). We might speculate that Kit/Kitl signalling is 
important for maintaining these germ cell-like subpopulations of ES cells and this 
Chapter 6      Expression of germ cell associated genes in mouse ES cells 226 
would be consistent with the presence of the Kit positive and Kit negative cells in our 
cultures. 
 
As germ cells develop within a differentiating ES cell culture system, we assume that 
a niche is created, which resembles the normal in vivo microenvironment.  Studies 
have shown that the formation of male germ cells requires embryoid body 
differentiation and the use of a 2D culture system only results in the formation of 
female germ cells (Hubner et al., 2003; Kerkis et al., 2007).  It has been reported that 
within the differentiating embryoid body, male germ cells tend to form on the 
surface, while female germ cells form inside the embryoid body (Kerkis et al., 2007).  
Directed differentiation of male germ cells has also been reported with successful 
derivation of developing male germ cell occurring when ES cells are allowed to 
differentiate in the presence of both retinoic acid (RA) and testosterone (Silva et al., 
2008) or testicular cell-conditioned media containing cytokines such as BMP4 and 
GDF-9 (Lacham-Kaplan et al., 2006).   If it is the case that a ‘germ cell- like’ 
phenotype is enhanced by the Kit/Kitl signalling, one possible way of enhancing 
germ cell formation during differentiation is to supplement the media with Kitl.  
However, the addition of Kitl to ES cell cultures has been shown to have no effect 
(Lu et al., 2007) possibly because the ES cells are themselves are already producing 
Kitl (Lu et al., 2007). 
6.4.4 Conclusion 
The expression of several germ cell- associated genes in different ES cell lines has 
been analysed.  Wild-type cells express a variety of germ cell markers in the 
undifferentiated state, raising questions about whether there are cells within an 
undifferentiated ES cell colony that have begun differentiating down the germ cell 
lineage or whether ES cells express germ cell genes as a consequence of their 
pluripotency.  Some of these genes (Blimp1, Fragilis and Stella) are expressed fairly 
highly in the undifferentiated state, and decrease upon differentiation.  Other germ 
cell specific genes such as Mvh and Dazl increase upon differentiation, suggesting 
the germ cell-like cells could be forming after 5 days of embryoid body 
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differentiation.  Analysis of the immunomagnetically bead sorted population, with 
low levels of Kit gene expression, have shown that the cells exist as a mix of Kit+ 
and Kit- cells and that the expression of Blimp1 is downregulated in the absence of 
Kit.  In the Kit null cells, Blimp1, Fragilis and Stella are expressed at lower levels. 
This would suggest that Kit dependent signalling may have some degree of influence 
on the expression of these genes in ES cells.   
 
Although it cannot be directly inferred that these Kit null ES cells have a less germ 
cell-like phenotype it could be speculated that the Kit null cells ES cells may be less 
capable of form ES cell derived germ cells.  However, there are several questions 
which this study has not addressed, for example, the reduction in Blimp1 expression 
in the heterozygous cells may suggest that in the null cells the reduced expression of 
Blimp1 may not be the direct result of a loss of Kit signalling, and further studies on 
new Kit heterozygous and null clones are required.  Additionally, with the exception 
of Mvh, no protein expression for any of these germ cell genes was successfully 
detected within the undifferentiated ES cells.  One possibility is that within ES cells 
there are a number of abundant transcripts which are not translated into protein.  Kit 
signalling may control the trancription of a number of these transcripts, and a more 
comprehensive analysis would be useful as Kit signalling may simply act by 
controlling the aberrant expression of a number of transcripts in ES cells. 
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7 Final discussion  
Germ cells are responsible for the transmission of genetic material between 
generations.  During fetal life germ cells must be established from pluripotent 
precursor cells, migrate into the developing gonad, where they can downregulate 
pluripotency genes and develop down either the spermatogonial or oogenic lineage.  
In the female, germ cells in the fetal ovary stop dividing and enter meiotic prophase 
I, only to arrest at the diplotene stage (McLaren and Southee, 1997).  In the 
developing male gonad, germ cells undergo differentiation and mitotic arrest, but do 
not enter meiosis until puberty. The normal development of germ cells is crucial for 
future fertility, and, the abnormal differentiation of germ cells can result in malignant 
germ cell tumours (Skakkebaek, 1972; Rajpert-De Meyts, 2006). The activation of 
sex-specific genes in the somatic cells of the gonad is critical in determining the 
pattern of maturation of germ cells in the two sexes.  The majority of research into 
germ cell development during fetal life, and especially those studies aimed at 
understanding the role the somatic cells, has utilised rodent models.  However, 
studies which have focussed on germ cell development in the human fetus have 
shown that there are several key differences from the process occurring in rodents 
(Gaskell et al., 2004; Honecker et al., 2004).   The main objective of the work 
described in this thesis was to obtain a better understanding of human fetal germ cell 
development and the impact which the somatic cells have, primarily in the human 
fetal gonad.  In addition, data suggests that further insight into germ cell 
establishment and differentiation can be obtained by studies using embryonic stem 
(ES) cells (Toyooka et al., 2003; Geijsen et al., 2004; Hubner et al., 2003), therefore, 
a study exploring germ cell gene expression in mouse ES cells was conducted. 
 
The specific aims of the studies described were: 1) to further characterize the 
subpopulations of germ cells in the human fetal testis, by documenting protein 
expression patterns through the use of double fluorescent immunohistochemistry;  2)  
to determine whether the mechanisms leading to retinoic acid based regulation of 
meiotic initiation in the mouse fetal ovary and meiotic inhibition in the mouse fetal 
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testis, are conserved in the human fetal gonads; 3) To establish cultures of human 
fetal testicular somatic cells in order to further understand gene expression in the 2nd 
trimester human fetal testis; 4) To study the expression of germ cell genes in mouse 
ES cells and determine the role of the Kit receptor in the germ cell gene expression. 
7.1 Characterisation of germ cells in the human fetal testis  
Previous studies into germ cells in the human fetal testis have shown that distinct 
germ cell subpopulations can be identified based on their morphology (Wartenberg, 
1981) and their protein expression pattern.  Notably the ‘less mature’ OCT4 positive 
gonocytes and ‘more mature’ OCT4 negative prespermatogonia, can be found 
residing within one seminiferous cord during the 2nd trimester (Gaskell et al., 2004; 
Honecker et al., 2004).   
 
This current study has expanded on our previous knowledge of the protein 
expression profile of germ cells in the human fetal testis.  Through the use of double 
fluorescent immunohistochemistry, the OCT4-positive (gonocyte) population have 
been shown to express M2A, NANOG, AP2γ and DAZL.  The OCT4-negative 
prespermatogonia have been shown to express low/negative levels of M2A and 
AP2γ, while expressing some DAZL and high levels of VASA and NANOS1 
(summarised in Figure 7-1).  The confined expression of VASA to the 
prespermatogonial population was confirmed by Western blot, which revealed that 
VASA protein could not be detected in extracts from 1st trimester testis.  In the 2nd 
trimester testes, a  putative ‘intermediate’ germ cell population has previously been 
identified, these are cells that were thought to be undergoing the transition from a 
gonocytes phenotype into the prespermatogonia (Gaskell et al., 2004).  In the current 
study, germ cells were identified that had reduced immunopositive staining for 
OCT4 compared with adjacent gonocytes, and also had a low level of expression of 
VASA, a marker considered characteristic of the spermatogonial population.  
Although no single protein exclusively localised to the intermediate cell population 
was found, it was notable that these cells were also marked by a relocation of DAZL 
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from the nucleus to the cytoplasm.  These observations provide more evidence for 
the gradual differentiation which occurs in human fetal testicular germ cells. 
 
Figure 7-1 Summary of main findings regarding protein expression in human fetal 
gonocytes and prespermatogonia.  Grey text refers to data reported by Gakell et al, 
2004, black text refers to novel findings reported in this thesis. 
Strikingly, analysis of testicular germ cell tumour samples revealed that within 
tubules containing carcinoma in situ (CIS), the OCT4-positive CIS cells expressed 
low/negative levels of VASA.  Previous studies have described VASA as a CIS cell 
marker (Honecker et al., 2004; Zeeman et al., 2002), but its expression in relation to 
other proteins known to be expressed in CIS had not been investigated.  The findings 
in the current study therefore raise questions as to whether some CIS cells do express 
VASA or whether the VASA positive cells are ‘normal’ CIS cells confined to a 
tubule which contains OCT4 positive CIS cells.  If the OCT4 positive/VASA 
negative cells are the true CIS population, then this would suggest that CIS cells arise 
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from the gonocytes population, alternatively, the VASA positive/OCT4 negative 
cells may also be CIS cells that have undergone some degree of differentiation.  
Further analysis on a larger number of samples needs to be performed and it would 
be interesting to determine whether other mature markers, such as NANOS1, are also 
distinct from the OCT4 positive population.    Germ cell maturation takes place 
gradually over weeks, during this time, any adverse changes in the cellular 
environment might contribute to a failure of normal differentiation (i.e. predispose to 
CIS), and this may be the reason why humans have CIS and rodents do not. 
 
Previous reports have demonstrated that germ cells within the human fetal gonad 
proliferate throughout the 1st and 2nd trimester (Honecker et al., 2004; Murray et al., 
2000).  This study has confirmed and extended these finding by showing that Ki67 
positive germ cells are present throughout the 2nd trimester, and although towards the 
end of the 2nd trimester, proliferation appeared to decrease, this was not statistically 
significant.  It would have been interesting to study germ cell proliferation beyond 
the 19 week period examined as Honecker et al. in 2004 reported that germ cell 
proliferation persisted throughout the 3rd trimester.  Notably the current study has 
revealed that germ cell proliferation was not restricted to either of the two main germ 
cell populations, as both the gonocytes and prespermatogonia were immunopositive 
for Ki67.  Fluorescent immunostaining of 1st trimester testis revealed a large number 
of Ki67 positive germ cells, ideally it would have been useful to quantify the 
numbers of proliferating germ cells throughout the 1st trimester, however accurate 
identification of germ cells within the 1st trimester gonad proved technically 
challenging and subsequent attempts to use non-fluorescent dual staining for 
identification and counting were unsuccessful.  
 
This study has improved upon knowledge of protein expression patterns in germ 
cells of the human fetal testis and moreover, it has highlighted the similarities in 
germ cell maturation which occur between fetal male and female gonads (Anderson 
et al., 2007).  Both germ cells in the ovary, as well as the testis, show a similar 
overlapping pattern of expression despite some germ cells in the ovary entering 
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meiosis (Anderson et al., 2007).  In the ovary, OCT4 positive germ cells were 
confined to the peripheral cortex, while VASA positive cells were low/negative for 
OCT4 and were found in larger cells located towards the centre of the ovary 
(Anderson et al., 2007).  This study has also contributed to a parallel study on the 
common marmoset (Callithrix jacchus) (Mitchell et al., 2008).  The protein 
expression pattern found in the human was similar in the marmoset, and, as both 
species appear to display a similar slow germ cell differentiation, the marmoset may 
provide a good model for studying germ cell development, and this could be a future 
model of CIS (Mitchell et al., 2008). 
 
7.2 Factors regulating the control of meiotic entry in the human fetal 
ovary and testis  
Studies suggest that in the mouse, retinoic acid (RA) plays a key role in controlling 
meiotic entry.  In the developing mouse, RA appears to be released from the 
mesonephros, and in the female, possibly through direct signalling to the germ cells 
(Koubova et al., 2006; Bowles et al., 2006), RA appears to initiate meiosis, perhaps 
by upregulating Stra8.  In the mouse testis, although RA is also synthesised in the 
mesonephros, the expression of the enzyme Cyp26b1 in the testicular somatic cells 
ensures degradation of RA and blocks the signal for meiosis (Koubova et al., 2006; 
Bowles et al., 2006).  The present study sought to determine if RA activation was 
also likely to operate in the human fetal gonad by examining the expression of 
enzymes and receptors involved in RA biosynthesis and action.   
 
To date, there have been no published reports documenting STRA8 expression in the 
human fetal gonads.  This study has shown that total concentrations of STRA8 
mRNA were significantly higher in extracts of ovary than testis between 14-15 
weeks gestation.  Notably this is the time when female germ cells are entering 
meiosis, suggesting that the functions of STRA8 may also play a critical role in 
human gametes as has been suggested by studies in the mouse (Menke et al., 2003; 
Baltus et al., 2006; Koubova et al., 2006).  These studies would have been enhanced 
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if the specific cells within the human fetal ovary expressing STRA8 could have been 
identified either using in-situ hybridisation or immunohistochemistry, in order to 
determine whether STRA8 was restricted to the premeiotic germ cells, as has been 
reported in the mouse.  However, no specific antibody was available and further 
optimisation is needed of in-situ hybridisation methodology.  Additionally, analysis 
of cell-specific expression of meiotic markers such as SYCP3 could provide an 
additional marker when studying the spatial distribution of germ cells in the human 
fetal ovary as they enter meiosis, since current information is based only on size and 
gross appearance.  Recent studies in the mouse suggest that Nanos2 may play a role 
in the suppression of Stra8 in the male (Suzuki and Saga, 2008) and our novel 
finding that expression of NANOS2 mRNA was restricted to the human fetal testis 
would be consistent with this idea, but again a limitation with this study is the fact 
that the identity of the cells within the fetal testis expressing NANOS2 was not 
determined and therefore further validation is required on testes sections. 
 
In support of the hypothesis that RA may have an impact on germ cell maturation in 
the human as well as the mouse, all RARs and RXRs were found to be present during 
both the 1st and 2nd trimester in both the human fetal ovary and testis.  Furthermore, 
protein expression of RARα, RARβ and RXRα were demonstrated in both the germ 
cells and somatic cells in both sexes.  This is in agreement with studies in the rodent 
where germ cells and somatic cells of the testis and ovary are immunopositive for 
many of the RA receptors (Boulogne et al., 1999; Morita and Tilly, 1999).  To our 
knowledge this is the first study examining RA receptor expression in the human 
fetal gonad.  Interestingly, the receptors RARα, RARβ and RXRα were 
immunolocalised to the cytoplasmic compartment of a number of cell types, as well 
as the nuclei of other cells.  Cytoplasmic staining was particularly prevalent in 
female germ cells, suggesting that they may be awaiting targets for stimulation by 
RA (Morita and Tilly, 1999). 
 
In the mouse, the mesonephros has been suggested as the likely site of RA 
biosynthesis (Bowles et al., 2006).  In this study although the human mesonephros 
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was found to contain the mRNAs for two enzymes involved in RA biosynthesis, the 
concentrations appeared to be lower than the amounts in gonadal extracts.  However 
since the retinaldehyde dehydrogenase enzymes are only a small part of a larger 
biochemical pathway leading to the production of RA, simply comparing the levels 
of transcript between tissues cannot be considered as a comprehensive method for 
determining the amount of RA produced by the cells.  Therefore a reporter cell line 
was employed to assess whether RA was released by the mesonephroi or produced 
by the gonads.  Disappointingly the initial studies have failed to yield conclusive 
results and questions exist about the sensitivity of the cell line.  Another potential 
method for measuring the levels of RA within tissues is through the use of high 
performance liquid chromatography (HPLC) (Kane et al., 2008).  Future studies will 
explore whether this method would allow a complete chemical analysis of the levels 
of RA in the developing ovaries, testes and mesonephroi. 
 
In the mouse Cyp26b1 is expressed at high levels in the testis at e13.5, at the time 
when germ cells in the ovary are entering meiosis (Koubova et al., 2006; Bowles et 
al., 2006).  In the present study, analysis of the concentrations of CYP26B1 mRNAs 
found in the developing human gonad actually suggests that total amounts are higher 
in the ovary than the testis.  In the mouse Cyp26b1 mRNA has been localised to the 
Sertoli cells and PTM cells of the testis using in-situ hybridisation (Koubova et al., 
2006; Bowles et al., 2006).  In our study we have as yet not been able to localise the 
expression of CYP26B1 mRNA or protein to specific cell types in the human fetal 
gonads.  A full understanding of the role of CYP26B1 will require that we ascertain 
the cell types within the developing ovary and testis that express CYP26B1.  
Additionally, no studies in the mouse have reported localisation of Cyp26b1 protein 
and studies into the protein expression patterns of CYP26B1 in both the mouse and 
human are vital in order to demonstrate any potential function.   
 
A number of groups have reported effects of RA on germ cells in vitro (Koubova et 
al., 2006; Bowles et al., 2006; Koshimizu et al., 1995; Morita and Tilly, 1999).  For 
example, RA treatment is reported to induce a decrease in expression of Oct4 and an 
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upregulation of Stra8 in intact gonads and upon incubation with a RA antagonist, the 
opposite occurs (Koubova et al., 2006).  In order to obtain a better understanding of 
the role of RA within the human fetal gonad, it would be useful to perform 
treatments on gonadal cells or explants in vitro.  For example, it would be interesting 
to determine whether RA has any direct effect on gene expression in germ cells in 
the human fetal ovaries and testes, and what effect treatment with the cytochrome 
inhibitor ketoconazole or a RA receptor antagonist has on germ cell development.   
 
The total amount of SDMG1 mRNA, was higher in the testes than in the ovaries, 
particularly towards the later part of the second trimester.  The transmembrane 
protein SDMG1 is believed to be part of a large network of proteins which control 
the release of peptides (Best et al., 2008).  It has been proposed that Sdmg1 plays a 
vital role in the control of molecular release from the Sertoli cells in the mouse, at the 
time when germ cells are committed to the male lineage, preventing meiotic entry.  
In our study, expression of, SDMG1 appeared to be upregulated in the testes late into 
the second trimester (18-19 weeks).  The time when germ cells commit to the male 
lineage is unknown, but is estimated to be between 8-11 weeks gestation.  A 
comprehensive analysis of protein expression and cellular localisation must be 
performed to give further insight into SDMG1 function in the human fetal testis.  
Further analysis of proteins associated with membrane trafficking would be of 
interest, to determine whether these genes are upregulated in the Sertoli cells of the 
human fetal testis. 
7.3 Establishment of cultures of human fetal testicular somatic cell   
From the studies described above, and also other data, including that on the 
functional maturation of Sertoli cells (Brennan and Capel, 2004), the somatic cells of 
the testis play a key role in modulating germ cell fate (Palmer and Burgoyne, 1991).  
Studies analysing gene expression in the somatic cells of the human fetal testis are 
limited.  One potential method for studying the somatic cells is through in vitro 
culture, but as yet there have been no reports in the literature of the successful in 
vitro culture of somatic cells from the human fetal testis. 
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The principle aim of this part of the study was to establish a culture system for 
testicular somatic cells so as to provide a tool allowing for the characterisation and 
modulation of gene expression.  Analysis of the levels of expression of mRNAs of 
Sertoli cell specific transcription factors, SRY and SOX9, revealed that these were 
detectable in cells from all 5 passages of cultured cells, although the expression of 
both decreased with increasing passage number.  However, expression of other 
Sertoli cell genes, AMH and DHH are almost immediately downregulated.  These 
data suggest that the Sertoli cells are surviving in the cultures but with an altered 
phenotype, and may have reverted back to a more primitive state, expressing only the 
earliest markers of Sertoli cell differentiation.  Despite the loss of AMH expression, a 
number of genes implicated in the control of AMH transcription (reviewed by Lasala 
et al., 2004) were found to be present within the cultures, including SRY and SOX9 
and also SF1 and GATA4, and this warrants further investigation.  Also detectable 
within the cultures were mRNAs for the Leydig cell markers, 3BHSD and SCCp450, 
however, expression of these genes was almost completely lost by passage 2, 
indicating an early loss of differentiated/functional Leydig cells.   
 
In contrast to the decrease in gene expression observed for the Sertoli cell markers 
and the Leydig cells markers, total expression of mRNAs normally detected in 
PTM/Fibroblasts appeared to increase in cell extracts.  This suggested that within the 
cultures that were initially established as a mixed population of somatic cells, 
overgrowth by fibroblasts was occurring.  Interestingly, AR was expressed both 
within the cultures and in fixed human fetal testis sections, where it was 
immunolocalised to both the fibroblast and PTM populations within the interstitium.  
Although we predict that these were the two cell populations that were increasing as 
a proportion of the total cell population in the cultures, AR mRNA concentrations 
decreased.  This suggested to us that the PTM/fibroblast population were also 
dedifferentiating within the cultures, despite the stimulation by DHT.  DHT was 
supplemented to the media to mimic the in vivo environment and in order to maintain 
the PTM population.  However in doing so, DHT may have positively selected for 
the fibroblast population, aiding their overgrowth.  With hindsight, an initial 
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experiment should have been performed comparing gene expression following 
treatment with DHT with untreated cultures, rather than supplementing the media 
with DHT in all cases.   
 
Passaging the cells with dispase rather than trypsin resulted in a slight improvement 
to the survival/phenotype of Leydig cells and Sertoli cells, but for only a short period 
of time.  The cells in the cultures were found to express the activin receptor subtypes, 
and this would be consistent with reports that a variety of cells within the human 
fetal testis express all of the required components for activin signalling and 
production (Majdic et al., 1997; Anderson et al., 2002).  However treatment with 
activin A caused no alteration in gene expression in the cultured cells.  These 
negative results may be because activin was incapable of signalling within the 
cultured cells or because activin induced no effects on the expression of genes 
analysed (AMH, DHH, SOX9 and SMA).  Further experiments are required to 
investigate the potential for activin signalling by analysing whether the cells 
expressed the protein of the activin receptors and whether treatment with activin 
could induce any phosphorylation of SMAD proteins, but due to limited tissue and 
time, this was not performed. 
 
A more comprehensive analysis of protein expression within these cells would also 
be beneficial.  SOX9 and GATA4 were both immunolocalised to subpopulations of 
the cells, however it was never determined whether these two proteins were 
expressed within the same cell type.  By performing dual staining to analyse this, 
more information would be obtained on the gene expression in the Sertoli cells, since 
GATA4 was also expressed in the PTM/fibroblast population. 
 
A common problem with primary tissue culture is the overgrowth by fibroblast 
(Singer et al., 1989).  The culture system could perhaps be improved if methods for 
removing or reducing fibroblasts are performed.  Fibroblast growth is enhanced in 
serum-containing media, so a strategy of optimisation of the culture of these cells in 
serum-free media may have proved useful at reducing fibroblast numbers.  There are 
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several reported methods for elimination of fibroblasts such as selective 
trypsinization (Harris, 1996) or their isolation using cell sorting procedures (Saalbach 
et al., 1997), and future experiments could attempt these methods. 
 
Further work must therefore be performed to try and maintain the differentiated 
phenotype of the cells.  Improved culture of somatic cells may also be achieved 
through culturing the cells on a basement membrane, for example with laminin or 
matrigel.  There are reports of reasonably successful culture of rodent Sertoli cells 
when they are cultured on an extra-cellular matrix (ECM) (Gassei et al., 2006).  
Others have made progress in culturing mouse ovarian tissues and neonatal testis in a 
3D cultures system with a ECM such as matrigel or sodium alginate (Xu et al., 2006; 
Hadley et al., 1985; Noguchi et al., 2006; Gassei et al., 2006).  It would be interesting 
to see if when subjected to this sort of environment, if human fetal testicular somatic 
cells maintained a normal phenotype for longer.  The ultimate aim with this study 
would be to generate a culture system where somatic cells are remixed with germ 
cells in order to support their development and/or determine those Sertoli cell or 
PTM cell factors critical for germ cell maturation. 
 
7.4  Expression of germ cell genes in mouse ES cells and the role of 
Kit  
One of the principle aims of this part of the project was to characterise the expression 
of genes normally considered to be germ cell specific in mouse ES cells, prompted 
by several reports claiming successful establishment of germ cells from ES cells 
(Geijsen et al., 2004; Pain et al., 2005; Kerkis et al., 2007; Hubner et al., 2003); 
although it is notable that several groups have also reported the expression of early 
germ cell marker in undifferentiated ES cell cultures (Toyooka, et al, 2003; Geijsen 
et al., 2004; Reviewed by Zwaka et al, 2005).  The mRNAs for genes such as 
Fragilis, Stella and Blimp1 was consistently detected in all three cell lines.  Although 
others have reported the expression of Stella and Fragilis in ES cells (Geijsen et al., 
2004; Pain et al., 2005), to our knowledge this is the first report of Blimp1 
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expression.  Upon embryoid body differentiation, expression of these genes 
decreased, along with the pluripotent genes, implicating Fragilis, Stella and Blimp1 
with the pluripotent state.  The expression of slightly later germ cell markers, Mvh 
and Dazl was also demonstrated in all ES cells, although at much lower levels than 
adult mouse testis. One limitation of this part of the study was that mRNA was 
analysed from whole ES cell cultures.  It would be exciting to look at the spatial 
expression of genes such as Blimp1 and Stella throughout the cultures, and determine 
through the use of immunohistochemistry, whether distinct subpopulations within the 
cultures express these genes at the protein level.  For example it would be interesting 
to investigate whether the Blimp1 positive cells within the cultures also expressed 
Stella and Fragilis. 
 
The expression of both Kit and Kitl mRNAs has confirmed previous studies which 
have detected both of these mRNAs in ES cell cultures (Bashamboo et al., 2006; Lu 
et al., 2007).  Previous studies suggest that Kit/Kitl signalling plays an important role 
in modulating gene expression in ES cells during the early stages of differentiation.  
In ES cells null for the Kit receptor, microarray analysis pointed to several genes 
important for the early stages of germ cell differentiation to be downregulated, 
namely Blimp1, Fragilis and Stella (Bashamboo and Forrester, unpublished).  To 
determine whether sub-populations of ES cells enriched or lacking expression for the 
Kit receptor could be obtained, immunomagnetic bead sorting using an antibody 
directed against Kit was performed.  Cells bound to the immunomagnetic beads 
displayed a significantly higher expression of the Kit mRNA compared to those that 
were unbound confirming that the cell-sorting had been successful.  In a comparison 
of the levels of expression of pluripotency genes between the bound and unbound 
population of cells, levels of Oct4, Nanog and Sox2 were found to be similar, and it 
was concluded that Kit signalling was not required to maintain the pluripotent state 
of ES cells.  This is in agreement with the findings of others (Bashamboo et al., 
2006; Lu et al., 2007).  Analysis of the Kit ‘high’ and ‘low’ populations may have 
been improved if fluorescent activated cell sorting (FACS) had been performed 
instead of the immunomagnetic beads.  FACS may have allowed for a purer 
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population of cells to be obtained and flow cytometry would also have been a useful 
way of quantifying the number of cells expressing Kit in these cell cultures.  In the 
Kit ‘high’ population of cells, Blimp1 was found to be significantly higher than in the 
Kit ‘low’ cell population.  The expression of Fragilis and Stella was also found to be 
reduced slightly in the Kit ‘low’ population.  These results were enhanced by 
analysis of a Kit null ES cell line (summarised in Table 7-1).  The expression of 
Blimp1, Fragilis and Stella were all reduced significantly in the null cells compared 
with the wild-type.  Heterozygous cell also showed decreased expression of these 
genes.  More mature germ cell markers such as Mvh and Dazl appeared to be largely 
unaffected by the lack of Kit.  Interestingly, despite the absence of Kit in the null ES 
cells, Kit ligand expression was normal.  This shows that in the ES cells, Kit ligand 
expression is not under the control of its receptor.   
 
One key prerequisite for the successful establishment of the germ cell lineage in vivo, 
appears to be the suppression of the somatic cell program, and cells destined to 
become germ cells, downregulate genes associated with the somatic cell lineage 
(Saitou et al., 2002; Ohinata et al., 2005).  In this study Hoxa1 was found to be 
higher in the Kit null and Kit ‘low’ cells, which could perhaps support the hypothesis 
that they are less germ cell-like, however, analysis of other genes such as Hoxb1, 











Table 7-1 Summary of germ cell gene expression in Kit null ES cell lines 
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In addition to the null cell line, Bashamboo et al., 2006 also generated an inducible 
cell line, where the ES cells carried a null allele of Kit Wlacz and a knock-in allele 
WFKB-kit, encoding a Kit ligand-independent hybrid receptor that becomes activated 
upon stimulation by the drug AP20187, which acts by binds the FKB receptor.  
Treatment with this drug has previously been shown to rescue the Kit null cell 
phenotype (Bashamboo et al., 2006).  Studies using the inducible cell line would be 
useful to verify the findings of the current study on the Kit null cells and critically 
whether the drug would cause the cells to upregulate their expression of Blimp1, 
Fragilis and Stella, confirming them as down-stream of Kit functional activation.  It 
will be necessary to repeat the RT-PCR analysis on this inducible line to ensure that 
the altered phenotype of the null cells we studied is not as a result of clonal effects, 
however in a set of array data, the cell line containing the knock-in allele WFKB-kit, 
also display reduced expression of Blimp1, Fragilis and Stella (Bashamboo and 
Forrester, unpublished). 
 
In order to fully understand the effect of Kit signalling on germ cell formation from 
ES cells, ES cell-derived germ cells need to be created from the mutant ES cells.  
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However, this would be difficult given that the Kit null cells die by apoptosis 
following LIF withdrawal (Bashamboo et al., 2006).  In order to study germ cell 
formation in the differentiating Kit null cells, embryoid bodies would need to be 
allowed to form in the presence of LIF, allowing mutant cells to survive the early 
stages of differentiation due to the presence of LIF, using the system previously 
described by Geijsen et al., 2004.   The hypothesis of the involvement of Kit/Kitl 
signalling controlling germ cells formation from ES cells is based solely from the 
data presented in this thesis, and that there is no in vivo data pointing to a role of 
Kit/Kitl in germ cell formation, as germ cells do initially form in embryos deficient 
in Kit and Kitl. 
 
ES cells consist of subpopulations of cells that exhibit distinct gene expression 
profiles (Hayashi et al, 2008).  Kit signalling is unlikely to be important for 
maintaining pluripotent stem cells within the ES cell culture, as Nanog, Sox2 and 
Oct4 expression is normal in the Kit null cells and the Kit low cells.  Kit signalling 
however may be important for the maintainance of differentiated cells present within 
the cultures.   Germ cell gene expression within the ES cell cultures may reflect 
distinct subpopulations of cells, rather than the homogenous expression of germ cells 
markers in ES cell cultures.  An example of this is Stella, which has been shown to 
be expressed in a subset of ES cells (Hayashi et al, 2008; Payer et al, 2006). 
 
7.5 General Conclusions 
In conclusion, results obtained during the current study have enhanced our 
knowledge of fetal germ cell development and differentiation, and the potential 
impact of the somatic cells. Further characterisation of protein expression patterns in 
germ cells of the human fetal testis has been performed and proteins have been 
shown to localise exclusively to the gonocytes population, while other proteins have 
been shown to be restricted to the prespermatogonia.  This study also raises questions 
about whether the proposed model controlling the meiotic entry of germ cells in the 
mouse can be applied to the human, several genes known to be expressed in a sex-
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specific manner in the mouse, have shown a similar pattern in the human, but other 
genes involved in RA production and metabolism appear to show a different 
expression pattern in the human.  The in vitro culture of human fetal somatic cells 
may lead to further understanding of gene expression in the human fetal testis and 
could potentially lead to studies on germ cell-somatic cell interaction, while data 
suggests that the Kit/Kitl signalling system may control the expression of early germ 
cell genes in mouse ES cells. 
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